CellTherapy-Peptides

PURPOSE The purpose for writing FOREVER YOUNG, The Secret to Health and Anti-Aging, is to educate the general public, members of the medical community and those who want to stay young and healthy, with basic knowledge concerning the technology, on what is commonly called, by the public as, “Cell Therapy”. This book will also discuss other breakthrough products, as well as, health habits that we believe are paramount for any person to stay young and healthy throughout life. It is designed and geared to the average person, who may know a lot, or nothing, about basic health and/or Cell Therapy. FOREVER YOUNG is not a technical book, but mainly a compilation of the knowledge gained during the past 28 years, while working in the health industry with some of the pillars of the Health Community, including Alternative Medicine doctors, Integrative Medicine doctors, the greatest doctors in the Anti-Aging field and the doctors, PhD’s and laboratory technicians, who have been, for the last seventy years, working in labs to develop these incredible, unique products. It has been my privilege and honor to be on both sides of the equation of the miracle process simply called “organotherapy” and to be involved with the best products of this type in the world today. Truly, I have been blessed. It was my goal twenty-eight years ago to bring Organotherapy to the masses. It is just too good, for just, the rich and famous. This is the beginning of that goal. I hope this simple book will give you an understanding, not only of Organotherapy, but other cutting-edge high-tech products available today, and will help to keep you as young and healthy as you can be, for as long as you can be. It is never too late. Start TODAY! Thank you, Sincerely and Incredible Health to you, Jean Berry
Copyright (c)Jean Berry 2009. Official Copyright Applied For
All rights reserved. This book may not be copied in full, or in part, without written permission from Jean Berry, for the purpose of information and education. It may not be copied or printed, in part or in whole, for any commercial purpose without the express written approval of Jean Berry. Disclaimer: The entire content of this book is based upon the opinions and working knowledge of Jean Berry. The information is not intended to replace medical advice. It is intended as a sharing of knowledge and information from the research and experience of Jean Berry and her experience of 28 years working with Organotherapy in the alternative health community. Your comments, suggestions and questions will be appreciated. This book may be downloaded for $12.95 at www.sysociety.com. A printed copy may also be ordered for $27.95 plus $ 4.95 shipping. Wikipedia: Permission is granted to copy, distribute and/or modify this document under the terms of the GNU Free Documentation License, Version 1.2 or any later version published by the Free Software Foundation; with the Invariant Sections being LIST THEIR TITLES, with the Front-Cover Texts being LIST, and with the Back-Cover Texts being LIST A copy of the license is included in the section entitled "GNU Free Documentation License".

B

INTRODUCTION What if you were told about one of the best kept secrets in the world? What if you knew, this secret, up until now, has only been known by a very few doctors and the rich and famous? And it is so powerful, that your government does not want you to know about it. What if you knew there is a way to help: Enhance immune function Improve memory and cognitive ability Remodel body musculature Reduce total body fat Enhance libido Increase rate of wound healing Increase aerobic capacity Enhance sports performance Increase muscle mass Grow hair And most Important, reverse the progression of “deterioration and ill health”. What if you knew that this secret does not utilize drugs, hormones or RX medications of any kind? What if you could improve eye sight, improve memory, improve cardiac function and look and feel 15 to 20 years younger? What if you knew, that this book would give you the specific programs that were just mentioned and tell you the products, that you need, to keep you, healthy as you can be, for as long as you live. Please continue……

C

Only the Best for Me… J.B., and my Dogs. A True Story:

Jean Berry

My mother was absolutely obsessed with looking good and staying young. She was a beautiful woman. My brother was in the Navy in Key West. I was sixteen and I had never driven a car beyond the corner and back to the dead end of the street where we lived, when mother was not home. My mother was also courageous. We left Oak Ridge, Tennessee, in my brothers ’42 Mercury, on our way to Miami. I was too young to have a drivers license and mother did not know how to drive. I was driving. She said, “Don’t worry. We will make it.” And we did. The one thing I remember most was driving West of St. Augustine for about forty miles to “The Fountain of Youth”, that a waitress at a diner told us about. Mother insisted that we had to bathe in “The Fountain”, that supposedly was discovered by Columbus when he first discovered America. She got right out of the Mercury, jumped into the fountain, clothes and all, threw her arms into the sky and said, “now we will stay young forever!”. I can see her today, as if it was yesterday. Throughout the years, many things happened. My grandmother had a severe stroke. My grandfather died from TB. I was hit by a car and the doctors wanted to amputate my leg. My mother refused, “if you cut her leg off, you may as well let her die”. My mother died from a heart attack. I had an operation on my right wrist to remove a ganglion resulting in severe nerve damage so bad, that the next year was spent trying to find a way to eliminate the pain. During that year, I was taking two percodans, three or four times a day, and carrying my right arm around on a pillow. The torture that traditional doctors put me through was absolutely atrocious. If I wrote the details, you would not believe it. I knew there had to be a better way. One day, my fourteen-year-old son, John, came home with a loaf of bread from a health food store that cost .78 cents (white bread was .12 cents) and a book by Adele Davis, Let’s Get Well. Then someone gave me a copy of Prevention Magazine, with an article by Jonathan Wright, M.D., How to Cure Carpal Tunnel Syndrome. I realized I had found the better way and my life has never been the same. My crusade had begun. Years later, while visiting a girlfriend and her husband in New York, their neighbors in the next apartment called to invite us to meet their house guest, a doctor from France, “who had the Fountain of Youth”. I was the first one out the door. The doctor had a product called “cell therapy” and he wanted a U.S. agent. My crusade was underway. That was twenty-seven (yes, 28) years ago. I am now 79 years old and I have reached my goal of bringing cell-therapy, health and youth, to the masses. I still see mother jumping into the Fountain, clothes and all, “Now we will stay young forever!” I have never forgotten it and I am, “Leading the Race to Stay Young Forever”. Actually, to stay Young and Healthy. Mother would be proud. P.S. Jonathan Wright is still my idol and now a very good friend. I truly believe it was my fate to do what I am doing. Perhaps all my medical problems were leading me to Cell Therapy…..AND you. D

First things first:

FRED KALFON

It all started for me fifteen years ago. I was fifty years old then, in pretty good shape and led a very active life style. It was September first, 1992 and I was involved in a serious motorcycle accident, broke several bones and had some internal injuries. I healed rapidly, except for my navicular, which is a small bone in the wrist. The navicular has a very poor blood supply. I was told by my orthopedic surgeon that I would need bone grafts; that only very young children can heal from an injury such as this; as they still have active bone growth-factors circulating throughout their body. Along about that time, I was introduced to one of the most amazing women that I have ever met. Her name was Jean Berry and she had a small company that sold embryonic organ dietary supplements. These products consisted of embryonic porcine (pig) specific cell tissue. I purchased embryonic organ bone dietary supplements and followed a program given to me by a doctor, who was familiar with Life Cell Therapy (Embryonic Organo Therapy or EOT) The bottom line, I completely healed three weeks faster than a 12-year old could heal. My orthopedic surgeon could not believe it. Jean Berry and I have been close friends and business associates ever since. Since then, one EOT program I take on a regular basis, (every six months) is Male Over 60 Program, and I can tell you, from personal experience, that it gives me a boost in energy, cognitive function, it seems to improve my vision and hearing, and there is no question that it has increased my libido. Typically, I get up at 6:00 am and go to bed between 12:00 am to 1:00 am. I am never tired, and for the most part, I am always in a good mood. I am slow to anger and have a general sense of well-being. This program consists of, 1 Combo Organ and 3 Individual Organs a week for four weeks. I do this twice a year. I have listed this program below so you can see how simple it is. Each week, I take 1 bottle a day for 4 days. You can see the organs below. In weeks 1 and 3, Embryonic Energy Combo, Placenta, Kidney and Liver. In weeks 2 and 4, I take the Embryonic Immunity Combo, Testicle, Embryo Total and Spleen. Then, I do it again. Does it work? Oh, YES! MALE OVER 60 + 4 Combos
Oral Program Schedule (OP)

Weeks 1 and 3
Day 1 Embryo Energy Co 3 Placenta 5 Kidney 6 Liver

Weeks 2 and 4
Day 1 Embryo Immunity Co 3 Testicle 5 Embryo Total 6 Spleen

Weeks 5 and 6
Rest and Evaluate

Weeks 7 thru 10 Repeat 1 thru 4 If Desired

Plus 10 ML’s Liquid Organic Silica 2 times per day on an empty stomach

E

Table of Contents
Topics Page

1 INTRODUCTION TO CELL THERAPY……………………………….…… Historical Evolution of Cell Therapy……………………………..….. 2 What is Cell Therapy and What does this Mean to You and 2 Your Health…………………………………………………………………… American Pioneers in Cell Therapy and a Brief History………… European Pioneers in Cell Therapy and a Brief History…….….. 8 9

The Good News, and the Bad News……………………………………10 And the Good News. ………........................................................... 15 Individual Embryonic Organ Supplements……………………….... 15 Combination Embryonic Organ Dietary Supplements…………… 28 Embryonic Tissue Groups and Order of Taking………...……….. 34

Simple Rules: To Do and Not To Do…………………….…………. 36 Organs Used in Important Combinations…………………………. Oral Liquid Embryonic Organ Supplements are Effective……... 36 38

General Information for Anti-Aging………………………................ 39 Reasons for Taking Cell Therapy…………………………………… 40

41 Decide on a Lifetime Anti-Aging Program.……………………………… Good, Better and Best Programs…………………………………… Programs/ Suggestions for Specific Health Conditions Abbreviations and General Maintenance Programs…………….. 55 62

F

Table of Contents Page Two
Topics Page

64 Your Wonderful Companion Pets and Animals…………………………. Animal Patients Photos : Baby – Duncan MacLoad – Hershey And Her Colt – Simba in Retirement – Prairie Cat Refuge 65

Special Formulations for Small and Large Animals………….….. 73 General Programs Small Animal Organ Dosage………………………………………..... 77 Liquid Organic Silica ………………………………………………….. 78 Testimonials………………………………………………………………. 84 EOT ……………………………………………..…...................... 84 Organic Silica………………………………………………………92 Frequently Asked Questions…………………………………………….96 Authors Notes……………………………………………………………..100 104 Recommended Health Websites………………………………………..…... Disclaimer…………………………………………………………………. 105 Glossary…………………………………………………………………….106 References by Footnotes……………………………………………… 139 140 General Bibliography…………………………………………………….. License Agreement on Wikipedia content………………………….. 178

INTRODUCTION TO CELL THERAPY
Cell therapy is the administration of specific peptides, or processed cells from specific organs, to improve specific human health problems and prevent further deterioration of the target organs and organ systems. The aim of cell therapy is to replace, repair or enhance the function of damaged tissues, or organs. The cells used can originate from the patient, or from a donor, or from another species. Other sources include cell lines and cells from patients' tumors, to make cancer vaccines. More recently, research with cell products has expanded to replace some conventional procedures. For example, bone marrow transplants are being replaced by peripheral blood stem cell transplants. Still, most of the interest in cell therapy centers on stem cells. The reason for the surge of interest in cell therapy is, that this natural form of product often results in long-term, or even permanent, return to natural body function, whereas; chemical treatment is temporary at best. A diabetic can only roughly control their blood sugar with insulin, even if he injects it often, even multiple times daily. But if the body will accept a graft of pancreatic islet cells, the pancreatic cells will join together with the pancreas and the pancreas will react instantly to changes in blood sugar concentration and secrete just enough insulin to maintain normal levels. Even after almost eighty years of cell therapy, as practiced throughout Europe, amazing results are still being discovered. Recently, a study was performed on diabetic induced mice, to determine if spleen would offset allergic reactions to pancreatic processed cells, injected from other mice.1 The injection of the spleen actually cured the diabetes. The pancreas began to produce islet cells and normal levels of insulin after the spleen was injected. So amazed were the study investigators, that they performed this same process twelve times, once with radio active male spleen, into female mice. All twelve times, the results were the same. The diabetes condition was cured, but there still is no understanding, or explanation, why spleen will have this effect on the pancreas. And therein lies the perfect example of “we know it works, but we do not know how, it works. In our business, we have known for many years, that if you take an embryonic organ supplement of one of the three embryonic tissue groups, either ectoderm, endoderm or mesoderm there will be an 80 to 85% effect on the target organ that is taken, PLUS, a 15 to 20% soft effect on the balance of the other organs in the same embryonic tissue group.2 For example, if brain, which is ectoderm, is taken, it will also have a soft improvement on the other ectoderm organs; bone, eye, hypothalamus, pituitary, skin and spine. This, perhaps, is one reason why there is a feeling of well-being and contentment when taking embryonic organ supplements.

1

Historical Evolution of Cell Therapy
The concept of cell therapy has been around for many years. It is a modern equivalent to the monkey-gland injections that were used one hundred years ago, for the treatment of impotence. During the years, many labs have developed a process for a product they call “cell therapy”. Since it is a natural product, there can be no patents, and consequently, every product, from every laboratory, is different. The only protection they have is to keep their process secret. And there truly is no protection for the consumers, as to whether, or not, they are buying a “cell therapy” product, that is what they think, or believe it is. There are even capsules sold as “cell therapy” and certainly there is nothing active in a powder. There are also clinics in different parts of Europe, that claim to slaughter a specific sheep for specific clients, or patients, overnight or in a day, and then administer up to 10 individual organ concentrates, to the client. It is impossible to perform a process, such as this, that is safe, sterile and in a form to be injected in a days time. Two very important German athletes died from taking this type of product a few years ago. This is the exact reason that Germany quickly made new laws that only allows this type of product to be produced, if it is either lyophilized (freeze-dried) or pasteurized. There is nothing left that is active in either of these processes. Most of the clinics that processed organs specifically for patients now use reconstituted lyophilized powder. This is well accepted by the patients, as the reconstituted lyophilized powder mixed with saline solution, does have an action on the tissue, that can be felt and seen in visible organs in a short period of time, BUT, it does not have the ability to revitalize or rebuild, as all of their biological activity has been destroyed. It also has to be administered every six months, as the effects are temporary.

What is Cell Therapy and What does this Mean to You?
In order to understand EOT, you should know some general information about commonly called “cell therapy”. The basic theory behind cell therapy was stated best by Paracelsus, a 16th-century physician who wrote: "Heart heals the heart, lung heals lung, spleen heals spleen; like cures like." Paracelsus, and many other early physicians, believed, that the best way to treat illness was to use living tissue to rebuild and revitalize ailing or aging tissue. Modern 2

orthodox medicine lost sight of this method, so it now uses chemicals to interrupt, or override, living processes. While chemicals and drugs work, only until they are broken down by the body's metabolic processes, organ therapy has a long-term effect, because it stimulates the body's own healing and revitalizing powers. Doctors, who practice cell therapy, believe that cell therapy acts like an organ transplant and actually makes the old organ "act younger." This biological "lesson" is not quickly forgotten by the organs. In Europe, the effectiveness of cell therapy is widely accepted. In West Germany, for example, more than 5,000 German physicians regularly administer different cell therapy programs. A great proportion of those programs are funded by the West German social security system. Several million patients, the world over, have received cell therapy programs since the mid-1950's. A Swiss physician, Paul Niehans, discovered the beneficial effects of cell therapy quite by accident. In 1931, Niehans was summoned by a colleague who had accidentally removed a patient's parathyroid glands during the course of thyroid surgery. So vital are these glands to life, that there was little chance that the woman could survive the day without them. A successful transplant was the only chance the surgeon had of saving her. So Niehans, who had a reputation for therapeutically transplanting organs and glands, was called in. On his way to the hospital, Niehans stopped off at the abattoir, where the animals he used in his revitalization experiments were slaughtered. He obtained fresh parathyroid glands from a steer and proceeded to the hospital, fully intending to perform a parathyroid transplant. However, when Niehans arrived, one look at the patient, who was violently convulsing, told him that there was simply not enough time to perform the operation. The woman would not survive long enough. But Niehans had an idea. He used a surgical knife to slice the steer's parathyroid glands into finer and finer pieces, taking care not to mash the tissue which contained the individual cells. He then mixed the pieces in a saline solution and loaded it into a large hypodermic needle. To the shock and dismay of his colleagues, Niehans injected the mixture into the fatally ill woman. Immediately, her convulsions ceased. Her condition improved, and continued improving. To everyone's surprise, including Niehan's, she recovered. Niehans wrote, many years later, "I thought the effect would be short-lived, just like the effect of an injection of hormones, and that I would have to repeat the injection. But to my great surprise, the injection of fresh cells, not only failed to provoke a reaction, but the effect lasted, and longer than any synthetic hormone, any implant or any surgical graft", longer indeed. The woman went on to live another thirty years, well into her nineties. Thus was born, cell therapy. And even though this was in 1931, Dr. Niehans is called the Father of Cell Therapy and given the prestige of discovering cell therapy, there are studies and papers on cell therapy treatments here in the United States in 1928 and 1929, using spleen from pigs, injected into humans, to cure hives, skin blemishes and shingles. At his Clinique, La Prairie in Montreaux, Switzerland, Dr. Niehans went on to administer cellular programs to thousands and thousands of patients, including many of the crowned heads of Europe, presidents, Pope Pius XII, and several Hollywood stars. In the not too 3

distant past, such notables as Charles DeGaule, Charlie Chaplain and Winston Churchill all visited Clinique La Prairie. Dr. Niehans stated the ultimate aim of cell therapy in this way: "What I am striving for, is not only to give more years to life, but especially, to give more life to years." Niehan's aim was to "make all the organs struck by old age capable once more of functioning properly." The conditions that cell therapy is designed to effect and solve, include the following: • • • • • • • • • • • • General loss of vitality Physical and mental exhaustion Strengthening after illness Premature aging Signs of dysfunction of the brain, heart, kidneys, lungs, liver, anddigestive organs Lack of drive and declining mental efficiency Weakness of the immune system Degenerative diseases of the connective tissue Dysfunction of the endocrine glands Disturbances of female functions Many conditions in children General improvement of body structure and body function

Cell therapy successfully helps to delay many symptoms of aging and extends youth. Cell therapists see their patients' skin tone and complexion improve, their vitality increase, their youthful optimism and energy return, and various other problems of aging much improve. Dr. Niehans used cell therapy for a lot more than youth extension. He used cellular extract programs not only to rebuild and stimulate slowly dysfunctioning, or aged organs, but also, to stimulate development of underdeveloped or retarded organs. In fact, Niehans' successful treatment of dwarfism provided him with some of his earliest notoriety in the United States. The basic therapeutic effect of cell therapy was described by Dr. Niehans as "organotropic cellular regeneration in the impaired organs." In other words, the therapy stimulated the disease and aging-damaged organs to regenerate. This restoration takes anywhere from just days to six months after the program. Doctors who use cell therapy have reported that arteriosclerosis patients also benefit. In a study performed on laboratory rats, cell therapy increased the residual pliability of aorta tissue to the extent that when stretched, it returned to its original shape much faster. This is a characteristic of younger tissue. Experiments on mesenchyme, which is all the connective tissue, have shown that cell therapy can increase the strength and pliability of this important structural element of the body. The youthful appearance of your skin is determined, in large part, by the health of your connective tissue. But that's not all. How youthfully your joints, muscles, and blood vessels function also depends on the condition of your connective tissue. Since the success of several cosmetic surgery operations depends upon the strength and elasticity of the skin, a program of cell therapy, including mesenchyme, placenta, skin and other structural organs, before rejuvenating surgery, is a good idea for older patients whose skin 4

has lost its elasticity. In some cases, even bone, cartilage, bone marrow and mesenchyme are advisable. When you think about it, cell therapy is practiced every day all over the world. Blood transfusions and the transfusion of various other blood components, such as red blood cells, white blood cells, blood platelets, is actually a form of cell therapy, where the acceptance has been uniformly widespread. Less commonly, implants of thymus extract has been utilized, essentially without any question from the medical authorities. It is cell therapy developed by Dr. Neihens, where components of cells, of various organs of the body, are being administered into a human being, that there is government control; particularly in the United States and Canada, due to the use of human embryos and fetus for stem cells. All other civilized countries of the world accept cell therapy using animal embryos, as it has been used in Europe. Cell therapy from animals is now being used, also, throughout the United States. The cell product is actually an implantation of xenogenic (of animal origin) embryonic, or fetal, suspensions of processed tissue, or tissues, with the final processed product being in a physiological solution. No one knows exactly how cell therapy works. As there are labs claiming to produce “cell therapy” and each labs’ process is kept secret, it is assumed that each is somewhat different, and thus, basically, cell therapy can be transplanting whole cells from a specific organ, or, various components of an organ, taken from an embryo, or fetus, in the first months of the pregnancy and given to the recipient. The transplanted, newly-created cell tissue, then brings about the improvement, or reprogramming of their corresponding organs, to a more youthful level. “Once the cells have found their way to the target organs or glands, do they have the power to do any good? “ The answer to that appears to be yes. Two Independent studies by cellular biologists have discovered that a single cell from a specific organ contains the information needed to rebuild the entire organW, or glandW. Scientists extracted kidney, skin, and liver cells from chick embryos. After processing them in much the same way, the cells were processed for cell therapy and they were re-injected into the membrane of an egg. The cells developed into their specific organs. Other independent research, by scientists who were not cell therapists, and who were not investigating cell therapy, has arrived at many of the same conclusions used to explain cell therapy. First of all, they have established, that embryonic tissue has the greatest growth stimulating effect. This makes sense. Young living things always contain more "life force" than mature ones. Secondly, they have confirmed that the growth stimulating effect of active proteins, or cells, is definitely, organ specific, but not, species specific. This means that liver cells will only stimulate the growth of liver cells9, but they will do so, no matter what animal the cells come from.

5

Finally, it has been demonstrated, that unwanted, or unnecessary, cells are rejected without doing harm to the body. Two major theories explain, how cells bring about revitalization of ailing, or aging, organs. One theory says, that the genetic information contained in the RNA and DNA of the "old" cells is defective, because of either age, or disease. Perhaps the old cells' genetic codes have developed gaps, or incorrect bits of information. This cellular genetic misinformation causes the cells to reproduce inefficiently. The old cells do not look or function, as well as, they should. Along come the fresh, young cells, with their fresh genetic information contained in their DNA and RNA. This theory says that the new cells carry the correct genetic message to the old cells. The new cells replace the misinformation with the proper, original genetic codes. The mistakes are corrected and the gaps filled. Once the correct information is in place, the organ or gland begins to function correctly, as if it, too, were as "young" as the donor cells. The second theory is simpler. It explains the aging of the cells, in much the same way, as we age. Our cells gradually lose their ability to function precisely, as they were intended. This theory, however, does not bother with genetic codes. It says that the mere presence of the fresh cells stimulates secretions that activate the aging, or diseased, cells to reprogram to youthful mode and function youthfully and properly. The implantation provides the recipient organisms, with a great number of biochemical substrates and enzymes that are found in very high concentrations and unique composition, in the embryonic cells and tissues11. There are many things we don't know about biochemical engineering. Perhaps we shall not know exactly how cell therapy works until cellular biologists unlock all the secrets of the cell. Prior to administering the process, many doctors give detoxification and cleansing therapies to prepare the body to receive the cell preparations. After “detox” and cleansing, free radicals, which have become affixed to the cell's genetic coding mechanism, (the hereditary determiners passed along through mitotic division of cells, at the fragility points along the genes), the free radicals are neutralized and no longer are attached to the genetic coding. After detoxifying, the cell's genes are regenerated, and normal transmission of non-contaminated genetic information is formulated, to be correctly transmitted in cell duplication11. Placenta, which contains a significant quantity of fetal hormone, inherent to placental tissue, is administered for the purpose of establishing an enhanced cell division rate consistent with a younger biological age and to increase function throughout the cardiovascular flow, thus increasing oxygen availability throughout the body. This entire described process of regenerative cellular therapy, allows the patient to actually become biologically younger11, while getting chronologically older.

6

The Resurgence of Cellular Extracts In the United States, cell therapy is still being practiced by physicians, who are open to alternatives, and by those, who have seen the dramatic results that can be achieved, using active cell tissue extracts. North Americans are much less familiar with cell therapy, than Europeans, because, today, only a small number of physicians know about it and use it. Until recently, it has also been very difficult to obtain good quality cellular extract products. In 1994, a limited number of cell products became available in the United States and Canada. Because they are considered dietary supplements, and as such, no therapeutic claims can be made for them. These products are more refined and contain some, or all, of the beneficial aspects of the cells, using a proprietary process to a more pure, energetic product. There are now many products on the market, claiming to be “cell therapy”. Therefore, the names, cell extracts, or cell tissue extracts, live cell therapy, oarganotherapy, ultra filtrates, even, just “cells”, are common, if not, precise terms for the products produced today. If cell therapy is to become more widely available and accessible to the general public in North America, there will have to be a consumer driven demand for cellular products and for information about their effectiveness. Even though cellular extracts are considered a dietary product, they are currently marketed to the general public, as well as, licensed health professionals including naturopaths, osteopaths, chiropractors, medical doctors and veterinarians. Over the past decade, there has been an exponential increase in the number of health care products available, but cellular extracts are the only therapy that can actually help regenerate cells and tissues. This is what makes it so unique. By 1933, physicians in the U.S. had treated many thousands of patients suffering from various ailments with oral or injected cellular extracts (Harrower, 1933) or dried, or desiccated glandular tissue, in order to restore, or regenerate, cells and boost function. Substances such as pituitary, pancreas, thyroid, adrenal, ovary and testes extracts were available commercially and used by some of the most eminent physicians. However, the advent of synthetic hormones, and their almost immediate and seemingly miraculous effect, led to a decline in the availability and the use of whole gland concentrates, Organotherapy. Now, often encountering the limitations and dangers of using synthetic hormones, some physicians are returning to, or experiencing for the first time, the benefits of using cellular extracts with their patients. From 1954 to 1993, more than 1,500 experiments involving whole cells, cell extracts and cell fractions were published in scientific journals. For example, Chase and Landsteiner, two of the founding fathers of Cellular Immunology, conducted a number of in vivo* (on the living) animal experiments, demonstrating that injections of whole spleen, or thymus cells, into live animals, such as mice, or guinea pigs, could enhance immunity.

7

AMERICAN PIONEERS IN CELL THERAPY and a BRIEF HISTORY Even though Dr. Paul Neihans of Switzerland, was called the “Father of Cell Therapy” in 1930, there are many studies, letters and records of doctors beginning to formulate and use very primitive versions of cell therapy, in the United States, even as early as 1926. One of these was Dr. Henry R. Harrower, who conducted many studies and experiments. He was one of the first to develop and sell endocrine products and organ products for commercial sale to the medical community. In his publication, “An Endocrine Handbook” Henry R. Harrower, (the Copyright is dated April 1939. They were in business and had been producing products for a number of years. I would like to quote: “AN INTRODUCTION TO ORGANOTHERAPY THE AIM of the Harrower Laboratory, from its inception twenty-one years ago, has been “to develop information pertaining to the internal secretations, in general practice, and to perfect the means, whereby this information can be applied.” Today endocrinology and its corollary, organotherapy, are more firmly established than ever. We believe we have a small part in this, and we are justly proud of it.” At the time of that publication, there were 1044 books about endrocrinology in the Harrower Laboratory Library, thousands of articles and clippings, and 239,000 files. Endocrine “Firsts” by Harrower Many biologically standardized natural endocrine extracts were first made available in commercial quantities to the medical profession by the Harrower Laboratory: For many years, he led the field of laboratories and research. Outstanding American Doctors in the 90’s and Into 2006 In the early 1990’s, there were doctors treating American patients with an improved version of Organotherapy, three of which were prominent doctors: Dr. Arthur Koch of Hazelton, Pennsylvania; Dr, John Baron of Cleveland, Ohio; and Dr. Norbert Becquet of Little Rock, Arkansas; all of whom are deceased within the last few years. They were all M.D.s, practicing a combination of the best of Alternative, Complimentary and Traditional Therapies. Each of these doctors were unique in the way they used supplements and therapies, including Organotherapy, to improve their patients' health. Dr. Arthur Koch had a specific protocol of Organotherapy to improve joints, bone and muscle structure and function 14. He used Organotherapy for himself and throughout his last years of practicing medicine. He was a leader in all the professional organizations where he was a member and the mentor of many of the younger doctors. Dr. John Baron, Cleveland, Ohio, was a strong supporter of Organotherapy and always told doctors he met, or new doctors to Alternative Medical Conventions, about his success, with Cell Therapy, and offered advice as to different combinations of organs to use for specific health conditions 15. He began to use cell therapy for himself in 1990 and always 8

took one individual organ each week, from 1990 until he sold his practice after 2005, of either Adrenal, Hypothalamus, Brain Total or Thymus. At least twice each year, he took an extensive program of six organs per-week for six to twelve weeks. During each year, he took at least one or two bottles of over 30 organs and combinations. He sold his practice at the age of 96 and at the age of 97, when he passed away, he was still a walking encyclopedia of health and medical therapies and information. He was highly regarded by all of the doctors who knew him and loved by all his patients and staff. There are few words to express Dr. Norbert Becquet’s greatness. He developed and taught the chelation workshop for ACAM during 26 years and continued almost until he passed away at the age of 97. Dr. Becquet was also a loyal supporter of Organotherapy and used it for himself, as well as his patients. He had patients with extreme health conditions (severe silicon poisioning, ALS, Parkinsons, advanced heart disease and Hepatitis), and he always explored using Organotherapy for all the last years of his long and successful practice. He was severly maimed and it is still a mystery how he survived and was able to live many years. In his early years in medicine, he flew around Africa in a small plane, treating natives in small villages that certainly never had seen a doctor, much less, an airplane. One day, while starting the plane by pulling the propeller, it started and caught him in the right side, leaving a huge “scoop” out of his side, from below his arm down his hip. If it had been the left side, it would have been very difficult for him to survive, especially in the back country of Africa. He somehow managed to live and treat patients for many years with his broken body. His dedication never suffered. *These are only three of the great humanitarians, who lived their life helping others. We hope that through this brief basic acknowledgement, of the above three heros, of supplying hope and treatments to hundreds of patients, that all three will be long remembered, and their pioneering spirit and lifetime dedication is carried on in the future . EUROPEAN PIONEERS IN CELL THERAPY and a BRIEF HISTORY Dr. Paul Niehans is known by everyone interested in Cell Therapy. I want to talk about the real leaders and researchers of Europe. In our Bibliography, you will find many studies by Dr. F. Schmid, the best-known doctor who published, “Experimental Fundaments, in ‘Cell Therapy’ A New Dimension of Medicine”, Ott Publisher Thoune, Switzerland, 1983, 65-104. Dr. Schmid was known all over the world for his work with mongolism and Down Syndrome. He traveled the world treating the children and teaching doctors everywhere the wonders of Cell Therapy. Dr. Milan C.Pesic for many years had laboratories that produced the best quality cell therapy products in Germany and is still known for his many products today. Dr. Paul Niehans original clinic, LaPraire, is still operating in Switzerland by businessmen who have owned and operated it for years. There are also many other small clinics throughout Europe offering cell therapy. • Some papers and programs from the pioneers mentioned above, can be seen on the Miami Medical Foundation Website. 9

Now for the Good News, and the Bad News, and, THE GOOD NEWS
The good news is, now for the first time in 70 years, cell products with embryonic tissue extracts, has become available to the public in the form of processed embryonic porcine (pig) cell tissue, making it possible, and affordable, to receive the incredible benefits of true cellular therapy (Embryonic OrganoTherapy). Embryonic Organo Therapy (EOT) uses the same principal as human stem cell therapy. However, instead of extracting stem cells, which are undifferentiated cellsW21, from a human placenta, EOT starts with the selection of specific organ cells9 from a porcine mammal embryo (unborn young). Many years of experience have shown that pigs are the best donor animals because they are vital, hardy animals and structurally, their bodies are the closest match to the human body14. Due to this fact, the majority of heart valve transplants for humans are derived from pigs. In addition, porcine proteins are particularly compatible with the human body, and in the embryonic stage, very seldom trigger an immune reaction. Therefore, EOT is essentially a form of porcine Specific Cell Therapy which is safer, cheaper and avoids the controversy and expense that is associated with the better known, Human Stem Cell Therapy. Specific Cell Therapy is also more focused, targeted and one step ahead of stem cells, as EOT goes direct to the specific organ you wish to effect and will only connect with that specific organ necessary, to improve the specific health condition of your choice9. Stem cells, which are undifferentiated cells, which can become any type of cell, and therefore, may not target the desired organ, or health condition. In addition, with the use of porcine embryonic extracts, there is little danger of disease in the donor animal. During their short lifetime, every factor effecting their life is known. In EOT, these vigorous young porcine cells, with their vital life-force, are taken by a human host. Since embryonic cells are normally non antigenic, they are not recognized as foreign by the host body. According to Dr. Niehans' theory, they circulate throughout the body until they recognize and attach to the human counterpart, of the organ from which they originated from: i.e. liver cells go to the liver, testicle or ovary cells go to the testicles or ovaries, heart cells go the heart, etc. These embryonic cells, which are functionally organ specific but not species specific, imprint their vigor upon old, tired, and degenerating cells, stimulating them to function with renewed youth and efficiency.11 The organ itself then, regains its vigor and vitality. In addition to general body revitalization, health maintenance, and life extension, EOT can effectively stimulate the cells of the specific organ system concerned with mental abilities, abnormal bones and joints, extreme energy loss, dysfunctional breathing, degenerative heart progression and vascular disturbances, degenerative bone structure, sexual 10

dysfunction, male insufficiency, abnormal pancreas function, hormonal disturbances, skin eruptions, lung weakness and disorders, liver dysfunction, senile ocular disorders and many other degenerative health conditions. Many physicians feel that the most important results of using EOT, are its’ revitalization of the body's immune system defense mechanisms. When damage occurs to the cells that make up the various tissues and organs involved in the immune system, either through the aging process, or from environmental poisons, the body becomes defenseless against both external invasion and internal degeneration. Damage to the organs of the immune system may be reversed through revitalization & regeneration with EOT. These new and energetic cell supplements act quickly and effectively, to stimulate the body's defense mechanisms. There are enormous benefits in the use of this therapy, to dramatically slow down the aging process and to help you regain beauty, health, vitality and vigor. The bad news is, “caveat emptor”, let the buyer beware. Today there are numerous products, on the market available to the public, that purport to be cell therapy (EOT). Unfortunately, these products consist of gel capsules, freeze-dried preparations (lyophilized) or frozen preparations. These products do not regenerate or rebuild, because in their preparation, they have lost all of their biological activity. There are also products available in the Dominican Republic, products processed in Mexico and products produced in Russia, that claim to be stem cells from humans. These vary in price from approximately $5,000.00 to $25,000.00, per treatment. None of these products are safe, if they are indeed, from humans. In a recent article in the Palm Beach Post, “four patients in the Chicago area, all tested positive for HIV and Hepatitis C, derived from transplants of organs from one donor18. At that point, blood preserved from the donor, was given a very sensitive test for viruses and the infection was found. Initially, the donor had tested negative for HIV and hepatitis C, apparently because the infection was too recent to be detected by commonly used blood tests. The body takes time to react and if the test is done too soon, within 22 days of HIV infection or 82 days for hepatitis C, antibodies may not be detected. There is another, more sensitive test that can pick up evidence of viruses, but still leaves a window that cannot be detected within 12 days for HIV and 25 days for hepatitis C. Anyone taking this type of product, without having any idea where the human products come from, or if the product actually contains stem cells, or any other type of cell product, human or otherwise, or if it is only sterile water and does not contain any human tissue, is taking an enormous risk, both health-wise and financially 18. It is my understanding that newer technology is now available. However, my opinion is that I would not want to expose myself to this circumstance, for ANY reason. Following is additional information and articles on both AIDS and hepatitis C being transferred to patients receiving organ donations from cadavers or living persons.

Four get AIDS virus from organ donor
Email|Print| Text size – + November 14, 2007 11

CHICAGO - An organ donor infected four transplant patients with the AIDS virus in what a donor group says is the first such transmission in the United States in at least 13 years. The transplants occurred in January at three Chicago hospitals. The patients infected with HIV and the virus for hepatitis C did not learn of their status until the last two weeks, medical officials said. (AP) GOOGLE more stories like this Washington, D.C.

Organ Transplant And/Or Blood Transfusion Patients
Mohammed Ali Al-Bayati As of January 1, 1997, the number of patients who received blood transfusions, blood components or tissues then subsequently developed AIDS in USA is 7,888 (Al-Bayati, 1999). The list of adverse reactions to blood transfusion is present and the standard treatment used to prevent or cure these reactions is glucocorticoid as stated by Fauci et., (1998). For example, the risk of getting an allergic reaction from a blood transfusion is 1-4 per 100. The risk for delayed hemolytic reaction is 1 per 1,500. In contrast, the risk of infection with HIV from blood transfusion is 1 per 490,000 (Fauci, et. al., 1998). However, immune suppression as a result of the use of glucocorticoids in these patients was not investigated. Furthermore, glucocorticoids and other immunosuppressive agents are also used to prevent tissue rejection in organ transplant patients. The complications from these treatment and the list of opportunistic diseases are also described by Fauci et al., (1998). The list of opportunistic diseases in organ transplant patient receiving immunosuppressive agents are identical to the list of opportunistic diseases listed in Fauci et al., (1998) in People with AIDS.

Causes And Pathogenesis Of AIDS In

3 Die of AIDS After Getting Organs From a Man Infected With the Virus
By LAWRENCE K. ALTMAN, Published: Saturday, May 18, 1991 Three people have died of AIDS after receiving organ transplants from a Virginia man infected with the AIDS virus, setting off a search for nearly 50 others who may have received his tissues and organs, Federal health officials said here today. 12

The search involves patients at 30 medical centers in this country, but the officials said that only a small portion of the patients were at substantial risk of becoming infected. At least one other recipient, an elderly Colorado woman who received a bone graft from the donor, has become infected, officials of the Colorado Health Department said. The transmission is the largest of the AIDS virus from an infected donor to recipients of organs and tissues, according to reports from the Centers for Disease Control in Atlanta, which has tracked the viral disease since it was discovered in 1981. Food and Drug Administration officials believe that all but three of 61 organs and tissues from the infected man, who was killed in 1985, have been implanted or destroyed, said Faye Peterson, a spokeswoman for the Federal agency. Processing of Tissues Experts said many of the tissues were processed with chemicals or irradiation that might have killed the AIDS virus. They were focusing on seven tissue samples deemed more likely to transmit the virus because they were not processed in the same way. Ms. Peterson said F.D.A. officials have found "no evidence to suggest that any improper procedures were followed in the recovery or distribution of the donor's tissues and organs." The date when the man's tissue was last transplanted to another person is not known, but the last shipment to a hospital was on July 1, 1986, from LifeNet Transplant Services of Virginia Beach, Va., which processed 54 tissue grafts, Ms. Peterson said. LifeNet officials said that all tissues probably had been used by 1987. After the man died, a team from the Medical School of Virgiana took five of his organs; his two corneas were handled by an eye bank. F.D.A. officials said the risk of developing an AIDS infection from an organ or tissue donation is slightly greater than from a blood transfusion, according to Ms. Peterson, who added that she could not cite a figure. Current tests may fail to detect the AIDS virus, known as HIV, once in 40,000 to once in 153,000 units of transfused blood, Ms. Peterson said. The reason is that it takes several weeks to months for a person infected with the AIDS virus to form the antibodies that are detected in the standard AIDS test. About 12 million to 15 million units of blood are transfused each year.

13

The slight risk cannot be totally eliminated by screening tests. But the odds have improved since 1985 when the Virginia man, a crime victim, was fatally shot in the head. A cruder version of an AIDS test than the one available now was used to test his blood before removal of his organs and tissues. The man's blood was tested twice for HIV in two laboratories, Bill Anderson, the chief executive officer of LifeNet, said in a telephone interview. Newer Test Is Used Mr. Anderson said that on Thursday technicians, using sophisticated laboratory tests developed in the last three years, detected evidence of the virus in stored samples of the man's blood. The Atlanta Journal-Constitution reported on the case today. Mr. Anderson declined to disclose the name of the infected donor for reasons of medical confidentiality. It is now known that deaths from suspected AIDS among the organ recipients first occurred in 1986. But the link only began to become apparent in April when Colorado Health Department officials wrote LifeNet about the infection in the elderly woman who received a bone graft. Her case came to the Colorado Health Department's attention in recent months through a routine review of data from hospital discharges, said Fred Wolf, a spokesman for the department. Initially, health officials thought the woman became infected through a blood transfusion. But further investigation found that she had received the bone graft without a transfusion. After reporting her case to the Centers for Disease Control and further investigation, the health department wrote to LifeNet on April 26. Emergency Plan Developed Mr. Anderson said LifeNet developed an emergency plan in a meeting last week with representatives of the F.D.A. and the Centers for Disease Control.

14

THE GOOD NEWS There is one efficacious source of EOT products available in the United States, with many different products of individual organs and combination organs that are sold to the general public. These products are formulated to help, and to support, body organs (heart, liver, brain, etc.) and systems (immunological, lymphatic, circulatory, endocrine, etc.), to function, at a more youthful and effective level, and has helped thousands of people over the past fifteen years20. Animal mothers, chosen as donors of the embryos, are porcine, and come from organic farms. They are raised from birth to slaughter, under controlled environment and are the closest animal match to the human body. Animals are processed in the embryonic stage, which is through the second month of the gestation period. The processed cell product must yield all of the cellular constituents and active factors of the original target organ of the tissue it was derived from. The content is sterile and contained in a sterile bottle, in a non-frozen state. Freezing changes the molecules, just as freezing changes a good steak. The manufacturing process takes place in a GMP laboratory and certification is obtained, as to the health and condition of the mother, before slaughter and after processing, by a government veterinarian. One bottle from each one-hundred bottles processed, is sent to an independent laboratory to be tested for parasites, fungus, bacteria, virus and pyrogens. All bottles are labeled according to FDA dietary supplement requirements. These EOT products conform to FDA requirements and guidelines for Dietary Supplements20.

Quality products available in the United States are:
• • • • Manufactured according to the requirements of GMP standards for both food and supplements.. Supplied in liquid form to preserve structure, and activity of peptides and growth factors.. Products are 100% pure and natural with no preservatives. Available in 3 ML and 7 ML sealed bottles, according to FDA requirements. Keep refrigerated, do NOT freeze.

Each supplement is composed of molecular weight cellular constituents and growth factors, that are absorbed through the oral mucosa. A company that supplies products in the United States, offers products that are available in 32 individual 3 ML embryonic organ supplements and 12 combination 7 ML supplements, 15

containing 3 to 8 organs. They are processed with a proprietary formulation from embryonic porcine tissue, which contain low molecular weight of active peptides. Supplied in liquid form, they consist of differentiated, active embryonic-porcine peptides and growth factors from bone, heart, liver, spleen, etc. and in the hands of a professional, often helps in health conditions, when allopathic modalities fail20. These products are formulated to help: (Partial List) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Enhance immune function Improve memory and cognitive function Enhance sexual function Increase rate of wound healing Increase aerobic capacity Enhance sports performance Restore fertility Restore cognitive function Restore liver function Reverse senile ocular conditions Increase energy and vitality Regenerate cells, tissues, and organs. Promote flexible joints and discs. Improve skin elasticity Promote general anti-aging

When ingested into the human body, “like goes to like”: bone to bone, liver to liver, heart to heart, etc. These ingested active peptides only fit onto the receptor sites, for the specific 9 organ from which they were originally derived . Once locked onto a specific receptor site, they begin to support and to help enhance the function of that specific target organ. Only in the embryonic stage (during the first two months of gestation) are the three tissue sheets, ectodermal, mesodermal and endodermal found. These tissue sheets differentiate into specific organs such as bone, heart, lungs, brain, etc. The Organ Dietary Supplements are derived, from organic porcine embryonic tissues during the second month of gestation. The products are processed in an approved GMP laboratory and certified to be free of parasites, bacteria, nano-bacteria, fungus and virus. The finished products contain processed peptides and growth factors from specific porcine embryonic tissue, or embryonic sheets, and are packaged sterile in individual bottles. The products are sold as dietary supplements. Every animal used to produce the Embryonic Organ Dietary Supplements are checked by a government veterinarian prior to and after slaughter. Once it is determined there is an embryo in excellent condition, it is taken to the lab to be processed. The mother is not slaughtered to harvest the embryos. It is slaughtered for organic food or medicinal purposes. If the embryo was not used to produce cell therapy, there is no other purpose for it and it would be discarded and thrown away. Under the care of a doctor, patients, undergoing “real” EOT have seen remarkable results, in the effects of age-related health conditions, with these non-toxic porcine nutritional supplements. In addition, users have observed the dramatic effect that organ 16

supplementation can have in the improvement and rejuvenation of mental speed and clarity, skin tightness and moisture, sexual function, hair growth and positive mood and energy levels. Users of EOT products, also overwhelmingly, report improved feelings of well-being.

WHAT TO BUY
There is actually a large variety of organ products that are available to the general public in the United States Below you can find some of the products and programs offered:

Individual Embryonic Organ Supplements and the Benefits of Taking these Dietary Supplements
Adrenal Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic porcine adrenal tissue and is formulated to help: • • • • • • • • • Increase energy Normalize adrenal function Increase vitality Enhance a sense of well-being Promote wellness Relieve stress Increase libido Causes soft, gentle improvement in all Mesodermal tissue organs Promote general Adrenal and related energy organ anti-aging

Artery Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic porcine artery tissue and is formulated to help: • • • • • • • • • • Revitalize entire arterial system Enhance circulation Increase cellular oxygen levels Strengthen arterial and venous walls. Strengthen the heart, lungs, kidneys and entire major organ system Regenerate the entire body and increase blood flow Encourage and shorten healing time Improve skin, hair, nails, eyesight, sexual functions and overall body function Causes soft, gentle improvement in all Mesodermal tissue organs Promote general artery and all other vascular system anti-aging 17

Bone Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic porcine bone tissue and is formulated to help: • • • • • • • Build stronger bones with increased density Accelerate bone healing Reduce osteoporosis Reduce bone breakage from falls Maintain youthful skeletal structure Causes soft, gentle improvement in all Ectodermal tissue organs Promote general bone structure anti-aging

Bone Marrow Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic porcine bone marrow and is formulated to help: • • • • • • • • • • Encourage red blood cell proliferation Increase cellular oxygen levels Regenerate the vascular system Encourage healing Assist in growth of new cells Support overall organ function Support overall body rebuilding Maintain healthy cell structure Causes soft, gentle improvement in all Mesodermal tissue organs Promote general Bone Marrow system anti-aging

Brain Total Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic porcine total brain and is formulated to help: • • • • • • • Normalize all major systems Enhance cognitive function and all mental abilities Increase communication between the brain, and all organs and systems Improve neurological response General overall improvement Causes soft, gentle improvement in all Ectodermal tissue organs Promote general Total Brain anti-aging

18

Cartilage Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic porcine cartilage and is formulated to help: • • • • • • • Improve range of motion and strengthen Joints. Support the entire skeletal system Reduce structural injuries Slow down structural aging Strengthen connective tissue and joints Causes soft, gentle improvement in all Mesodermal tissue organs Promote anti-aging of entire cartilage structure

Eye Total Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic porcine total eye and is formulated to help: • • • • • • • • • • • • Improve overall vision Increase and improve peripheral vision Strengthen ocular tissue Normalize all eye functions Increase focusing ability Improve vascular circulation in the eye Strengthen veins, arteries and muscles of all ocular tissue Improve muscle and eye coordination Overall ocular Anti-aging Delay the onset of senile ocular conditions Causes soft, gentle improvement in all Ectodermal tissue organs Promote anti-aging of entire Total Eye and related vascular systems

Gall Bladder Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic porcine gall bladder and is formulated to help: • • • • • • • • Normalize Gall Bladder function Aid digestion Neutralize acid balance Normalize bile production Emulsify Fat Support the liver and pancreas Causes soft, gentle improvement in all Mesodermal tissue organs Promote general anti-aging of Gall Bladder and related systems 19

Heart Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic porcine heart and is formulated to help: • • • • • • • • • Strengthen the heart muscle Improve chamber functions Strengthen and improve arterial system, including the aorta Increase energy and vitality Regulate heart rhythm Improve circulation Improve valve performance Causes soft, gentle improvement in all Mesodermal tissue organs Promote general anti-aging of Heart, Aorta and related systems

Hypothalamus Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic porcine hypothalamus and is formulated to help: • • • • • • • • Alleviate stress Strengthen nervous system, immune function, and digestive system Increase energy Balance normal body weight Enhance sense of well-being Improve endocrine function Causes soft, gentle improvement in all Ectodermal tissue organs Promotes general Hypothalamus and all related endocrine system organs antiaging

Intestines Total Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic porcine total intestine tissue and is formulated to help: • • • • • • • •
•

Maintain and strengthen intestinal walls Increase digestive functions Improve absorption of all nutrients Improve elimination of matter Strengthen intestinal muscle Improve enzymatic functions Support immune function Causes soft, gentle improvement in all Mesoderm tissue organs Promotes general anti-aging of Total Intestines and all related digestive system organs 20

Kidney Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic porcine kidney tissue and is formulated to help: • • • • • • Strengthen all kidney functions Enhance and normalize detoxification of the blood Maintain general body electrolyte balance Regulate blood pressure and plasma volume Causes soft, gentle improvement in all Mesoderm tissue organs Promotes general anti-aging of the Kidney and all related cleansing system

Liver Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic porcine liver issue and is formulated to help: • • • • • • Improve lipid metabolism Improve and normalize liver functions. Regulate and normalize plasma protein synthesis Normalize the removal of toxic substances Causes soft, gentle improvement in all Mesoderm tissue organs Promotes general anti-aging of the Liver and all related digestive and filtering system organs anti-aging

Lung Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic porcine lung tissue and is formulated to help: • • • • • • • • • Optimize arterial oxygen levels Strengthen lung tissue Normalize gas exchange (O2 & CO2) Strengthen heart, liver, kidney and brain functions Strengthen and improve hair, nails and skin tissue Optimize all body functions due to increased oxygen Increase athletic abilities Causes soft, gentle improvement in all Endoderm tissue organs Promotes general anti-aging of the Lung

21

Mesenchyme Extract
It is a single-organ, animal-based dietary supplement, extracted from embryonic porcine Mesenchyme tissue and is formulated to help: • • • • • • • • • Strengthen all connective tissue: joints, muscles, skin, organs and glands Shorten healing time Reduce structural injuries Improve general body balance, maneuverability and flexibility Increase freedom of movement Retard skin deterioration and wrinkling Strengthen all structural tissue and improve athletic abilities Causes soft, gentle improvement in all Mesoderm tissue organs Promotes general anti-aging of connective tissue and related organs

Muscle Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic porcine muscle tissue and is formulated to help: • • • • • • • • Improve muscle tone and motor skills Increase physiological and mechanical fitness Enhance mechanical strength Increase athletic ability and stamina Improve muscle coordination Normalize and enhance heart function Causes soft, gentle improvement in all Mesoderm tissue organs Promotes general anti-aging of the Musculature System

Ovary Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic porcine ovary tissue and is formulated to help: • • • • • • • Enhance fertility Regulate estrogen and progesterone production Enhance possibility of producing offspring Increase and strengthen bone structure in later years Normalize menstrual cycle Causes soft, gentle improvement in all Mesoderm tissue organs Promotes general Ovary and all related female reproductive system organs antiaging

22

Pancreas Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic porcine pancreas tissue and is formulated to help: • • • • • • • Normalize insulin production Regulate digestion Increase and strengthen pancreatic functions Improve synergy with digestive and food processing organs Revitalize the pancreas Causes soft, gentle long-term improvement in all Endoderm tissue organs Promotes general Pancreatic and all related digestive system organs anti-aging

Pituitary Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic porcine pituitary tissue and is formulated to help: • • • • • • Increase the production of growth hormone Enhance sexual function and libido Increase muscle tone Strengthen endocrine system functions Causes soft, gentle long-term improvement in all Ectodermal tissue organs Promotes general anti-aging of the Pituitary and all related system organs

Placenta Extract It is a fluid, animal-based dietary supplement, extracted from embryonic porcine placenta fluid and is formulated to help: • • • • • • • Improve and help to revitalize the body Revitalize, rebuild and strengthen entire arterial and vascular system Enhance circulation and increase cellular oxygen levels Provide additional strength to the heart, lungs, kidneys and all major organs Shorten healing time Causes soft, gentle long-term improvement throughout entire body Promote general anti-aging in all systems

23

Porcine Total Extract It is a multi-organ, complete-animal-body-based dietary supplement, extracted from embryonic total-animal porcine cells and tissue and is formulated to help:
• • • • • • •

•

Improve and revitalize all systems and components of the body Enhance with a soft effect on all organs, glands and body tissues. Strengthen the basis of all organs and glands as to structure and function: three embryonic tissue groups, (Ectoderm, Endoderm and Mesoderm) Increase overall communication between all organs Strengthen and enhance entire body structure Create an overall feeling of well-being Causes soft, gentle long-term improvement in all organs, structural components, body functions and entire overall communication and flowing response to all automatic health movements and well-being thoughts. Promote general total body anti-aging

Prostate Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic prostate tissue and is formulated to help:
• • • • • • •

Support and enhance normal prostrate function Regulate and produce male fluids Maintain reproductive balance Encourage reproductive normalization Maintain urine flow in later years Causes soft, gentle long-term improvement in all dermal tissue organs Promote general Prostate and related systems anti-aging

Skin Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic skin tissue and is formulated to help:
• • • • • • •

Enhance collagen production Promote a vibrant dermis Enhance and strengthen all 3 layers of skin Encourage strong youthful skin Support healthy hair and nail growth Enhance strong and quick healing Promote general anti-aging of the Skin, vascular structure and all related systems

24

Spine-Nerves Extract .It is a multi-organ and structure, animal-based dietary supplement, extracted from embryonic porcine spine, spinal cord/ marrow and all connected nerve tissue and is formulated to help:
• • • • • • • •

Strengthen and enhance the entire spinal column, cord and related bone structure Strengthen and enhance spinal discs, joints and neural connections Normalize neural system flow and connections throughout Enhance all neural structure and functions Normalize neural system communications throughout Strengthen and enhance the overall spinal structure and neural network Causes soft, gentle long-term improvement in all Ectodermal tissue organs Promote general spinal structure and neural network anti-aging

Spleen Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic spleen tissue and is formulated to help:
• • • • • •

Strengthen, support and improve spleen functions Support immune function Filters and eliminates dead cells, bacteria, fungus and virus from the blood, Improve and eliminate skin blemishes, including hives, rashes and shingles Causes soft, gentle long-term improvement in all Mesodermal tissue organs Promote general spleen, immune and related network organ systems anti-aging

Stomach Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic stomach tissue and is formulated to help:
• • • • •

Strengthen, support and improve stomach function Normalize absorption of ions, water and lipid soluble compounds Supply acids necessary for final digestion Causes soft, gentle long-term improvement in all Endodermal tissue organs Promote general stomach, network organs and related systems anti-aging

25

Testicle Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic testicle tissue and is formulated to help:
• • • • • • •

Maintain and normalize all major male sexual functions Enhance the production of sperm, and the regulation of male hormones, Revitalize entire male reproductive system Enhance libido Increase fertility Causes soft, gentle long-term improvement in all Mesodermal tissue organs Promote general testicular and related network organs anti-aging

Thymus Extract
It is a single-organ, animal-based dietary supplement, extracted from embryonic thymus tissue and is formulated to help:
• • • • • •

Strengthen, support and improve the function of the thymus Normalize T-4 “killer cell” production, to fight disease Improve all immune functions with related organs; spleen, total brain, bone marrow and total intestines Supply a constant source of ‘baby cells’ to renew organs affected by disease Causes soft, gentle long-term improvement in all Endodermal tissue organs Promote general anti-aging of the thymus, network immunity organs and related systems

Thyroid Extract
It is a single-organ, animal-based dietary supplement, extracted from embryonic thyroid tissue and is formulated to help:
• • • • • • • • • •

Regulate metabolic activity, body temperature, and weight control, Assist the bodies' general adaptation to the environment Normalize the production of thyroid hormones Regulate calcium balance, which has body weight indications Coordinates functions of endocrine system with other endocrine organs Strengthens ability to adapt to change Improves digestion Improves physical visual appearance Causes soft, gentle long-term improvement in all Endodermal tissue organs Promote general thyroid, endocrine organs and related systems

26

Veins Extract
It is a single-organ, animal-based dietary supplement, extracted from embryonic venous tissue and is formulated to help:
• • • • • •

Strengthen, support and improve the venous system Strengthen venous walls Build new veins and repair other veins Improve venous elasticity Causes soft, gentle long-term improvement in all Mesodermal tissue organs Promote general venous and related network systems anti-aging

Vessels Extract It is a single-organ, animal-based dietary supplement, extracted from embryonic vessel tissue and is formulated to help:
• • • • • • •

Strengthen, support and improve the peripheral vascular system Strengthen and thicken vascular walls Build and repair new vessels Improve vascular elasticity Increase blood flow, oxygen, nutrients hormones, etc. to all peripheral areas of the body Improve sexual function, hair growth, nail growth, skin and all other tissue Causes soft, gentle long-term improvement in all Mesodermal tissue organ antiaging

Skin-Placenta Mini-Combo It is a multi-organ, animal-based dietary supplement, extracted from embryonic porcine skin and placenta cells and is formulated to help: 1. 2. 3. 4. 5. 6. 7. Improve and revitalize the body Revitalize, rebuild and strengthen entire arterial and vascular system Enhance circulation and increase cellular oxygen levels Provide additional strength to the heart, lungs, kidneys and all major organs Shorten healing time Cause a soft, gentle long-term improvement throughout entire body Enhance collagen production, promote a vibrant dermis, enhance and strengthen all layers of skin 8. Encourage strong youthful skin, support healthy hair and nail growth 9. Enhance strong and quick healing 10. Promote general anti-aging of the skin, vascular structure and all related systems

27

COMBINATION EMBRYONIC ORGAN DIETARY SUPPLEMENTS A U.S. company, produces combination porcine embryonic organ products with three to eight organs in one bottle. The company promotes their “Combos’ as anti-aging in nature and are designed to address, an entire health condition, all in one 7ML bottle. They take the guess work out of, which products you should use, and when to take them”. All embryos develop from three tissue groups: 1. ectoderm, 2. endoderm and 3. mesoderm. In the study of cell therapy, it is best, when taking individual organs, to take them in that order during the week. Stop a few days and then start over the next week. If the product is truly embryotic tissue, there will be a high focus of action, 70 to 80%, on the target organ that is taken; and a 20 to 30% action on the balance of all the other organs, that are derived from the same tissue group. For example, Brain is ectoderm, which is the command system. When you take Brain, there will be a strong 70 to 80% effect on helping to rebuild and maintain the Total Brain, and then a 20 to 30% effect, distributed between the other ectoderm embryonic organs: Bone, Eye Total, Hypothalamus, Pituitary, Skin and Spine-Nerves. Thereby, a strong overall effect on the entire ectoderm group of organs, the command system organs. I always teach using the organs according to the tissue groups. You could take each individual ectoderm organ during the same day. All of the endoderm organs two or three days later and then, many of the mesoderm two or three days after that. The idea is to keep the tissue groups separate from the other groups, so that the body only has to work with one group, at a time. EXCEPT: when you are working on one system, or one function, at one time. THEN, because different organs work together, for one purpose, it is acceptable to take them together. Thereby, the explanation of designing the “Combos.” They are developed to address one entire system, or function. The Company, that produces combination products, has provided a list of their embryonic combos. A perfect example is the Embryonic ADRENAL-ENERGY Combo:

Embryonic ADRENAL/ ENERGY Combination contains a proprietary blend of porcine cellular preparations of Adrenal, Brain Total, Hypothalamus, Pituitary, Thymus and Thyroid and is formulated to help:
• • • • • • • •

Increase energy Normalize adrenal function Increase vitality Promote wellness Relieve stress Normalize all endrocrine systems Enhance cognitive function Enhance sense of well-being 28

• • • • • •

Enhance sexual function, growth hormone production, cellular oxygen levels, and muscle tone. Enhance immune system and maintain fight against disease with increase T-4 helper-cell production Assist the bodies' general adaptation to the environment Increase cellular oxygen levels Causes soft, gentle improvement in all organs and body structure General Anti-aging

Embryonic BONE-JOINT Combination contains a proprietary blend of Bone Mesenchyme, Placenta and Total Porcine. It is formulated to help:
• • • • • • • • • •

Build stronger bones with increased density Accelerate osteo healing Strengthen connective tissue, joints, muscles, skin, organs and glands Encourage general healing Enhance circulation, increase cellular oxygen levels and strengthen arterial and vascular walls. Improve the entire vascular system Enhance the immune system function Normalize the functioning of all organs and glands such as, bone marrow, ligaments and tendons Causes soft, gentle improvement in all organs and body structure General Anti-aging throughout entire body

Embryonic EYE/ Vision Combination contains a proprietary blend of Brain Total, Eye Total, Muscle, Placenta, Artery, Veins, Vessels and Thymus. It is formulated to help:
• • • • • • • • • • • •

Improve overall vision Normalize eye functions Increase focusing ability improve vascular circulation in eyes and throughout body Strengthen veins, and arteries in ocular tissue Increase cellular oxygen levels Strengthen and support arterial and venous walls Sustain body through general homeostasis Enhance healing Enhance immune function Causes soft, gentle improvement in all organs and body structure General Anti-aging

29

Embryonic FEMALE ENHANCE Combination contains a proprietary blend of Adrenal, Heart, Liver, Ovary, Placenta, Porcine Total and Thymus. It is formulated to help:
• • • • • • • • • • • • • • • • • •

Enhance circulation Increase energy Normalize adrenals Increase vitality Enhance a sense of well being Improve ability to handle stress Maintain nervous system, immune function and all related systems Increase cellular oxygenation Strengthen and regenerate arterial and vascular walls. Enhance fertility Regulate estrogen and progesterone production Enhance possibility of producing offspring Causes soft, gentle improvement in all Mesoderm tissue organs Normalize the functioning of all organs and glands such as heart, liver, ovaries and thymus. Improve skin, hair, nails and libido Improve all immune function systems Causes soft, gentle long-term improvement in all organs and tissue groups General Anti-aging

Embryonic LIVER HC Combination contains a proprietary blend of Total Brain, Hypothalamus, Liver, Kidney, Placenta, Spleen and Thymus. It is formulated to help:
• • • • • • • • • • • • • • • • • • • • • • •

Normalize all major systems Causes soft, gentle improvement in all Ectodermal tissue organs Improve ability to handle stress Strengthen nervous system, immune function, and digestive system Increase energy Enhance sense of well-being Normalize liver functions. Normalize lipid metabolism Strengthen all kidney functions Enhance and normalize cleansing of the blood Maintain general body balance Constant purification of body fluids Enhance electrolyte balance Regulate blood pressure and plasma volume Promotes anti-aging for kidneys and all related cleansing system organs Enhance circulation and increase cellular oxygen levels Improve skin, hair, and nails Strengthen, support and improve spleen functions Support immune function Normalize T-4 “killer cell” production, to fight disease Supply a constant source of ‘baby cells’ to renew organs affected by disease Causes soft, gentle long-term improvement throughout entire body Promote general anti-aging in all systems 30

Embryonic LIVER SUPPORT Combination contains a proprietary blend of Placenta, Porcine Total and Thymus. There is No Liver. It is formulated to help:
• • • • • • • • • • • • • • • • •

Strengthen and improve a distressed liver Gently improve liver function Strengthen immune function, and digestive system Increase energy Enhance sense of well-being Slowly normalize liver functions. Normalize lipid metabolism Enhance and normalize cleansing of the blood Improve general body balance Encourage purification of body fluids Enhance electrolyte balance Regulate blood pressure and plasma volume Promotes soft anti-aging for all related cleansing system organs Enhance circulation and increase cellular oxygen levels Improve skin, hair, and nails Strengthen, support and improve liver functions Support and improve liver function relations with immune function

Embryonic HEART/ Cardio Combination contains a proprietary blend of Heart, Artery and Placenta. It is formulated to help:
• • • • • • • • • • • • • •

Strengthen heart muscle Improve chamber functions Increase energy Increase vitality Regulate heart rhythm Enhance circulation Increase cellular oxygen levels Strengthen and support arterial and venous walls Strengthen and support the entire aorta/ artery system Strengthen and support related systems such as the lungs, brain, digestive and immune Revitalize all body functions and body structure Causes soft, gentle long-term improvement throughout entire body Promote general anti-aging in total vascular systems, including the aorta General anti-aging in the heart

31

Embryonic MALE ENHANCEMENT Combination contains a proprietary blend of porcine cellular preparations of Adrenal, Heart, Liver, Placenta, Porcine Total, Testicle and Thymus. It is formulated to help:
• • • • • • • • • • • • • • • • •

Enhance circulation Increase energy Normalize adrenals Increase libido and sexual function Increase vitality Enhance a sense of well being Improve ability to handle stress Maintain nervous system, immune function and all related systems Increase cellular oxygenation Strengthen and regenerate arterial and vascular walls. Causes a soft, gentle improvement in all three embryonic tissue groups, (Ectoderm, Endoderm and Mesoderm) Normalize the functioning of all organs and glands Regulate Testerone Production Improvement throughout male reproductive system Improve all immune functions General Anti-aging in all male organs and systems General Anti-aging in all major systems and organs for long-term

Embryonic *SKIN SUPPORT Combination contains a proprietary blend of Mesenchyme, Placenta, Porcine Total and Thymus. It is formulated to help:
• • • • • • • • • • • • • •

Retard skin deterioration and wrinkling Strengthen all structural tissue Enhance circulation Increase cellular oxygenation Strengthen vessel walls Maintain the entire vascular System Strengthen all connective tissue: joints, muscles, skin, organs and glands Shorten healing time Reduce structural injuries Encourage healing Enhance the immune system function Causes soft, gentle improvement in all organs and tissue General Anti-aging throughout the bodies largest organ and all support organs *For added results, combine with Individual Skin

32

Embryonic SKIN – BONE - HAIR Combination contains a proprietary blend of porcine cellular preparations of Skin, Bone, Mesenchyme, Placenta and Total Porcine. It is formulated to help: Build stronger bones with increased density Accelerate osteo healing ! Strengthen connective tissue, joints, muscles, skin, organs and glands ! Encourage general healing ! Enhance circulation ! Increase cellular oxygen and strengthen arterial and vascular walls ! Strengthen the vascular system ! Enhance the immune system function ! Normalize the functioning of organs, glands and support structures such as, bone marrow, ligaments and tendons ! Cause a soft, gentle improvement in all three embryonic tissue groups, Ectoderm, Endoderm and Mesoderm ! Promoting general structural anti-aging overall
! !

Embryonic THYMUS-IMMUNITY Combination contains a proprietary blend of porcine cellular preparations of Thymus, Bone Marrow, Spleen, and Total Intestines. It is formulated to help:
• • • • • • • • • • • • • • •

Enhance the immune system Encourage healing Shorten healing time Control and regulate all immune functions Strengthen and improve the thymus gland functions Encourage red blood cell proliferation Increase cellular oxygen levels Clean and drain blood contaminates Provide general support for all immune function organs and glands Maintain and strengthen intestinal tissue Increase digestive functions Improve absorption Improve enzymatic functions Causes soft, gentle improvement in all Mesodermal and Endodermal tissue Promote general immune system organ anti-aging

33

Organ Relations, Embryonic Tissue Groups,
Embryonic Tissue Groups and Order of Administration
It is very important to understand the relations and needs, of one organ to the other, in using Cell Therapy. Even though I have stressed using organs of the same tissue group together, over and over, so as to have a more focused effect on a long-term basis, it is also extremely important, to administer organs together, that work together, in specific functions, or structure. Also, the order administered, of the three embryonic tissue groups, is very important. Always start your week with No. 1. Ectoderm, the command system organs. Brain should always be first. Other command system organs are Bone – Eye - Hypothalamus – Pituitary – Skin and Spine-Nerves. No. 2. group, Endoderm organs are Intestines – Pancreas – Prostate – Stomach – Thymus and Thyroid. The No. 3 group is Mesoderm, the largest group of the three, with many of the life sustaining organs. They are Adrenal – Artery – Bone Marrow – Cartilage – Gall Bladder – Heart – Kidney – Liver – Lung – Mesenchyme (all connective tissue) – Muscle – Ovary – Spleen – Testicle – Veins and Vessels. To simplify this for you, study the following charts. If you are using Cell Therapy, copy them and keep them convenient to review when needed.

Embryonic Tissue Groups Showing Organs
1. Ectoderm Bone Brain Total Eye Total Hypothalamus Pituitary Skin Spinal/Nerve 2. Endoderm 3. Mesoderm Intestine Total Pancreas Prostate Stomach Thymus Thyroid Adrenal Artery Bone Marrow Cartilage Gall Bladder Heart Kidney Liver Lung Mesenchyme Muscle Ovary Spleen Testicle Veins-Vessels Neutral Placenta Porcine Total

34

Organs by Embryonic Tissue Groups
Organs Adrenal Artery Bone Bone Marrow Brain Total Cartilage Eye Total Gall Bladder Heart Hypothalamus Intestine Total Kidney Liver Lung Mesenchyme Muscle Ovary Pancreas Tissue Group Tissue Group Tissue Group Mesoderm Mesoderm Ectoderm Mesoderm Ectoderm Mesoderm Ectoderm Mesoderm Mesoderm Ectoderm Endoderm Mesoderm Mesoderm Mesoderm Mesoderm Mesoderm Mesoderm Endoderm

Pituitary Ectoderm Placenta (Neutral) Prostate Porcine Total (Neutral) Skin Ectoderm Spinal/Nerve Ectoderm Spleen Stomach Testicle Thymus Thyroid Veins-Vessels

Endoderm

Mesoderm Endoderm Mesoderm Endoderm Endoderm Mesoderm

Ecdoderm, Endoderm and Mesoderm Found Only in the Embryonic Stage
Again, I wish to state, these embryonic tissue groups are just that. They are found only in the embryonic stage during the first two months of the pregnancy. During this stage, the entire embryo is at its’ strongest creative state. Therefore, all products derived during this stage are the most productive. Amtmann, Eberhard : Restoration of the responsiveness to Growth Factors in Senescent Cells by an Embryonic Cell Extract, Experimental Cell Research 189, 202207 (1990). This study is posted on the Miami Medical Foundation site www.miamimedicalfoundation.com. 35

Simple Rules: TO DO and NOT TO DO
1. Never take more than six organs per week 2. Do not take if you are allergic to the meat source; beef, pork, lamb, etc. (Antihistine can be used under physicians care). 3. If there is high blood pressure, do not take Adrenal. It could increase blood pressure 4. Do not take Adrenal, if you are on Adrenal medication. ‘You cannot speed up and brake, at the same time.’ 5. Never take the organ, that has a serious medical condition. i.e. lung for lung cancer, liver if there is chhrosis, or severe hepatitis. etc. 6. Do not take heart, if there has been a heart attack, or stroke, within the past year. 7. It is important to do simple Kinesiology/ muscle testing to determine if the organs are good for you. Perhaps check with your health food store to find someone who can help you with the muscle testing. 8. REMEMBER, If the target organ is very deficient, SO ARE THE SUPPORT ORGANS. Especially in later years. 9. Never use a liquid organ if it is “clouldy or soupy”. It may be colored and even have small particles in it, but never cloudy. 10. If you are using a frozen product, and it defrosts unexpectedly, use it immediately, or up to eight hours in the refrigerator. DO NOT REFREEZE IT. 11. Read all instructions for products ORGANS USED in IMPORTANT COMBINATIONS Many organs that work together are so strongly related, that if you revitalize one, and do not treat the other, one or two, it can definitely upset the balance and cause problems, even in the revitalized target organ. The following are very important relationships. 1. BRAIN / HYPOTHALAMUS / PITUITARY The rejuvenation of the Brain, Hypothalamus and Pituitary together, immediately starts improving specific functions of the Central Nervous System, plus many other master body functions, including resistance to stress, and all major Function Systems controlled by this triangle of major Ectoderm control organs, to strengthen and improve. The Hypothalamus and Pituitary, also, will strengthen and improve the essential functions of organ relations, including, but not limited to: - digestive (hypothalamus/ pancreatic axis), - on the gonads (pituitary/ gonad axis) - the climatic adaption ( heat/ cold) - the hydration balance The revitalization of the cerebral (Brain Total) as a whole, is justified by the essential role played by the control systems on the total body and the role of the central nervous system in all pathologies. 2. LUNG / HEART / ARTERY This is a very important association in Chinese medicine. This combination is also justified in occidental physio-pathology and particularly in all the cardiopulmonary syndromes. When the Heart/ Artery is deficient and needs treating, so does the Lung. This is a combination not normally considered by many physicians. 36

3. PANCREAS / INTESTIN In all digestive pathologies, it is important to help the Pancreas and support it to the maximum, in order to have good function of the Duodenum, where enzymatic digestion takes place. When the Duodenum is not performing at least sufficiently, the Pancreas might become exhausted, which will lead to bad assimilation, by the Small Intestine and disturbance in all intestinal eliminations. 4. LIVER / GALL BLADDER Associated in the same function of elimination, they complement and support each other. If the Liver is cleansed and regenerated, without the Gall Bladder being stimulated and regenerated also, this is a serious error as a Liver engorgement (icterus, enlargement or inflammation – same as jaundice) could occur. 12. SPLEEN / STOMACH This is also an association found in Chinese medicine, as these organs have an antagonistic, but also, a complimentary action, in dealing with food. The Stomach governs the reception and decomposition, while the Spleen governs the carrying and the transformation, of the results, of the Stomach digestion. Both will be essential in treating digestive disorders and should be given together. They are also, important together, for the leukocyte process created by digestion. 13. EMBRYO / PLACENTA These two products produce a complete general revitalization. The Total Embryo/ Porcine has a soft action, during a long general revitalization and the Placenta has nutritive and vascular action, which revitalizes the entire vascular system, as it nurtures with all the vital nutrients in the Placenta. 7. BONE / CARTILAGE / BONE MARROW As these three glands/ organs are originally formed from the same embryonary leafs/ sheets, this association will strengthen and improve all the Bone and Cartilage degeneration. 14. MUSCLE / LIGAMENT Because of their close anatomical relation, the Muscles and Ligaments must be connected and revitalized together. A strong Muscle needs a very strong Ligament connection and vice-versa. 9. MESENCHYME / VEINS / VESSELS The Mesenchyme, which is a connective embryo leaf, or sheet, forming the Mesoderm, is used as a priority in cosmetic medicine. Veins and Vessels are added to increase the vascularization of the tissues. 15. TESTICLE / PROSTATE Closely linked to the functioning of the male gonads, this association strengthens and improves libido and all other male function systems.
Henry R. Harrower, The Harrower Laboratory, once said, “The single gland therapy is often an endocrine version of the common error of treating symptoms rather than the disease. We are still too prone to treat only the gland, which is obviously malfunctioning, without seeking to discover whether the cause of that malfunction may be some disorder in another related gland.” 1938.

37

ORAL LIQUID EMBRYONIC ORGAN DIETARY SUPPLEMENTS
ARE EFFECTIVE - According to the Following 1. Small cellular molecular components are absorbed in the digestive tract: Endocrine Rejuvenation Interview with Dr. Jonathan Wright by Life Enhancement “John: Do we know for sure that thyroid hormone, cortisol and other hormones are efficiently absorbed through the digestive system? Wright: Yes, and we also know that small polypeptides can be absorbed from the GI tract unaltered. That's been proven. Not all protein is broken down into single amino acids. Our bodies can and do absorb polypeptides, particularly smaller ones. And although it's impossible to predict what portion of a polypeptide is going to get through unscathed and what is going to get through broken down, some of it is going to get through in its original form.” 2. From Henry R. Harrower’s papers 1938: “Oral Organotherapy” “THERE was a time when it was fashionable to believe that no glanduler product ‘with the exception of thyroid, of course,’ was effective by mouth. To take this position now will be to ignore hundreds of excellent clinical and experimental reports to the contrary, many of which are cited in this book. This misconception is typical of other mental attitudes that have frequently delayed the acceptance and application of therapeutic advances. Sir Walter Langdon-Brown tells of his own original inability to believe that liver feeding could be an effective treatment of so serious a disease as pernicious anemia.” But a Nobel Prize in medicine was awarded in 1934 for this outstanding organotherapeutic attainment.” This was the second Nobel Prize for endocrine therapy accomplishments. Obvously, this was taken orally.

3. Schmid F, 1996. Like goes to Like One of Germany’s best known clinicians and researchers, finalized one of the most wellknown studies: Subject, “Like goes to Like”. By adding radio-active dye into processed liver cell extracts, he demonstrated that this liver cell tissue, after being administered to the recipient mouse, the liver cell tissue traveled around in the mouse’s body, to it’s liver, the target organ and even to some of the livers support organs.9 It is my own experience, that EOT taken orally is effective. I have been proving this for a long time with all my little dogs. I dribble it into their mouths. They respond so quickly, it is amazing. Also children respond very quickly.

38

GENERAL INFORMATION FOR ANTI-AGING
Organ systems work together. That’s why they should be taken together. If a target organ is mal-functioning, all the support and related organs are also under stress. In the words of Dr. Henry Harrower in 1938, “Single gland therapy is often treating the symptoms rather than the disease”. Organotherapy works like building blocks. With continued treatments, the glands and organs continue to get stronger. Optimum dosage for each organ is four times in a set program. That can be once each week or once every other week per organ. No more than six different organs should be taken during one week, a total of 6 bottles, one organ in each bottle. If there are twelve organs in a program, or schedule, then it should be six organs the first week and the last six in the second week. It is repeated every other week and continued for as long as necessary. If you are using “Combos”, containing 3 to 8 organs in one 7ml bottle, that should be taken alone, or with one individual organ to concentrate the focus: such as, one Thymus-Immunity Combo with one Single Organ Thymus. This is to be taken Day 1. On Day 4 or 5, three Single Organ Products can be administered, or one Combo. For healthy people, wanting health maintenance and anti-aging, a person; 20 to 40, should probably take a 10 to 20 bottle program, twice a year, with perhaps one or two bottles each month for maintenance. For the baby boomers 50 to 60, our opinion, would be to double the 20 to 40 schedule. It is absolutely more desirable to start, as young as you can, and continually rebuild. On the other side, even just one bottle is beneficial. Over 60 years old, 20 to 30 bottles 4 times a year is desirable, with a maintenance of 2/4 bottles a month in between. Dr. John Baron, who sold his practice at 96, took one bottle every week (usually Adrenal, Thymus, Hypothalamus or Brain Total) from 1989 and in addition, took a 12-week program, taking 6 organs each week, twice each year. The “organ of youth”, the Thymus gland, starts to atrophy at puberty. A European doctor once advised, “Take a Thymus each week for the rest of your life and you will stay young and live a long time”. If money is no object, an annual program of 1 month in every four, or 1 month out of 3, should be designed with 6 organs taken each week. Another interesting quote, “The human body is nothing but a brain with a bunch of organs hanging off of it”. Simply said, nothing works right if the brain isn’t working correctly. A doctor that produces cell therapy products in Europe once said to me, “Remember, these products are not miracles.” And I replied, “If you have tried everything and nothing helps; if you are slowly going blind, or having failure of one of your major organs and these products help you….. then they are miracles to you.” The future of medicine and medical treatments, will give way in the very near future, in my opinion, to health therapies and health maintenance. Those doctors who begin now to bring health therapies into their practice will be ahead of the masses. Forms of cell therapy will be the treatment of choice, not only by most physicians, but by the majority of patients. Consequently, that is one purpose for writing this book. It is extremely important for physicians, and patients, to understand and know the real and the fake. I 39

do not intend to imply that I am the ultimate expert, but I have learned a great deal in the thirty years I have been working with cell therapy products.

Reasons for Taking Embryonic Organo Cellular Therapy Usually is for One of Two Purposes:
1. Anti-aging and health maintenance
• • • • • •

Over 30 to any age Athletes who want to be, and stay, physically superior and wish to use a legal product that is a dietary supplement Preformers who wish to appear young and look the best they can Weathy people who wish to stay as healthy as they can be, for as long as they can be, and, live as long as they can 69,000,000 Baby-boomers who want to stay mentally and physically superior their entire life. Millions and millions of people like me, over 60, who want to live as long as they can, as healthy as they can be

2. To help improve body structure, or body function: the “diseases of aging”, Chronic diseases or even birth defects.
• •

At any age, specific abnormal body function or body structure, such as low adrenal function or Down Syndrome. Muscle disorders, physical health conditions or functions

Hippocrates said it first: “Like goes to like, heart goes to heart, liver goes to liver”…… and like heals like. These are some simple rules that should be followed. 1. Do not take organs, if you are allergic to the source of the organs, i.e. lamb or pig. 2. Do not take Adrenal if you have high-blood pressure. Contact the processing laboratory. 3. Do not give organs, if there is a current, or underlying chronic infection anywhere in the body. 4. Do not take Heart for 1 year after, if there has been a heart attack or stroke. Take all support organs: Placenta, Veins, Vessels, Brain, Thymus and Muscle. 5. Do not take Liver if there is severe cirrhosis or hepatitis, until after taking support organs. Contact the processing laboratory. 6. In the case of a severe pathology, such as cancer, chronic fatigue, AIDS, etc. Contact the processing laboratory. 7. Children should be dosed according to weight. Under 40 pounds – 1cc. Under 70 pounds- 2cc. Over 70 pounds- 3cc. 8. Small animals should be dosed according to weight. Under 10 pounds, 1cc. Under 40 pounds 2cc.

40

Decide on an ANTI-AGING Embryonic Organ Cell therapy Program for Your Lifetime
Anyone interested in true anti-aging and maintaining optimum health during their lifetime, should decide on a plan and follow it for his/ or her entire lifetime, or until they feel a change is desired. Almost anyone will find a way to afford an anti-aging program, if it is not too expensive, gives good results and something they think they can afford to continue for a long time. One such system and program is designed around just two bottles of Organ Dietary Supplements; one multi-organ combination, or Combo supplement, and one individual organ. The concept is that this two-bottle program, when given every three months throughout life, will continually and constantly, help to renew and maintain the various systems for body function and body structure constantly. The organ supplements work like building blocks and are continually helping to improve the patients’ overall general health, mentally and physically. It is a known fact, that most people tell their friends about a good product, or a good doctor, and want their friends to benefit as they have. So the idea of people networking is built into this concept. Examples of this program follow. This system is designed to be used by any individual or group: families, friends, clubs, sports clubs, professional athletes, professional ball clubs, boxers, body-builders, golfers, tennis players and certainly, senior citizens, or anyone who desires to maintain optimum health, maintaining optimum health, AND anti-aging. It is “Anti-aging in Just 2 Bottles”; one Combo and one Individual Organ Supplement, to address one specific body function, or body structure. It is to be repeated every three months; four times each year. There are eleven programs and the patient can take different programs every time or continue with the previous program. And of course, it can be taken every month, or even more often. It is inexpensive enough that the majority of people can afford to continue this program for life. If your doctor uses an E.A.V., which is a computerized program, he/she will be able to measure the percentage of function, of each organ that you take, and the improvement in the percentage each month, in all the different organs and glands, that you take, of this “Anti-aging in Just 2 Bottles” program. In addition to the Just 2-Bottle Programs, are the custom programs, which are designed specific for the customer; MALE OVER 60 - FEMALE OVER 60 - MALE OVER 40 FEMALE OVER 40 and many others. Most of these custom anti-aging programs contain 20 to 30 bottles. Following is a “White Paper”, which describes the schedule and eleven programs that are offered in the 2-Bottle Program. Additional programs will be designed in the near future.

41

Cell Therapy Is Now Available
Embryonic Organ Supplements are regenerative in nature and represent an effective and affordable approach to cell therapy and anti-aging.

Available for the past 70 years in Europe, porcine embryonic cellular supplementation is now available from your Coach, or our website, in the form of sterile embryonic cellular preparations, making it possible, and affordable, to receive the incredible benefits of Embryonic Organo Therapy, without traveling to expensive European Clinics. Embryonic Organo Therapy supplementation uses the same principal as human stem cell therapy. However, instead of extracting whole intact stem cells, from a human placenta, EOT starts with the selection of specific organ cells from an organic porcine animal embryo, in the second month of gestation. E.O.T. then, is a few steps ahead of stem cells (which are non-specific cells), as all E.O.T. cellular products are specific organ products and as such, can be chosen to address any specific organ, or organs, in the body. Many years of experience have demonstrated that pigs are the best donor animals because they are vital, hardy animals and immunologically, their bodies are the closest match to the human body. Due to this fact, many heart valve transplants for humans are still derived from pigs. In addition, porcine cellular preparations are particularly compatible with the human body, and in the embryonic stage, there is a very low degree of immunogenicity. Embryonic Organo Therapy preparations, which are derived from specific embryonic organ cell tissue, are gently harvested and processed via proprietary technology, in a way that their vital life force remains active. Because of this fact, these Nutritional Supplements can help address almost any health problem. Embryonic Organo Therapy individual organ active peptides are available in thirty-one 3ml vials and 12-combination 7ml vials, containing 3 to 9 organs. Each extract is composed of low molecular weight, sterile cellular constituents, thus enhancing absorption both through the oral mucosa and intestinal wall. They may be taken orally and, with careful planning with a trained coach, can often perform little miracles in making you feel young and healthy again. Since these embryonic cellular preparations have such a low degree of immunogenicity, they are typically not recognized as foreign antigens by the host body. According to Dr. Niehans', Father of Cell Therapy, when ingested into the human body, “like goes to like”; bone to bone, liver to liver, heart to heart, etc., where they begin to support and to help enhance the function of that specific target organ. Embryonic Organo Therapy cellular preparations, which seem to be organ specific, are not species specific and “educate” human and animal organs alike to function at a more youthful level. The organ itself, then, retains its’ vigor and vitality for an extended period of time. 42

In addition to body revitalization, health maintenance, and anti-aging, Cell Therapy will effectively stimulate the cells of specific organ systems concerned with immune function, memory and cognitive function, sexual function, liver function and bone structure and function. E.O.T. Cell Therapy will also help to, remodel body musculature, enhance sexual function, increase rate of wound healing, increase aerobic capacity, enhance sports performance, restore fertility, reverse senile ocular conditions, increase energy, strengthen vitality, improve skin elasticity and promote general anti-aging, as it gently improves all three embryonic tissue groups, ectoderm, endoderm and mesoderm. Embryonic Organo Therapy products are manufactured according to the requirements of GMP (Good Manufacturing Procedures), meet the standards for both food and oral nutritional supplements, are supplied sterile in liquid form to preserve structure and activity of peptides and growth factors, are 100% pure and natural, and contain no preservatives. Standard quarterly programs, such as the ones listed below, are available for well under $1000.00, from your coach. Compare this to the famous Switzerland Clinic’s $15,000.00 Revitalizing Program.

Quarterly Programs Using Just Two Bottles
Male Enhance Program Female Enhance Program Thymus – Immunity Program Adrenal - Energy Program Cognitive Enhance Program Heart - Cardio Enhance Program Eye - Vision Program Skin - Bone - Hair Program Pre-Op Program Female Post-Op Program Male Post-Op Program
(1 Male Enhance Combo, plus 1 Testicle) (1 Female Enhance Combo, plus 1 Porcine Total) (1 Thymus-Immunity Combo, plus 1 Thymus) (1 Adrenal-Energy Combo, plus 1 Placenta ) (1 Adrenal–Energy Combo, plus 1 Brain) (1 Heart-Cardio Combo, plus 1 Placenta) (1 Eye-Vision Combo, plus 1 Placenta) (1 Skin-Bone-Hair Combo, plus 1 Mesenchyme) (1 Thymus-Immunity Combo, plus 1 Total Porcine) (1 Female Enhancement Combo, plus 1 Placenta) (1 Male Enhancement Combo, plus 1 Porcine Total)

(Standard Concentrated 4-Week Programs consisting of 20 to 24 bottles are also available.)

Custom programs and detailed information is available upon request: Samples of the above Programs Follow 43

INTRODUCING
Cell Therapy Supplementation
Now Embryonic Organ Therapy, is available in the form of sterile preparations of embryonic porcine cellular tissue, making it possible, and affordable, to receive the incredible benefits of Cell Therapy, without traveling to expensive European Clinics. When taken orally, and on a regular schedule, these natural products help to strengthen and improve body structure and body function. According to Dr. Paul Niehans, Father of Cell Therapy, these porcine cellular preparations circulate throughout the body, until they recognize, and attach, to their human counterpart. Then the embryonic cells, which are functionally organ specific, but not species specific, imprint their vigor upon tired and degenerated cells, stimulating them to function with renewed youth and efficiency.

The MALE ENHANCE Program
Including 1 MALE ENHANCE Combo, plus 1 TESTICLE, should be taken each quarter Embryonic MALE ENHANCEMENT Combination contains a proprietary blend of porcine cellular preparations of Adrenal, Heart, Liver, Placenta, Porcine Total, Testicle and Thymus. It is formulated to help: enhance circulation, Increase energy, normalize adrenals, increase libido and sexual function, increase vitality, enhance a sense of well-being, improve ability to handle stress, maintain nervous system, immune function and all related systems, increase cellular oxygenation, strengthen and regenerate arterial and vascular walls, regulate testerone production, causes a soft, gentle improvement in all three embryonic tissue groups, Ectodermal, Endodermal and Mesodermal tissue organs, normalizing the function of all organs and glands, improving immune functions, and promoting general anti-aging overall. Embryonic TESTICLE Extract is a single-organ, animal-based dietary supplement, extracted from embryonic porcine testicle cells and is formulated to help: maintain and normalize all major male sexual functions, enhance the production of sperm, and the regulation of male hormones, revitalize entire male reproductive system, enhance libido, increase fertility, causes a soft, gentle long-term improvement in all Mesodermal tissue organs, and promotes general testicular and related network organs function and longterm anti-aging. The MALE ENHANCE Program is available for well under $1000.00. from your coach, or our website, and when you signup for a year’s program (one 2bottle program every 3 months), you will receive free of charge, 1 Cell Therapy product, “The European Clinic Formula”, similar to the formula offered at the famous Switzerland Clinic’s $15,000.00 Revitalizing Program.

44

FEMALE ENHANCEMENT ProgramALE ENHANCEMENT Program

INTRODUCING
Cell Therapy Supplementation
Now Embryonic Organ Therapy, is available in the form of sterile preparations of embryonic porcine cellular tissue, making it possible, and affordable, to receive the incredible benefits of Cell Therapy, without traveling to expensive European Clinics. When taken orally, and on a regular schedule, these natural products help to strengthen and improve body structure and body function. According to Dr. Paul Niehans, Father of Cell Therapy, these porcine cellular preparations circulate throughout the body, until they recognize, and attach, to their human counterpart. Then the embryonic cells, which are functionally organ specific, but not species specific, imprint their vigor upon tired and degenerated cells, stimulating them to function with renewed youth and efficiency.

The FEMALE ENHANCE Program
Including 1 Embryonic FEMALE ENHANCE Combo, plus 1 Porcine Total, should be taken each quarter

Embryonic FEMALE ENHANCE Combination contains a proprietary blend of porcine cellular preparations of Adrenal, Heart, Liver, Ovary, Placenta, Porcine Total and Thymus. It is formulated to help: enhance circulation, increase energy, normalize adrenals, increase vitality, enhance a sense of well-being, improve ability to handle stress, maintain nervous system, immune function and all related systems, increase cellular oxygenation, strengthen and regenerate arterial and vascular walls, enhance fertility, regulate estrogen and progesterone production, promote a soft, gentle improvement in all three embryonic tissue groups, Ectodermal, Endodermal and Mesodermal tissue organs, normalizing the function of all organs and glands, improving immune functions, and promoting general anti-aging overall. Embryonic TOTAL PORCINE Extract is a multi-organ complete animal-based dietary supplement, extracted from embryonic porcine cells and is formulated to help: improve and revitalize all systems and components of the body, enhance with a soft effect, all organs, glands and body tissues, strengthen the basis of all organs and glands as to structure and function in all three embryonic tissue groups, Ectodermal, Endodermal and Mesodermal tissue organs, increasing overall communication between all organs, strengthen and enhance entire body structure, create an overall feeling of well-being, and promoting general anti-aging overall. The FEMALE ENHANCE Program is available for well under $1000.00, from your coach, or our website, and when you signup for a year’s program (one 2bottle program every 3 months), you will receive free of charge, 1 Cell Therapy product, “The European Clinic Formula”, similar to the formula offered at the famous Switzerland Clinic’s $15,000.00 Revitalizing Program.

45

INTRODUCING
Cell Therapy Supplementation
Now Embryonic Organ Therapy, is available in the form of sterile preparations of embryonic porcine cellular tissue, making it possible, and affordable, to receive the incredible benefits of Cell Therapy, without traveling to expensive European Clinics. When taken orally, and on a regular schedule, these natural products help to strengthen and improve body structure and body function. According to Dr. Paul Niehans, Father of Cell Therapy, these porcine cellular preparations circulate throughout the body, until they recognize, and attach, to their human counterpart. Then the embryonic cells, which are functionally organ specific, but not species specific, imprint their vigor upon tired and degenerated cells, stimulating them to function with renewed youth and efficiency.

The THYMUS-IMMUNITY Program Including 1 Embryonic THYMUS-IMMUNITY Combo, plus 1 THYMUS,
should be taken each quarter Embryonic THYMUS-IMMUNITY Combination contains a proprietary blend of porcine cellular preparations of Thymus, Bone Marrow, Spleen, and Total Intestines. It is formulated to help: enhance the immune system, encourage healing, shorten healing time, control and regulate immune function, strengthen and improve thymus gland functions, encourage red blood cell proliferation, increase cellular oxygen levels, regenerate the vascular system, clean and drain blood contaminates, provide general support for all organs and glands, maintain and strengthen intestinal tissue, increase digestive functions, improve absorption, improve enzymatic functions and causes soft, gentle improvement in all Endodermal and Mesodermal tissue, as it helps to promote general immune system organ anti-aging. THYMUS Extract is a single-organ, animal-based dietary supplement, extracted from embryonic porcine thymus cells and is formulated to help strengthen, support and improve the function of the thymus, normalize T-4 “killer cell” production, improve immune function, enhance both general structure and function, cause a soft, gentle long-term improvement in all Endodermal tissue organs and promote general anti-aging of the thymus, as it supports immunity organs and related systems. The THYMUS-IMMUNITY Program is available for well under $1000.00, from your coach, or our website, and when you signup for a year’s program (one 2-bottle program every 3 months), you will receive free of charge, 1 Cell Therapy product, “The European Clinic Formula”, similar to the formula offered at the famous Switzerland Clinic’s $15,000.00 Revitalizing Program.

46

INTRODUCING
Cell Therapy Supplementation
Now Embryonic Organ Therapy, is available in the form of sterile preparations of embryonic porcine cellular tissue, making it possible, and affordable, to receive the incredible benefits of Cell Therapy, without traveling to expensive European Clinics. When taken orally, and on a regular schedule, these natural products help to strengthen and improve body structure and body function. According to Dr. Paul Niehans, Father of Cell Therapy, these porcine cellular preparations circulate throughout the body, until they recognize, and attach, to their human counterpart. Then the embryonic cells, which are functionally organ specific, but not species specific, imprint their vigor upon tired and degenerated cells, stimulating them to function with renewed youth and efficiency.

The ADRENAL-ENERGY Program
Including 1 Embryonic ADRENAL-ENERGY Combo, plus 1 PLACENTA
Embryonic ADRENAL-ENERGY Combo contains a proprietary blend of porcine cellular preparations of Adrenal, Brain Total, Hypothalamus, Pituitary, Thymus and Thyroid. It is formulated to help: Increase energy, normalize adrenal function, increase vitality, promote wellness, relieve stress, normalize endocrine function, enhance cognitive function, enhance sense of well-being, enhance sexual function, growth hormone production, cellular oxygen levels, and muscle tone; enhance immune system, increase T-4 helper-cell production, assist the bodies' general adaptation to the environment, regulate normal sleep and cause a soft, gentle improvement in all organs and body structure, as it promotes continual general anti-aging. Embryonic PLACENTA Extract is a single-organ, animal-based dietary supplement, extracted from embryonic porcine placenta cells and is formulated to help: improve and revitalize the body, revitalize, rebuild and strengthen entire arterial and vascular system, enhance circulation and increase cellular oxygen levels, provide additional strength to the heart, lungs, kidneys and all major organs, shorten healing time, cause a soft, gentle longterm improvement throughout entire body, and promote general anti-aging of all systems. The ADRENAL-ENERGY Program is available for well under $1000.00, from your coach, or our website, and when you signup for a year’s program (one 2bottle program every 3 months), you will receive free of charge, 1 Cell Therapy product, “The European Clinic Formula”, similar to the formula offered at the famous Switzerland Clinic’s $15,000.00 Revitalizing Program.

47

INTRODUCING
Cell Therapy Supplementation
Now Embryonic Organ Therapy, is available in the form of sterile preparations of embryonic porcine cellular tissue, making it possible, and affordable, to receive the incredible benefits of Cell Therapy, without traveling to expensive European Clinics. When taken orally, and on a regular schedule, these natural products help to strengthen and improve body structure and body function. According to Dr. Paul Niehans, Father of Cell Therapy, these porcine cellular preparations circulate throughout the body, until they recognize, and attach, to their human counterpart. Then the embryonic cells, which are functionally organ specific, but not species specific, imprint their vigor upon tired and degenerated cells, stimulating them to function with renewed youth and efficiency.

The COGNATIVE ENHANCE Program
Including 1 ADRENAL-ENERGY Combo, plus 1 Brain, should be taken each quarter
Embryonic ADRENAL-ENERGY Combination contains a proprietary blend of porcine cellular preparations of Brain Total, Adrenal, Hypothalamus, Pituitary, Thymus and Thyroid. It is formulated to help: increase energy, normalize adrenal function, increase vitality, promote wellness, relieve stress, normalize endocrine function, enhance cognitive function, enhance sense of well-being, enhance sexual function, growth hormone production, cellular oxygen levels, and muscle tone, enhance immune system, increase T4 helper-cell production, assist the bodies' general adaptation to the environment, regulate normal sleep, cause a soft, gentle improvement in all organs and body structure and promotes general anti-aging. Embryonic BRAIN TOTAL Extract is a single-organ, animal-based dietary supplement, extracted from embryonic porcine brain cells and is formulated to help: normalize all major systems, enhance cognitive function, increase communication between the brain and all organs and systems, improve neurological response, cause a soft, gentle improvement in all Ectodermal tissue organs and promote general brain anti-aging The COGNATIVE ENHANCE Program is available for well under $1000.00, from your coach, or our website, and when you signup for a year’s program (one 2bottle program every 3 months), you will receive free of charge, 1 Cell Therapy product, “The European Clinic Formula”, similar to the formula offered at the famous Switzerland Clinic’s $15,000.00 Revitalizing Program.

48

INTRODUCING
Cell Therapy Supplementation
Now Embryonic Organ Therapy, is available in the form of sterile preparations of embryonic porcine cellular tissue, making it possible, and affordable, to receive the incredible benefits of Cell Therapy, without traveling to expensive European Clinics. When taken orally, and on a regular schedule, these natural products help to strengthen and improve body structure and body function. According to Dr. Paul Niehans, Father of Cell Therapy, these porcine cellular preparations circulate throughout the body, until they recognize, and attach, to their human counterpart. Then the embryonic cells, which are functionally organ specific, but not species specific, imprint their vigor upon tired and degenerated cells, stimulating them to function with renewed youth and efficiency.

The HEART-CARDIO ENHANCE Program
Including 1 Embryonic HEART-CARDIO Combo, plus 1 PLACENTA, should be taken each quarter Embryonic HEART-CARDIO Combination contains a proprietary blend of porcine cellular preparations of Heart, Artery and Placenta. It is formulated to help: strengthen heart muscle, improve chamber function, increase energy, increase vitality, regulate heart rhythm, enhance circulation, increase cellular oxygen levels, strengthen and support arterial and venous walls, strengthen and support related systems such as the lungs, brain, digestive and immune, revitalize all body functions and body structure, cause a soft, gentle long-term improvement throughout entire body, promote general anti-aging in the total cardiovascular system. Embryonic PLACENTA Extract is a single-organ, animal-based dietary supplement, extracted from embryonic porcine placenta cells and is formulated to help: improve and revitalize the body, revitalize, rebuild and strengthen entire arterial and vascular system, enhance circulation and increase cellular oxygen levels, provide additional strength to the heart, lungs, kidneys and all major organs, shorten healing time, cause a soft, gentle longterm improvement throughout entire body, and promote general anti-aging of all systems. The HEART-CARDIO ENHANCE Program is available for well under $1000.00, from your coach, or our website, and when you signup for a year’s program (one 2-bottle program every 3 months), you will receive free of charge, 1 Cell Therapy product, “The European Clinic Formula”, similar to the formula offered at the famous Switzerland Clinic’s $15,000.00 Revitalizing Program.

49

INTRODUCING
Cell Therapy Supplementation
Now Embryonic Organ Therapy, is available in the form of sterile preparations of embryonic porcine cellular tissue, making it possible, and affordable, to receive the incredible benefits of Cell Therapy, without traveling to expensive European Clinics. When taken orally, and on a regular schedule, these natural products help to strengthen and improve body structure and body function. According to Dr. Paul Niehans, Father of Cell Therapy, these porcine cellular preparations circulate throughout the body, until they recognize, and attach, to their human counterpart. Then the embryonic cells, which are functionally organ specific, but not species specific, imprint their vigor upon tired and degenerated cells, stimulating them to function with renewed youth and efficiency.

The EYE-VISION Program
Including 1 Embryonic EYE-VISION Combination, plus 1 PLACENTA, should be taken each quarter Embryonic EYE-VISION Combination contains a proprietary blend of porcine cellular preparations of Total Eye, Total Brain, Muscle, Placenta, Artery, Veins, Vessels and Thymus. It is formulated to help: improve overall vision, normalize eye functions, increase focusing ability, improve vascular circulation in eyes and throughout body, strengthen veins, and arteries in ocular tissue, increase cellular oxygen levels, strengthen and support, arterial and venous walls, sustain body through general homeostasis, enhance healing, enhance immune function, cause a soft, gentle improvement in all organs and body structure and promotes general anti-aging. Embryonic PLACENTA Extract is a single-organ, animal-based dietary supplement, extracted from embryonic porcine placenta cells and is formulated to help: improve and revitalize the body, revitalize, rebuild and strengthen entire arterial and vascular system, enhance circulation and increase cellular oxygen levels, provide additional strength to the heart, lungs, kidneys and all major organs, shorten healing time, cause a soft, gentle longterm improvement throughout entire body, and promote general anti-aging of all systems. The EYE-VISION Program is available for well under $1000.00, from your coach, or our website, and when you signup for a year’s program (one 2-bottle program every 3 months), you will receive free of charge, 1 Cell Therapy product, “The European Clinic Formula”, similar to the formula offered at the famous Switzerland Clinic’s $15,000.00 Revitalizing Program.

50

INTRODUCING
Cell Therapy Supplementation
Now Embryonic Organ Therapy, is available in the form of sterile preparations of embryonic porcine cellular tissue, making it possible, and affordable, to receive the incredible benefits of Cell Therapy, without traveling to expensive European Clinics. When taken orally, and on a regular schedule, these natural products help to strengthen and improve body structure and body function. According to Dr. Paul Niehans, Father of Cell Therapy, these porcine cellular preparations circulate throughout the body, until they recognize, and attach, to their human counterpart. Then the embryonic cells, which are functionally organ specific, but not species specific, imprint their vigor upon tired and degenerated cells, stimulating them to function with renewed youth and efficiency.

The SKIN – BONE - HAIR Program
Including 1 Embryonic SKIN – BONE - HAIR Combo, plus 1 MESENCHYME, should be taken each quarter.

Embryonic SKIN – BONE - HAIR Combination contains a proprietary blend of porcine cellular preparations of Skin, Bone, Mesenchyme, Placenta and Total Porcine. It is formulated to help: build stronger bones with increased density, accelerate osteo healing, strengthen connective tissue, joints, muscles, skin, organs and glands, encourage general healing, enhance circulation, increase cellular oxygen and strengthen arterial and vascular walls, strengthen the vascular system, enhance the immune system function, normalize the functioning of organs, glands and support structures such as, bone marrow, ligaments and tendons, cause a soft, gentle improvement in all three embryonic tissue groups, Ectodermal, Endodermal and Mesodermal tissue organs, normalizing the function of all organs and glands, improve immune functions and systems, and promoting general antiaging overall. Embryonic MESENCHYME Extract is a single-organ, animal-based dietary supplement, extracted from embryonic porcine mesenchymal cells and is formulated to help: strengthen all connective tissue, joints, muscles, skin, hair, organs and glands, shorten healing time, reduce structural injuries, improve general body balance, maneuverability and flexibility, increase freedom of movement, retard skin deterioration and wrinkling, strengthen all structural tissue, and improve athletic abilities, cause a soft, gentle improvement in all Mesodermal tissue organs and promotes general anti-aging of connective tissue and related organs. The SKIN – BONE - HAIR Program is available for well under $1000.00, from your coach, or our website, and when you signup for a year’s program (one 2-bottle program every 3 months), you will receive free of charge, 1 Cell Therapy product, “The European Clinic Formula”, similar to the formula offered at the famous Switzerland Clinic’s $15,000.00 Revitalizing Program.

51

INTRODUCING
Cell Therapy Supplementation
Now Embryonic Organ Therapy, is available in the form of sterile preparations of embryonic porcine cellular tissue, making it possible, and affordable, to receive the incredible benefits of Cell Therapy, without traveling to expensive European Clinics. When taken orally, and on a regular schedule, these natural products help to strengthen and improve body structure and body function. According to Dr. Paul Niehans, Father of Cell Therapy, these porcine cellular preparations circulate throughout the body, until they recognize, and attach, to their human counterpart. Then the embryonic cells, which are functionally organ specific, but not species specific, imprint their vigor upon tired and degenerated cells, stimulating them to function with renewed youth and efficiency.

The PRE-OP Program
Including 1 Embryonic THYMUS-IMMUNITY Combo, Plus 1 TOTAL PORCINE, should be taken each quarter. Embryonic THYMUS-IMMUNITY Combination contains a proprietary blend of porcine cellular preparations of Thymus, Bone Marrow, Spleen, and Total Intestines. It is formulated to help: enhance the immune system, encourage healing, shorten healing time, control and regulate all immune functions, strengthen and improve thymus gland functions, encourage red blood cell proliferation, increase cellular oxygen levels, regenerate the vascular system, clean and drain blood contaminates, provide general support for all organs and glands, maintain and strengthen intestinal tissue, increase digestive functions, improve absorption, improve enzymatic functions and causes soft, gentle improvement in all Endodermal and Mesodermal tissue, as it helps to promote general immune system organ anti-aging. Embryonic PORCINE TOTAL Extract is a multi-organ, complete animal-based dietary supplement, extracted from embryonic total porcine cells and is formulated to help: improve and revitalize all systems and components of the body, enhance with a soft effect, all organs, glands and body tissues, strengthen the basis of all organs and glands, as to structure and function in all three embryonic tissue groups, Ectodermal, Endodermal and Mesodermal tissue organs, increasing overall communication between all organs, strengthen and enhance entire body structure, create an overall feeling of well-being, and promoting general anti-aging overall. The PRE-OP Program is available for well under $1000.00, from your coach, or our website, and when you signup for a year’s program (one 2-bottle program every 3 months), you will receive free of charge, 1 Cell Therapy product, “The European Clinic Formula”, similar to the formula offered at the famous Switzerland Clinic’s $15,000.00 Revitalizing Program.

52

INTRODUCING
Cell Therapy Supplementation
Now Embryonic Organ Therapy, is available in the form of sterile preparations of embryonic porcine cellular tissue, making it possible, and affordable, to receive the incredible benefits of Cell Therapy, without traveling to expensive European Clinics. When taken orally, and on a regular schedule, these natural products help to strengthen and improve body structure and body function. According to Dr. Paul Niehans, Father of Cell Therapy, these porcine cellular preparations circulate throughout the body, until they recognize, and attach, to their human counterpart. Then the embryonic cells, which are functionally organ specific, but not species specific, imprint their vigor upon tired and degenerated cells, stimulating them to function with renewed youth and efficiency.

The FEMALE POST-OP Program
Including 1 FEMALE ENHANCE Combo, plus 1 SKIN-PLACENTA Embryonic FEMALE ENHANCE Combination contains a proprietary blend of porcine cellular preparations of Adrenal, Heart, Liver, Ovary, Placenta, Porcine Total and Thymus. It is formulated to help: enhance circulation, increase energy, normalize adrenals, increase vitality, enhance a sense of well-being, improve ability to handle stress, maintain nervous system, immune function and all related systems, increase cellular oxygenation, strengthen and regenerate arterial and vascular walls, regulate estrogen and progesterone production, enhance fertility, promote a soft, gentle improvement in all three embryonic tissue groups, Ectodermal, Endodermal and Mesodermal tissue organs, normalizing the function of all organs and glands, improving immune functions, and promoting general anti-aging overall. Embryonic SKIN-PLACENTA Extract is a multi-organ, animal-based dietary supplement, extracted from embryonic porcine skin and placenta cells and is formulated to help: improve and revitalize the body, revitalize, rebuild and strengthen entire arterial and vascular system, enhance circulation and increase cellular oxygen levels, provide additional strength to the heart, lungs, kidneys and all major organs, shorten healing time, cause a soft, gentle long-term improvement throughout entire body, enhance collagen production, promote a vibrant dermis, enhance and strengthen all layers of skin, encourage strong youthful skin, support healthy hair and nail growth, enhance strong and quick healing, promote general anti-aging of the skin, vascular structure and all related systems The FEMALE POST-OP Program is available for well under $1000.00, from your coach, or our website, and when you signup for a year’s program (one 2-bottle program every 3 months), you will receive free of charge, 1 Cell Therapy product, “The European Clinic Formula”, similar to the formula offered at the famous Switzerland Clinic’s $15,000.00 Revitalizing Program.

53

INTRODUCING
Cell Therapy Supplementation
Now Embryonic Organ Therapy, is available in the form of sterile preparations of embryonic porcine cellular tissue, making it possible, and affordable, to receive the incredible benefits of Cell Therapy, without traveling to expensive European Clinics. When taken orally, and on a regular schedule, these natural products help to strengthen and improve body structure and body function. According to Dr. Paul Niehans, Father of Cell Therapy, these porcine cellular preparations circulate throughout the body, until they recognize, and attach, to their human counterpart. Then the embryonic cells, which are functionally organ specific, but not species specific, imprint their vigor upon tired and degenerated cells, stimulating them to function with renewed youth and efficiency.

The MALE POST OP Program
Including 1 MALE ENHANCE Combo, plus 1 TOTAL PORCINE
Embryonic MALE ENHANCE Combination contains a proprietary blend of porcine cellular preparations of Adrenal, Heart, Liver, Placenta, Porcine Total, Testicle and Thymus. It is formulated to help: enhance circulation, Increase energy, normalize adrenals, increase libido and sexual function, increase vitality, enhance a sense of well-being, improve ability to handle stress, maintain nervous system, immune function and all related systems, increase cellular oxygenation, strengthen and regenerate arterial and vascular walls, regulate testosterone production, enhance fertility, causes a soft, gentle improvement in all three embryonic tissue groups, Ectodermal, Endodermal and Mesodermal tissue organs, normalizing the function of all organs and glands, improve immune functions and systems, and promoting general anti-aging overall. Embryonic TOTAL PORCINE Extract is a multi-organ whole-animal-based dietary supplement, extracted from embryonic porcine cells and is formulated to help: improve and revitalize all systems and components of the body, enhance with a soft effect, all organs, glands and body tissues, strengthen the basis of all organs and glands, as to structure and function in all three embryonic tissue groups, Ectodermal, Endodermal and Mesodermal tissue organs, increasing overall communication between all organs, strengthen and enhance entire body structure, create an overall feeling of well-being, and promoting general anti-aging overall. The MALE POST OP Program is available for well under $1000.00, from your coach, or our website, and when you signup for a year’s program (one 2-bottle program every 3 months), you will receive free of charge, 1 Cell Therapy product, “The European Clinic Formula”, similar to the formula offered at the famous Switzerland Clinic’s $15,000.00 Revitalizing Program.

54

Good

-

Better

-

THE BEST

A U.S. company has supplied us with their suggestions for EOT programs that are designed to benefit your health and fit your budget, with a choice of: A Good Program, which includes: Individual Embryonic Organ Extracts, to support and enhance the desired (target) organ, plus 1 or 2 support organs. Recommended is 1 bottle of each organ per week, from 2 to 6 weeks. A Better Program, which includes: a Combination (Combo) Embryonic Organ Extract, to support and enhance the desired, target organ, or system, plus 1 or 2 Individual Embryonic support organs. Recommended is 1 of each organ per week, from 2 to 6 weeks) And THE BEST Program, which includes: 1 or more Combos, plus Individual Support Organs to help rebuild and stimulate the entire target system to the best possible antiaging function. Bottles average from 16 to 24, taken over 4 to 6 weeks and are designed for long-term health and maintenance. Any of THE BEST helps to bring the body to a best possible homeostasis function condition. All of the above programs can be customized to include any organ, or system, that you desire, or need to correct a health problem. Customized Programs are usually designed, or suggested, by the Company’s Program Manager, who has been working with physicians and health professionals for over twentyeight years to customize programs for specific needs of individual patients and clients. Organotherapy is totally different than general health products, such as vitamins and minerals, where you know you need Vitamin C, or magnesium. That is simple, but when you are addressing complete systems in the body, such as, Immune System, Endocrine System, Vascular System, etc.: and also support organs, such as, spleen, bone marrow and total intestines, which support the thymus gland, as it regulates the immune system; and veins, vessels and artery/ aorta, which support the heart; and, of course, all organs involved in a specific health condition, all target organs, all support organs and all organs involved in specific systems, that work together to accomplish specific functions and actions; must all be considered in doing a specialized program.3 And, of course, even today, most medical schools do not require even a 1-hour course in nutrition. We have never heard of an American college offering a course in cell therapy of any type, but possibly there are courses now that involve stem cell information along with DNA, etc. As you read and focus on programs that you are interested in, concentrate on the various organs involved. You will find that some of the support organs are ones you would not have considered and begin to associate them with a health condition. One good example is, “Men Over Sixty” all need kidney, liver and spleen, the cleansing, draining organs, plus testicle. This is not the case with women, who need ovary, mesenchyme, adrenal and hypothalamus.

55

An Example of a Program Available from a leading company is:

Male Over 60 GOOD Program
GENERAL HEALTH ORAL PROGRAMS Contains: Adrenal, Hypothalamus, Thymus, Brain Total, Placenta, Testicle Pituitary, Thyroid and Embryo Total

Formulated to Support and Helps To:
• • • • • • • • • • • •

Increase energy Normalize adrenal function Improves ability to handle stress Strengthen, support and improve the function of the thymus Enhance cognitive function Increase communication between the brain and all organs and systems Improve neurological response throughout the body Enhance circulation and increase cellular oxygen levels Provide additional strength to the heart, lungs, kidneys +all major organs Increases cleansing throughout the body in all systems Improves libido and sexual functions Causes soft, gentle long-term improvement in all embryonic tissue organs

MALE OVER 60 GOOD PROGRAM
Oral Program Schedule (OP)

Week 1 Day 1 3 5 Adrenal Hypothalamus Thymus Day 1 3 5

Week 2 Brain Total Placenta Testicle Day 1 3 5

Week 3 Pituitary Thyroid Embryo Total

Plus 10 ML’s Liquid Organic Silica 2 times per day

on an empty stomach Any organ may be added to this program: Cartilage, Eye Total, Bone Marrow, Heart, Liver, Lung, Spine- Nerves, Spleen, any organ, or organs, or any of the Embryonic Combos, as desired.

56

Male Over 60 BETTER Program
GENERAL HEALTH PROGRAMS Contains: Adrenal, Hypothalamus, Thymus, Placenta, Pituitary, Thyroid, Testicle and Embryo Total

Formulated to Support and Helps To:
• • • • • • • • • • • • • • • •

Increase energy Normalize adrenal function Improve immune function and all related systems Enhance mental and physical energy Improve libido, sexual performance and ability Release growth hormone Increase cellular oxygenation Strengthen vascular walls and circulation Detoxify the body Increases cleansing throughout the body in all systems Encourage proliferation of red blood cells and T-4 fighter cells Regulate and improve the physiological functioning of the Intestines Normalize the endocrine system and production of hormones Improve and revitalize all major systems Rejuvenate the body to improve homeostasis condition Cause soft improvement of all Ectoderm, Endoderm and Mesoderm tissues

MALE OVER 60 BETTER PROGRAM

Weeks 1 and 3 Day 1 3 5 6 Adrenal Hypothalamus Thymus Placenta

Weeks 2 and 4 Day 1 3 5 6 Pituitary Thyroid Testicle Embryo Total

Weeks 5 and 6 Rest and Evaluate Weeks 7 thru 10 Repeat 1 thru 4 If Desired

Plus 10 ML’s Liquid Organic Silica 2 times per day on an empty stomach Any organ may be added to this program: Cartilage, Eye Total, Heart, Lung, SpineNerves, or any organ, or organs, or any of the Embryonic Combos, as desired.

57

Male Over 60 The BEST Program
GENERAL HEALTH PROGRAMS + 4 Combos Contains: Embryonic Adrenal-Energy Combo, Brain, Placenta, Pituitary, Thyroid Embryo Immunity Combo, Liver, Kidney, Testicle and Embryo Total,

Formulated to Support and Helps To:
• • • • • • • • • • • • • • • •

Increase energy ! Increase sexual ability ! Normalize adrenal function Enhance cognitive function ! Enhance immune system ! Shorten healing time Regulate normal sleep ! Improve liver function ! Improve digestion Enhance mental and physical energy Encourage proliferation of red blood cells and T-4 fighter cells Improve libido, sexual performance and ability Regenerate and strengthen the vascular system Enhance circulation and increase cellular oxygen levels Normalize the endocrine system and production of hormones Enhance libido and sexual function, growth hormone production, cellular oxygen levels and muscle tone and strength, athletic ability and endurance Assist the bodies' general adaptation to the environment Maintain and strengthen intestinal tissue Strengthen all connective tissue, joints, muscles, tendons and ligaments Improve general body balance, maneuverability and flexibility Rejuvenate the body to best possible homeostasis condition Causes soft, gentle improvement in all Mesodermal, Endodermal and Ectodermal organs

MALE OVER 60 + 4 Combos – BEST PROGRAM Weeks 1 and 3 Day 1 Emb. Energy Com 3 Brain Total 5 Placenta 6 Pituitary 7 Thyroid Weeks 5 and 6 Rest and Evaluate Weeks 7 thru 10 Repeat 1 thru 4 If Desired

Weeks 2 and 4 Day 1 Emb. Immunity Com 3 Liver 5 Kidney 6 Testicle 7 Embryo Total

Plus 10 ML’s Liquid Organic Silica 2 times per day on an empty stomach Any organ may be added to this program: Cartilage, Eye Total, Heart, Lung, Spine-Nerves, or any organ, or organs, or any of the Embryonic Combos, as desired.

58

An Example of a Program Available from a leading company is:

Female Over 60 GOOD Program
GENERAL HEALTH PROGRAMS Contains: Adrenal, Hypothalamus, Thymus, Brain Total, Bone, Skin, Mesenchyme (all connective tissue), Placenta, Thyroid

Formulated to Support and Helps To:
• • • • • • • • • •

Increase energy Normalize adrenal function Improves ability to handle stress Strengthen, support and improve the function of the thymus Enhance cognitive function Increase communication between the brain and all organs and systems Improve neurological response throughout the body Enhance circulation and increase cellular oxygen levels Provide additional strength to the heart, lungs, kidneys and all major organs Causes soft, gentle long-term improvement in all embryonic tissue organs

FEMALE OVER 60 Good Program Weeks 1 and 3 Day 1 3 5 Adrenal Hypothalamus Thymus Weeks 2 and 4 Day 1 3 5 Brain Total Bone Skin Weeks 5 and 6 Day 1 3 5 Mesenchyme Placenta Thyroid

Plus 10 ML’s Liquid Organic Silica 2 times per day

on an empty stomach Any organ may be added to this program: Cartilage, Eye Total, Bone Marrow, Heart, Liver, Lung, Spine- Nerves, Spleen, any organ, or organs, or any of the Embryonic Combos, as desired.

59

Female Over 60 BETTER Program
GENERAL HEALTH PROGRAMS Contains: Adrenal, Hypothalamus, Thymus, Placenta, Bone-Cartilage-Bone Marrow, Skin, Mesenchyme and Embryo Total

Formulated to Support and Helps To:
• • • • • • • • • • • • • • •

Increase energy Normalize adrenal function Causes soft, gentle improvement in all Mesodermal, Endodermal and Ectodermal tissue organs Assist the bodies' general adaptation to the environment Normalize the production of thyroid hormones Regulate calcium balance Strengthen, support and improve the function of the thymus Enhance and strengthen all 3 layers of skin Increase density and structure of bone systems Strengthen connective tissue and joints Encourage red blood cell proliferation Improve skin, hair, nails, and eyesight Increase freedom of movement Retard skin deterioration and wrinkling Improve and revitalize all systems

FEMALE OVER 60 Better Program Weeks 1 and 3 Day 1 3 5 6 Adrenal Hypothalamus Thymus Placenta Weeks 2 and 4 Day 1 Skin 3 Bone-CartilageBone Marrow 5 Mesenchyme 6 Porcine Total Weeks 5 and 6 Rest and Evaluate Weeks 7 thru 10 Repeat 1 thru 4 If Desired

Plus 10 ML’s Liquid Organic Silica 2 times per day on an empty stomach Any organ may be added to this program: Cartilage, Eye Total, Heart, Lung, SpineNerves, or any organ, or organs, or any of the Embryonic Combos, as desired.

60

Female Over 60 The BEST Program
GENERAL HEALTH PROGRAMS + 4 Combos Contains: Embryonic Adremal-Energy Combo, Bone, Placenta, Skin, Bone Marrow, Embryo Immunity Combo, Mesenchyme, Embryo Total, Spleen, Liver

Formulated to Support and Helps To:
• • • • • • • • • • • • • •

Increase energy ! Relieve stress ! Normalize adrenal function Enhance cognitive function ! Enhance immune system ! Shorten healing time Regulate normal sleep ! Improve Liver function ! Increase digestion Encourage red blood cell proliferation Regenerate the vascular system Retard skin deterioration and wrinkling Enhance libido and sexual function, growth hormone production, cellular oxygen levels and muscle tone, Assist the bodies' general adaptation to the environment Maintain and strengthen intestinal tissue Strengthen all connective tissue, joints, muscles, tendons and ligaments Improve general body balance, maneuverability and flexibility Causes soft, gentle improvement in all Mesodermal, Endodermal and Ectodermal organs Enhance circulation and increase cellular oxygen levels Increase density and structure of bone systems

FEMALE OVER 60 + 4 Combos – THE BEST PROGRAM Weeks 1 and 3 Day 1 Embryo Energy Co 3 Bone 5 Placenta 6 Skin 7 Bone Marrow Weeks 2 and 4 Day 1 Embryo Immunity Co 3 Mesenchyme 5 Porcine Total 6 Spleen 7 Liver Weeks 5 and 6 Rest and Evaluate Weeks 7 thru 10 Repeat 1 thru 4 If Desired

Plus 10 ML’s Liquid Organic Silica 2 times per day on an empty stomach Any organ may be added to this program: Cartilage, Eye Total, Heart, Lung, Spine-Nerves, or any organ, or organs, or any of the Embryonic Combos, as desired.

61

Embryonic Organ Extract Abbreviations Oral Use Only ECTOderm – Group 1
(BO) (BT) (EY) (HT) (PI) (SK) (SM) Bone Brain Eye Total Hypothalamus Pituitary Skin Spinal/Nerves

Organic Porcine Extracts ENDOderm – Group 2
(IT) Intestine (GB) Gall Bladder (PA) Pancreas (PR) Prostate (ST) Stomach (TH) Thymus (TY) Thyroid

MESOderm – Group 3
(AD) (AR) (CA) (HE) (KI) (LI) (LU) (ME) (MU) (OV) (SP) (TE) (VE) (VS) Adrenal A rtery Cartilage Heart Kidney Liver Lung Mesenchyme Muscle Ovary Spleen Testicle Veins Vessels/Blood

Neutral
(PL) (PT) Placenta Porcine Total

General Programs for Organ Use To Maintain Optimum Body Structure and Body Function From European Laboratory Take 1 bottle of each EOT Organ Listed that Week To Maintain and Improve 1-3 Nervous System General Use :
1. Stress 2. Anxiety 3. Nervous Breakdown

Weeks 2-4 LI BT TH BM CA BM CA CA LI SP LU 5 BT BT BT PT TH PT PT PT LU LI AD

Total Months May Be Added

HT BT HT CA PL ME PL LG TH TH LU

1 to 3 1 to 2 1 to 3 1 1 1 1 1 to to to to to 6 3 6 6 3

TH PL PT PL PT PT TH BM TH PT ME PT PT PT BT BT

Skeletal – Joints General Use :
4. Rheumatism 6. Demineralization 7. Oestoporosis 8. Arthritis 9. Inflammation

Lung/ Pulmonary Problems Use:
10. Bronchitis 11. Asthma 12. Emphysema

1 to 2 1 to 3 1 to 3

KI HE BT LU TH PT 62

To Maintain and Improve 1-3 Genital Systems General Use :
13. Menopause 14. Pre-Menstrual 15. Incontinence - Female 16. Incontinence - Male 17. Prostate 18. Sexual Asthenia

Weeks 2-4 PL IT HT VS KI ADPL BT BT BT HT PT OV-TE 5

Total Months May Be Added

PI PI OV PR PR HTBT

1 1 1 1 1

to to to to to

3 2 3 6 6

OV OV ME BT HT LI

TY LI MU ME TH VS

1 to 3

Digestive Systems: Colon, Liver and Pancreatic
19. Colitis 20. Hepatitis 21. Diabetes 22. Pancreatitis

PA TH HT LI

LI SP PA PA

LU BT PT HT

1 1 1 1

to to to to

3 3 6 3

BT IT GB LI LI IT PT PL

Vascular Systems: Arteries, Veins and Blood Vessels
23. Weak Veins 24. Post – Phlebitis 25. Post – Infarction 26. Artherosclerosis

PL PL PL PL

VS AR AR AR

LI LI BT PT

1 1 1 1

to to to to

3 3 3 3

VE BM SP PT KI HE SP PT

Dermatology Systems: Skin, Hair and Ulcers
27. Allergy 28. Acne 29. Ulcer 30. Alopecia - Baldness

TH PL LI VS

SP LI VE LI

BT PT PL SP

1 1 1 1

to to to to

3 2 3 6

LI IT IN BT VS PT VS BT

Degenerative:
31. Medical Esthenia – No Zest for Life – Enhance Energy and PL Vitality 32. Auto Immune – Severe

TH BT TH HT ST TH VS

PT SP TH AD TH LI PI PL

BT BM PT HT TE/OV PT HT EY

1 1 to 6 1 to 2 1 1 1 1 1 to to to to 2 3 2 3

TH ME BT ME PL LI AD ME AD VS/PL IN PA TY BT BT PT 63

General Revitalization :
33. Revitalization – General 34. Revitalizaion – Quick Renewal 35. Body Tune-Up – Male or Female 36. Regulate Digestive System 37. Puberty, Delayed 38. Cataracts – Eye Support

YOUR WONDERFUL FAMILY COMPANIONS: PETS AND ANIMALS

Anti-Aging Products will Benefit Companion Pets and Animals Just as Much As They Will You

PLEASE REMEMBER TO

• Make Certain They have Good Pure Water to Drink • Never let them in a Yard or Grass that has Pesticides, even when Dry • Plan their Food and Cook for Them, or Buy the Best you can from a Health Food Store. Never feed just dry food. • Never Buy Food from a Grocery, Drug or Chain Pet Store, Unless it is an Excellent Health Brand, Preferably Organic • Give them Lots of Love • Check the recommended animal websites on page 83 to find: 1. Recipes for home-made food for dogs and cats, possibly cheaper than what you are now buying. 2. An informative article on what is in commercial foods. 3. Sites you can donate to help animals and children.

64

HELLO! MY NAME IS ‘BABY’
I am The Poster Pet for EOT

BABY I am five years old and I weight three pounds. I have had two open heart surgeries and one experimental operation. I was a “Blue Baby”. A vein that did not close at birth so the blood went backwards from the heart. My little heart had to pump 20 or more times faster to keep blood and oxygen going to keep me alive. My first open heart operation was at 6 months old and 2 pounds. On top of all that, I was a bleeder! Bottom Line…. My vet said I could not live long and would be in extreme pain near the end. You know the rest. My breeder was told to put me to sleep. She really cares about her dogs and was determined to find another answer for me. I am the luckiest dog in the world. She found a person who loves animals, too. My New Mommy started giving me EOT Supplements for animals, heart and placenta. I immediately began to get better. And now, “You know the rest of the Story” As you see me here today. Healthy and Happy. My new Mommy had two other dogs, one with unhealthy kidneys and another Maltese, ‘Alexander the Great, with a liver shunt. Neither of these dogs, Candy or Alexander, were supposed to live a long life, even past one year old. Candy was 13 and Alexander was 18 ½. As I said, I am the luckiest dog in the world.

Baby
Oh, yes, Join our Club! 65

Duncan MacLeod

Hello, my name is Duncan MacLeod. I am eight years old and I had a tracheal collapse PLUS allergies. I had a really terrible time. Please read my story.

Du n ca n
**Rheeda H. has used EOT animal products for at least 20 years. This is Duncan’s story from September 14th through November 18th.

66

September 18, 2005 Duncan's Treatment - Chapter 1 Dear Jean, As you know, my Yorkshire Terrier, Duncan MacLeod, has a terrible problem with tracheal collapse. He also has allergies. He is now eight years old, and the tracheal collapse condition has become worse over the years. This year, during the allergy season, we almost lost him. The combination of his coughing from the allergens, combined with the worsening of the tracheal collapse, made it almost impossible for him to breathe at times. In his struggle to breathe, he would also become overheated. We had to keep him in a cool environment at all times. On two different occasions, we had to take him to an emergency treatment center. The last time he had to be put on oxygen for four hours, in addition to two sets of injections of steroids, sedatives, and antihistamines. Upon being discharged from the emergency treatment facility, he was put on large oral doses of steroids, sedatives, and antihistamines. His condition became so bad that we could not even reduce the high doses, let alone get him off these medications. Even with all the medications, he would often wake up in the middle of the night, panting and struggling to breathe. I would give him a cool bath, which would help. Then I ended up walking the floor with him, crying my eyes out, while he licked my nose and let me know he was concerned because I was crying. We knew he wouldn't live long if something wasn't done. We then turned to cell therapy. So far, his treatment has been as follows: Week 1 - Muscle, cartilage, and mesenchyme. Within 48 hours, we saw a big improvement. During the week that followed, I started reducing his medications. I discontinued the sedatives that were being used to control the coughing, and started tapering down his dose of steroids. He tolerated this well, and there were no bouts of panting or struggling to breathe. Duncan and I started to get sleep at night. Week 2 - Brain and adrenal - I discontinued the steroids. He has tolerated this well. He still has episodes of coughing; but, so far, I have only had to give him a small dose of medication twice. Unfortunately, whatever he is allergic to is outside where he goes to the bathroom. No matter where I take him, its there. Now, I've got to figure out how to address the allergies. I plan to give him another dose of muscle, cartilage, and mesenchyme, in a continuing effort to improve the tracheal collapse. Needless to say, my husband, friends, and I are all overjoyed and so thankful to see this kind of progress. I will keep you posted as we continue treatment.. Reeda H.

67

November 27, 2005 Duncan MacLeod - Update We cannot believe the progress Duncan has made since his first EOT treatment. On September 14, we gave him muscle, cartilage, and mesenchyme. We were able to take him off the torbutol, which is an anti-cough and sedative; and aminophilin, which is a bronchial dilator. We started reducing his dose of prednisone. His breathing started to improve within a few days, and he was coughing very little. Ten days later, we gave him brain and adrenal, and discontinued the prednisone. The improvement in his breathing continued, and he started to have more energy. (We were all able to stop holding our breath, and our breathing improved, also!) He still had occasional episodes of coughing, but they were of short duration and he did not require any medication. However, we were still very worried by these episodes, as we had seen how quickly it can escalate into a lifethreatening crisis. Due to the seasonal nature of his attacks, we suspected that Duncan has allergies. My own experience with cellular EOT therapy for the treatment of allergies had been that it took several months before I saw improvement. We were looking for a way to "tide him over" while we waited for the cell extract to work. For that reason, we took him to a holistic veterinarian on October 21. This vet felt that Duncan should be tested for things in his environment to see what, if anything, was contributing to the problems caused by the tracheal collapse. Since the allergy testing that was recommended was a form of muscle testing, it didn't seem as if there could be any danger. However, he started to go into distress during the testing. The vet then gave him a desensitization treatment. Big mistake. Duncan started coughing and had difficulty breathing. The vet gave him an injection of Torbutol. After twenty minutes, his coughing had stopped completely, and he seemed to be ok. Later that night, he had one of his worst attacks. This vet has no after hour's facilities, nor was there any way to contact her. Jim and I were up all night giving him everything we could think of. The next day, we took him back to the vet. She insisted that the prior night's attack could not have been caused by the treatment he had received earlier the previous day, and tried to demonstrate that the de-sensitization treatment had been effective by muscle testing him again. He went into a full blown attack, requiring injections of prednisone, torbutol, inhalation therapy, and fifteen minutes on oxygen. Jean, if we hadn't been so scared, I really don't know what Jim would have done. We were both so angry. We walked into that office with a dog in stable condition, and we left with a dog practically at death's door. She never even gave us a follow up call to see how he was doing. We finally got the poor little guy stabilized, and he continues to improve. It is our plan to continue the EOT campaign. We're now going to go with the cellular EOT for allergies. Obviously, even the holistic veterinary medicine approach doesn't work. A dog with both tracheal collapse and allergies has a real up-hill battle. By the way, many holistic veterinarians seem to think that the rabies vaccine is implicated in tracheal collapse. Did you know that they give the same dose to a five pound dog as they do to a 120 pound dog? 68

I'll continue giving you updates on the campaign we have dubbed "Saving Duncan MacLeod".

We both thank God for the EOT, for your love for animals. We can't tell you how grateful we are. Every day we give thanks that we still have him with us. Thank you so much for all you've done to help Duncan, as well as, all your other little animal friends. Reeda, Jim, and Duncan Sent: Friday, March 10, 2006 10:24 PM Subject: Duncan - update Duncan MacLeod Update Duncan's progress has really been impressive. Like all dogs, a special treat for Duncan is to go to the park and get to run off his leash. He had reached the point where he really couldn't do much running without stopping to cough. At times, it was just too risky because we couldn't control the coughing and he would have trouble breathing. As of the last two months, we have been able to take him out and watch him run like a little rabbit. In fact, when we try to put his leash on, he teases us by waiting until we are just about to pick him up, and then running in the other direction. (Of course, he is very obedient, and if we tell him firmly to sit, he will stop.) He just loves to "fake us out" and tease us. It's very touching to us because he hasn't been able to do this for a long time. We see a dramatic increase in his stamina and endurance.

69

Hershey, the Barrel Racer and her Colt
Here is just one story of how EOT Animal Products have helped our four legged friends. Hershey was a quarter-horse barrel racer good enough to qualify for the Nationals. They raced her without training. She ended up with a huge hole in the suspensor ligament, “big enough to put my thumb through” said her vet. She could not walk and she could not lie down. Only one answer remained, put her down. That was unacceptable and the owners, as a last ditch effort, arranged for EOT products that the vet would to give her. She immediately seemed better. Shortly after, the owners bred her, hoping to get a foal, in case the treatment didn’t work. She had only delivered one foal when she was four years old. She was now thirteen. Many times she had aborted. The decision was made to gave her EOT organs to strengthen the pregnancy. Instead of keeping her in her stall, they let her out in the field. Soon she was walking around, wide as the barn door, and standing on her injured hind leg. She had stone-bruised the good hind leg and was walking normally, and standing on the injured leg, while holding up the good leg that was stone-bruised. She did not seem to have any pain from the injured ligament that she was standing on, even with all the weight from the foal. Obviously, she was much better. When the colt was born, they said, “He hit the ground running. In a matter of a couple of hours he was under the fence and we couldn’t catch him The owners think of the colt as a miracle baby and call him, EOT. Hershey, the mother horse, lived another 7 years and never had another problem with the left hind leg and the suspensor ligament.

Hershey, and her Miracle Baby, “EOT” 70

Article in Alternative Medicine magazine on Dr. Jeffrey Harsh and ‘Sepegway’, one of the cats in Dr. Harsh’s “Prairie Cat Animal Refuge”, which was Disney’s model for ‘Simba”, in the “Lion King”, when he was a young lion. Sepegway now lives at The Refuge in Goodland, KS.

71

Dr. Jeffrey Harsh with Tiger at Prairie Cat Animal Refuge
Dr. Harsh regularly uses donated organ supplements for the retired cats. He operates the Refuge with only private donations to maintain his Refuge. You may donate to Miami Medical Foundation, a 501(C)(3). MMF will forward your donation to the Big Cats for you.

72

Special Formulation for Long-term Health and Longevity for Small and Large Animals
A company that distributes EOT Supplements that are formulated to help and support your pets’ body organs - heart, liver, brain, etc. - and systems - immunological, lymphatic, circulatory, endocrine, etc.- and function similar to human EOT preparations. In addition, they often work in chronic conditions and in general anti-aging, where other allopathic veterinary modalities fail. These products, like their human analog, contain low molecular weight peptides and active growth factors, that help to rebuild and maintain the best possible body function and body structure. It is processed from the entire embryo of porcine and has a very unique, stimulating, soft effect throughout the entire body. It is specifically formulated to improve and strengthen body functions and body structure with a soft effect on all three tissue groups: ectoderm, endoderm and mesoderm. The Company recommends that you use this great product each week, or as often as you like. Even one bottle will be helpful. Your pet should take this product once a week for four weeks, then once a month on an annual basis to help assure good health and longevity. The older the animal, the more beneficial. This product is also very stimulating and can be used in conjunction with a placenta EOT product that, helps to strengthen and maintain the entire vascular system, while dispersing all the necessary elements of life, that is contained in the placenta.

The following are samples of a few of the programs available for your pets and animals:
DOGS - CATS - SMALL ANIMALS GENERAL ANTI-AGING Week 1 Bone Marrow Week 2 Porcine Total Week 3 Gall Bladder Week 4 Kidney

Repeat as desired. Plus ___ *ml’s* Liquid Organic Silica 1 time per day This is a basic program designed to add more organs according to specific conditions, such as, Anti- Aging, Cardio Health, Structure and Bone-Joint, Mental, Etc.

73

STRONG BODY - MUSCLES and JOINTS

Week 1
Cartilage Muscle Porcine Total

Week 2
Bone Marrow Cartilage Porcine Total

Week 3
Liver Bone Porcine Total

HEALTHY LIVER Plus ___ *ml’s* Liquid Organic Silica 1 time per day Week 3 Week 4 Week 1 Week 2 Thymus Intestines Placenta Hypothalamus Pancreas Intestines Placenta Hypothalamus Liver Placenta Spleen Kidney Liver Placenta Spleen Kidney

All programs can be repeated and have more organstime per day Plus ___ *ml’s* Liquid Organic Silica 1 added, as desired.

VERY STRONG HEART Professional Use Suggested Week 1 – 3 - 5 Brain Total Muscle Week 7 REST Week 9 - 10 Brain Total Muscle Week 2 – 4 - 6 Heart Placenta Week 8
REST

Week 10 - 12
REST

Plus ___ *ml’s* Liquid Organic Silica 1 time per day Any Program may be shortened or lengthened as desired. Re-evaluate during REST Weeks

SKIN PROBLEMS Week 1 Brain Total Liver Placenta Plus Week 2 Kidney Skin Spleen 74 *ml’s* Liquid Organic Silica 1 time per day

SKIN PROBLEMS + ALLERGIES Week 1 Brain Total Gall Bladder Week 2 Kidney Skin Week 3 Brain Total ***Adrenal

Plus ___ *ml’s* Liquid Organic Silica 2 time per day VERY STRONG KIDNEYS Professional Use Suggested Weeks 1-2-3-4-5-6 Kidney Liver Placenta Weeks 7 and 8 REST Re-evaluate Weeks 9-10-11-12 Kidney Liver Placenta

Plus ___ *ml’s* Liquid Organic Silica 2 time per day This Program may be shortened or lengthened as desired. Week 9 - Continue if needed as long as necessary animal or major health problem****Very young, contact veterinarian. DOGS - CATS - SMALL ANIMALS VERY STRONG IMMUNE FUNCTION Professional Use Suggested Weeks 1-2-3-4-5-6 Thymus Spleen Bone Marrow Weeks 7 and 8 REST Re-evaluate Weeks 9-10-11-12 Continue if Necessary Weeks 1 thru 6

Plus ___ *ml’s* Liquid Organic Silica 2 time per day

75

Here is a program that has been very popular.

General Anti-Aging
DOGS, CATS and SMALL ANIMALS Formulated to Support and Helps To:
• • • • • • • • • • • • • • • • • • • • •

Enhance energy Increase strength Strengthen immune function Increase cellular oxygenation Strengthen vascular walls Stimulate cellular replication Enhance cleansing and drainage Normalize all organ functions Detoxify the body Increase red blood cell production Improve digestive system Improve absorption of nutrients Improve utilization of nutrients Strengthen kidney function Improve circulation throughout body Rejuvenate the body Improve all enzymatic systems Increase mental function and abilities Improve skin and strengthen coat Generally improve body structure Generally improve all body functions

GENERAL ANTI-AGING Concentrated
Week 1 Bone Marrow Placenta Week 2 Porcine Total Heart Week 3 Gall Bladder Liver Week 4 Kidney Spleen

Plus ___ *ml’s* Liquid Organic Silica 1 time per day

Any organ, or organs, can be added to this Program.

76

SMALL ANIMAL ORGAN DOSAGE ACCORDING TO WEIGHT Make certain that you follow this dosage schedule at all times.
These tables are very important for small dogs and animals. Especially, if you have more than one, the bottle can be split between the animals. All young animals should be treated by a veterinarian. All animals should be tested prior to treatment. Any animal allergic to pork should not be treated. Humans, if allergic, are given antihistamine/ Benedryl. Even 1 tablet works. All DVM’s and MD’s are told to muscle test.
Organic Embryonic Organs:

should be given, per dose, as follows.

1 Year +

Up to 15 lbs./ 1 ml's 16 to 40 lbs./ 2 ml's Over 40 lbs./ 3 ml's Up to 5 lbs./ 1/8 to 1/4 ml 5 lbs to 15 lbs / 1/4 to 1/2 ml 15+ lbs./ 1/2 to 1ml

*Baby to 1 Year

Embryonic Adrenal: 1 Year +

Up to 15 lbs./ 1/2 ml 16 to 40 lbs./ 1 ml Over 40 lbs./ 1½ ml's

should be given, per dose, as follows. Silica is in every cell in the body and helps to increase the cellular oxygen level. It should be given throughout your animals lifetime. Up to 15 lbs./ 1 ml's 16 to 40 lbs./ 3 ml's Over 40 lbs./ 5 ml's
* Liquid Organic Silica

If you buy for your small animals, please print this page and have it available all the time.

77

LIQUID ORGANIC SILICA
This text book would not be complete without mention of liquid Organic Silica. Silica is found in every cell in your body and, as we age, silica levels, in much the same way as growth hormone and melatonin, start to decrease. It is our opinion that liquid organic silica should be part of every person’s daily supplementation after thirty. The Polarity of Cells For some time, it has been known that healthy cells, whether in humans, animals or plants, have a negative and a positive pole on opposite sides. It has been proven that when a cell is disturbed, for instance by bacteria, a virus or a wound, its’ poles move a little. This means that the disturbance in the organism is largely the result of this electrical maladjustment in the cell. And we know that to rebalance the polarity of the cells - even where it is possible - takes a long time. Mineral Silica and Organic Silica As a mineral, silica is the second most common constituent of the earth (27.8% in weight), oxygen being the first (46.6% in weight). Silica may be amorphous or crystallized in rocks, such as granite and rock quartz, as well as, in clays and sand grains. Organic silica is different from the mineral form, because there are one or more atoms of carbon associated with hydrogen. The organic form of silica is a component of living tissue, and occurs very often in plants, animals and human beings. In the human body, it is found particularly in the tissues; cartilage, vascular walls, in the thymus gland and the adrenals, liver, pancreas, spleen and so on. Organic Silica and the Human Body It has been proven, also, that the quantity of organic silica present in the body decreases with age. It is impossible to stop this loss because the human body cannot assimilate the mineral silica ingested in food and drink, or convert it into organic silica. However, many plants and micro-organisms (diatoms, bacteria, radiolaria and mushrooms) are able, by various processes, not yet fully understood, to make this conversion and assimilate organic silica from the mineral silica present in the soil. The Discovery In 1957 a chemist at the University of Bordeaux discovered a way to synthesize molecules of organic silica, and in collaboration with several doctors began to use them in medical applications. In 1967 the French Academy of Sciences awarded one of the practitioners concerned, the J. Lévy-Bricker Prize for Medicine in acknowledgement of the results obtained in the treatment of cardiovascular diseases. Over a period of more than twenty years, thousands of patients suffering from a wide variety of diseases were cured, and several articles were published in various scientific journals. One of the pioneer countries using silica is France. Silica is tested by the Scanning Electron Microscope (SEM), a method called 'exoscopy', now used throughout the world, by which the geological history of sedimentary sand grains could be determined. In two 78

articles published in the journal of the French Academy of Sciences(3) it is demonstrated that some of these grains have, on their surface, thin layers of highly soluble silica. These layers were made by micro-organisms, mainly bacteria. In 1975, it was discovered by chance, the therapeutic qualities of the silica produced by micro-organisms. A researcher, who was suffering from a form of psoriasis which had affected his hands for ten years, had been diagnosed as incurable. His right hand was accidentally bathed in a solution of silica extracted from quartz grains, and rich in organic silica. Two days later, he was astonished to see the psoriasis had disappeared from this hand, though it was still present on his left hand. Intrigued and wanting to clarify cause and effect, he bathed his left hand in a similar solution, and again, in two days saw the same amazing result. That was the beginning of several years of work in collaboration with various doctors treating skin diseases such as psoriasis and herpes. Organic Silica Until this time, it had been necessary to activate the organic silica by adding small quantities of products used in allopathy or homeopathy; products which were chosen specifically for each illness being treated. These molecules could only be used in cutaneous applications. In 1994, a new molecule was perfected, which can be used, without any additive, in the treatment of many different diseases. Another important advance was that this molecule, is absolutely non-toxic, and can be taken orally. This is Organic Silica. The Properties of Organic Silica For years, proof has been accumulating of the effectiveness of organic silica. With regard to organic silica, its effectiveness is proven by tests in official laboratories and by many testimonies from doctors and patients, supported by a great variety of records (blood analyses, X-rays, photos, etc), and its’ use by more than 100,000 patients has proven that it has the following characteristics: • • • • • • • • • • • it is completely non-toxic. it can be assimilated directly by the human organism, and by animals and plants. it has a significant capacity to penetrate the skin and be diffused throughout the body, reaching those organs or areas suffering from pain, damage or malfunction. it plays a vital role in restructuring the fibers of elastine and collagen, in he early stages of bone mineralization and in the metabolism in general. it accelerates the processes of tissue healing. it is anti-inflammatory. it strengthens the immune defenses of the organism. it is a very efficient pain-killer which acts within a few minutes, notably for joint pain, burns, cuts and stings (wasps, mosquitoes, nettles, jellyfish, etc). it has no side-effects, even after being used for many years. it is compatible with any other treatment that may be prescribed.

79

How does Organic Silica work? How can a single molecule cure so many different conditions? It's impossible to give a precise answer to this question, but a simple hypothesis is offered in view of what has been proven so far. 1: We know that when a cell function is disturbed, its polarities move slightly, so much of the disturbance in the organism is linked to this electrical maladjustment in the cells. 2: Studies with the scanning electron microscope prove that molecules of organic silica such as Organic Silica are very unstable, especially when mixed with water. They are always changing shape, revolving continuously a hundred times a second. Under the SEM the molecule looks like a fern leaf, the prominent parts being the positive poles and the hollows the negative ones. 3: Thus, it is probable that Organic Silica acts in the organism to restore the polarity of the disturbed cells, supplying positive or negative charges as required so that the cells have the power they need to resist invasion or repair damage. Why is Organic Silica able to make rapid improvement in general health, as well as, curing the disease that is specifically treated? 1 There is conclusive evidence that organic silica plays a vital part in the general health of the human organism. 2: We know that the amount present in the body decreases with age. 3: We also know that this loss cannot be prevented, because the body can only assimilate silica in its organic form and cannot obtain it from the mineral form. 4: The results obtained by drinking Organic Silica show that it can be assimilated and that it replenishes the supply of Organic Silica. 5: Though the amount provided by the absorption of Organic Silica decreases slowly, too, it can be replenished again by another course of treatment if the patient feels their symptoms returning. Why is it useful in some cases to drink Organic Silica and apply it to the skin as well? 1: Organic Silica acts like a rocket, to carry Organic Silica to all parts of the body suffering from disease or disturbance, even if the latter is not causing pain. 2. Drinking it will cure, in most cases, the cause of the problem, but this may take a little time. It will act first on the fundamental health problems, which are not necessarily the most acutely painful. That is why it is necessary, as explained above, when using it to treat a specific pain, to apply it, also on the skin, as near to the source of the pain as possible. 80

Directions for use Organic Silica comes in liquid form and as a gel. The liquid is taken orally, and both forms can be used on the skin. Oral use The treatment consists of taking one tablespoon of Organic Silica a day for one month. Within 2 - 4 days, maybe a week, there is usually a noticeable improvement in various indicators of well-being, such as sleep patterns, appetite, tonicity, state of nerves. Organic Silica is so adaptable, and has never shown any side-effects, each person is free to use it as they wish. We recommend taking it first thing in the morning but this is not obligatory. If other treatment is being followed at the same time and other medication, allopathic or homoeopathic, has been prescribed, it is best to take the Organic Silica at least one hour before or after the other preparation, so that it has its maximum effect. In the few seconds, or minutes, after taking Organic Silica , you may feel a slight prickling sensation or feeling of warmth moving through your body. This is normal and such reactions usually disappear in a few minutes. Compresses Moisten a piece of gauze, or cotton wool, the size of the area that is painful or malfunctioning with the liquid. Apply this over the area and cover it with a piece of plastic secured all round with adhesive tape. The compress should be left in place for 6-8 hours, for instance at night. Poultices Moisten a piece of gauze, or cotton wool, as above, and apply it to the skin for about 10 minutes. There often, there is a sensation of pricking like 'pins and needles', or of warmth or cold, spreading through the treated area. If there is no particular sensation, however, this does not mean that the Organic Silica is not working. Remove the poultice after about 10 minutes and let the skin dry in the open air. Repeat, as necessary, if the trouble or pain recurs. Occasionally the skin reacts with redness or itching. In this case, try the massage treatment instead. Massage Spread a thin coat of gel on the skin of the painful, or affected area. Leave it untouched for about 1 minute, then massage it in gently until it is all absorbed. Repeat as necessary, if the pain or trouble reoccurs.

81

The following information is from a European Lab that produces Organic Silica. EXAMPLES OF THERAPIES FOLLOW

Silica is a micro-mineral which is in every cell of the body. Liquid Organic Silica Products have generally been formulated to help and Support:
1: acne: massage 3 times a day. 2: allergies (various): 1 tablespoon of liquid a day for 1month 3: articular pains (arthritis, rheumatism, etc): 1 tablespoon of liquid a day for one month + poultices or massage on the painful joints as often as necessary. 4: asthma: same as (2). 5: bruising: poultices or massage. 6: burns: atomization. 7: cardiovascular problems: 1 tablespoon of liquid a day for one month. 8: cholesterol imbalance: 1 tablespoon of liquid a day for one month, then blood tests to check the results and adjust the treatment if necessary. 9: Crohn's disease: same as (8). 10: cuts: poultices or atomization. 11: diabetes: same as (8). 12: eczema: 1 tablespoon of liquid a day for a month + massage 2-4 times a day on the areas affected. 13: general debility (tiredness, excitability, irritability, insomnia, digestive problems, etc): 1 tablespoon of liquid a day for a month. 14: headaches (persistent): 1 tablespoon of liquid a day for a month + poultice or massage on the painful area in the case of fits. 15: hepatitis: 1-3 tablespoons of liquid a day for a month, then blood tests to check the results and adjust the treatment if necessary. 16: herpes: same as (12). 17: nervous breakdown: same as (13). 18: psoriasis: same as (12). 82

19: shingles: same as (12). 20: sinusitis: poultices 3-4 times a day. 21: sprains: compresses 6-8 hours a day. 22: stings (fleas, wasps, mosquitoes, nettles, jellyfish, etc): poultices or massages. The pain or swelling usually disappears in a few minutes. Note: Do not use for bites from poisonous animals such as snakes, which require the injection of specific serums.

23: sunburn: atomization or massage. 24: tendonitis: same as (21). References: (3) Tests made by SIR International Institute, Professor of Pharmacy and Neurobiology in the University of Pavia, former Director of the Centre for Therapeutic Experimentation in the Hôpital de la Pitié-Salpêtrière in Paris, former Director of the Institute for Experimental Therapy and Clinical Research in Paris. Tests made involving 110 patients suffering from various allergies and immune dysfunction. It was also proven to be very effective, in healing other skin conditions. (4) Official tests carried out by the French Agence du Médicament for the French Public Health Department and published in the press 18 December 1988.

83

EOT ORGAN TESTIMONIALS
What people are saying Fibromyalgia Andrea, January 2006 South Hamilton, Massachusetts. EOT products have changed my life. I was a 44 year old with Fibromyalgia. The fatigue was debilitating. The EOT program, given to me by my doctor, decreased my pain and increased my energy levels dramatically. I am now 48, and I do at least one rejuvenating program annually. I travel internationally several times a year, and work long hours, which was something I was previously unable to do. Friends say I look much younger and healthier. Another change for the better and very important to me, is my attitude. Andrea" PROGRAM: Andrea took Adrenal, Thyroid, Hypothalamus, Heart, Placenta, Pituitary and Thymus on the advice of her doctor, and an Anti-Aging program for general health. *Doctor's Program for Fibromyalgia FEMALE OVER 40 Anti-Aging Program Stress and Strength - Anti-Aging Carolyn, February 2006 Palm Beach, Florida " I am very fortunate to have had, for many years, access to embryonic organ products. Without them, I am sure that I would not be alive today. Stress is very destructive to your body. To be able to rejuvenate my body has been invaluable. It allowed me to be a caregiver to my husband for 21 years after his stroke. It also helped me immensely, after his death, to deal with the ensuing grief and loss. I now am active, playing golf and tennis at age 73 and I feel wonderful. For this, I am extremely grateful and continue to be very excited about EOT supplements." PROGRAM: Stress - Strength - Anti-Aging Program With Maintenance Schedule Female Over 60 Anti-Aging. Carolyn takes the Over 60 Program at least twice a year. Congestive Heart Failure Father J., Catholic Priest South Carolina November 2004 Dr. C., Pennsylvania 84

Letter to doctor who treated him. Dear Doctor : Five years ago, I was in acute congestive heart failure with pitting edema (4+). I could not wear shoes. I suffered from acute respiratory distress, particularly nocturnal. I was no longer able to work and no longer slept in a bed. I was able to get a few minutes sleep, each hour, of each night. My physicians had increased my Lasix to 360 mgs per day, with 40 mgs of Accurpril and 10 mgs of Zaraczyln. All of my renal studies were showing major damage with the promise of renal dialysis looming on the horizon. Then I began a six month therapeutic treatment of EOT organ supplements treating all of the systems' organs. Since that treatment five years ago, I have reduced the Lasix and Accupril and eliminated the Zaraxzyln completely. And my renal studies are back in to reference laboratory levels. My prognosis five years ago was moribund. Today, I am really improved, able to care for myself and teach classes again. I consider cell therapy to be a miraculous treatment; one which surely saved my life. My thanks to you and my total support by this letter as a testimony, to Cell Therapy products. PROGRAM: Father J.'s doctor gave him Thymus, Placenta, Vessels, Bone Marrow and Heart. Strong HEALTHY HEART PROGRAM Body Building - Physical Improvement John A., Body Builder and Personal Trainer New Jersey 1996 "Two weeks into my EOT program, my body fat decreased to 20%, a loss of 7 pounds of body fat, which was accompanied by a 2 pound increase in lean body mass. At three weeks, there was a substantial increase in energy, endurance, and strength in all areas of my exercise program. At the end of the seven-week period, my body weight was 187 with a body fat percentage of 12%. This proves there was a substantial increase in lean body mass. The benefits of the EOT supplements have not diminished after discontinuing their use. As a personal trainer, I can attest to the fact, that in the past I have only seen these results with those who have used steroids and other body-enhancing drugs. Live Cell Therapy supplements work and have no side effects. I highly recommend them to my clients and others interested in enhancing their bodies naturally." PROGRAM: John used many organs during the period he referred to in this letter, including Brain Total, Placenta, Adrenal, Bone Marrow, Porcine Total, Cartilage, Mesenchyme, Muscle, Liver, Kidney and Thymus. BODY BUILDER PROGRAMS Rejuvenation and Increased Vitality** Jane K., Author, California 1995 85

"1994 was a very stressful and difficult year for me. My energy was at an all time low. After my program of EOT supplements, I was amazed at my increased energy and sense of well-being. I now realize this is the only authentic “embryonic organ " supplementation product I have ever taken. Also, my skin has a glow, which is wonderful. You seldom see someone over 50 glowing !" Ms. K. had taken a series of “active cell therapy", which gave very few results, from a doctor who goes to Mexico regularly to give his treatments. Jane took a FEMALE OVER 60 PROGRAM, even though she was in her 50's, due to her extreme low energy and adrenal function and the fact that there was continuing severe stress in her life. It was suggested she take the longer program with additional organs, instead of the FEMALE OVER 40, to address her difficult health problems. PROGRAM: FEMALE OVER 60 and FEMALE OVER 40 PROGRAM Combined Macular Degeneration Dr. W., October 2001 Winston-Salem, North Carolina In 1997, I started treating a patient with hypertension, coronary artery disease, a calcified aortic valve and degenerative macular degeneration. His vessel problem improved with chelation, but his vision deteriorated, even though he tried every treatment and product he could find in the United States, until he became blind. The blindness was documented by an ophthalmologist. In 2000, I began giving him EOT Brain Total, Placenta, Vessels, Eye Total and Thymus. Within three months, he no longer had to be led around in the daylight and was back to driving his car. I kept him on a maintenance program of the same EOT organs every two months. Additional patients were treated and all had success stories to various degrees. Thank you for your help. Dr. W. PROGRAM: Great HEALTHY EYESIGHT Alzheimer’s Dr. C., September 2004 Bangor, Pennsylvania An 80 year old patient of many years, had 120 chelation treatments for various conditions including coronary artery disease. He was doing well- totally asymptomatic. Then 2 years ago, he started a steady mental decline. It was not bad in the beginning, but slowly 86

progressed until he did not recognize his wife or children, could not drive, write checks, or, read the newspaper. He was sent to a neurologist for evaluation, testing and treatment. During 4 months, he continued to worsen. At that point, his family asked me to supervise his treatment. An E.A.V. test revealed Cerebral (Brain) organ dysfunction of 37% and Hypothalamus of 40%. EOT Brain Total and EOT Hypothalamus were each given once per week for five weeks. The patient made a remarkable recovery. On E.A.V. retesting, the brain improved to 68% and the Hypothalamus went up to 85%. The patient could now balance his checkbook, read the newspaper and drive his car. Instead of going to a nursing home, he and his wife went to their winter home in Delray Beach, Florida. He had three additional Brain Total organ supplements. He continues to do well. PROGRAM: Brain Total, Hypothalamus and Placenta. MALE OVER 60- Focus on neurological. Anti-Aging - Maintaining Youthfulness and Health : Dr. D., March 2000 Federal Way, Washington "Some of us who practice Hippocratic medicine, believe that the body functions as a whole. The aging process is, seemingly, programmed into us and in each tissue cell line. Embryonic cells pass through phases of specialization. There is a point in the development of the embryo in which tissue cells are organ specific, but not immunologically distinct. After all the embryo is not rejected by the pregnant mother. These observations have opened a 'window of opportunity' for rejuvenation. This is the basis of "Cell Therapy". Luckily, it is possible to use animal embryos for harvesting cellular extracts. Interestingly, the tissue cells from the animal embryos find their way from sub-lingual administration to the matching organ. This is part of the morphogenetic miracle, which is the tissue and anatomical balance of all creatures. EOT products have proven to be a wonderful source of this material for the American market. The clinical uses strengthen specific organ systems, based on the cell lines the physician selects for use. When patients have weakness in any organ system, such as endocrine, or GI, embryonic cellular products boost that system so your regular therapeutic interventions begin to work again. Think of it as rejuvenation. Dr. D." PROGRAM: Endrocine Program . Stomach and Intestional Program Anti-Aging generally. 87

Post Spinal Fracture Syndrome – Disc Syndrome and Ankylosing Spondylitis Back/ Spine/ Disc Severe Problem Dr. B., 94-year old M.D. Cleveland, Ohio September 16, 1991 “Thank you very much for introducing me to cell therapy last year. I enjoyed the conference. My problem of post-spinal fracture syndrome, disc syndrome and ankylosing Spondylitis is no easy problem to overcome. Thanks to just one series of EOT Organ Extracts, my problems have practically ceased with increased energy, mobility and free of NSAIDS. I am also very excited to introduce EOT in my practice with also great results. Best, Dr. B. P.S. My golf handicap dropped from 26 to 18." *Dr. B sold his practice at the age of 96. He was the first doctor in the U.S. in the early 1990’s to use cellular extracts for himself and his patients. Twice a year, he took six different organs each week, for twelve weeks. In between those concentrated Programs, he took at least one bottle each week of either Adrenal, Thymus or Hypothalamus, since 1990 and continued as long as he had his practice. Dr. B. was highly respected in the Alternative Medical Community and had a huge practice. He was a walking encyclopedia of Alternative products and treatments and a great friend to our company and never failed to call our office each week. He is greatly missed. PROGRAM: Over the years, Dr. B. took every organ in our inventory, but primarily focused on the Concentrated Male Over 60, designed Chronic Fatigue Dr. C., Ohio. 1998 "I had a patient, 65 male, with severe Chronic Fatigue, that had spent practically the last 7 years in bed, with no zest for life and basically had given up. We tried everything to improve his condition. Nothing helped. At this point, he was so skeptical that anything would help him, that he did not want to try anything else, but finally agreed to try EOT Organ Supplements. He responded extremely well, his energy perked up and he had a much greater zest for life. He was so pleased that he decided to take a second course of EOT Dietary Supplements and that, too, provided him with further improvement." PROGRAM: Basic Program, Strong Healthy Immune System Brain Total, Thymus, Bone Marrow, Intestines Total and Spleen.

88

89

Severe Lifetime of Adrenal Deficiency Dwight K., Ph.D., Ohio 1995 "Both my mother, who is 80, and I have found the Adrenal Organ Dietary Supplements very helpful in improving our general health! Both of us have suffered from poor adrenal function most of our lives. Adrenal EOT offers us significantly improved stamina, strength, and staying power. We have noticed this gradual, yet observable, improvement over a period of 6 months to a year. And because the steady improvement has lasted for such a long time, I believe it will continue to help us in the future." Update Dr. K., Sept. 27, 2007 I have been successfully using Adrenal EOT for over 12 years now. It not only helps increase my overall general stamina, but it also continues to give me additional energy and physical strength. In fact, it actually helps to increase my muscle strength which has been weakened by the congenital condition: Nemaline Myopathy. I will continue to recommend it without any reservation: indeed, with a great deal of enthusiasm, to anyone who needs additional energy, physical stamina, and muscle strength. Dwight K. PROGRAM: Dr. K., and his mother, have taken 1 bottle each of Adrenal each week in the beginning and then, as needed. Occasionally, he took also Thymus and Hypothalamus with Adrenal, which is the basic energy program.

90

SMALL ANIMALS GIVEN ORGAN DIETARY SUPPLEMENTS ORALLY by OWNERS
5. Two small animals have both been treated orally by the owner of a company that distributes organ tissue extracts. • 4-pound female Yorkie with a severe kidney condition. Was given Kidney and Placenta, 1cc of each, each week, dribbled in the mouth from a syringe. She lived until 13 years old and was a very normal, happy dog. 6-pound male Maltese with a liver shunt: the main artery distributing the blood to be filtered and cleansed through the liver. He was so sick, so full of toxins and the vet said he would go into a coma and die before 1 year old. He was given 1cc of Liver, once each week for 3 months, injected by the vet, during which time he gained 1½ pounds, started growing hair, began to eat and started playing like a normal puppy. For the rest of his life, he was given Liver, Placenta, Thymus and various other organs orally, dribbled from a syringe. He lived a very happy, normal life until 18 years old.

•

6. A 13-year old female cat, owned by the manager of a popular restaurant in Miami, had a very large tumor on her side. Her vet said it was inoperable, put her on steroids and sent her home to “be comfortable”. She went under the bed, would not come out, would not drink water or eat and would not come to her owner. Her owner took her off the steroids, started giving her 1cc of Thymus orally, dribbled in her mouth from a syringe. She started eating, drinking water, playing like a kitten and in 5/6 weeks, the tumor was completely gone. She lived another 4 very happy years. All letters on file with Authors.

91

Testimonials for Organic Silica
Hair Re-Grow

92

Acne Philippe R., dental surgeon, 10/06/95: 'My children have been using Liquid Organic silica, and are delighted with it.' Arthritis Mr R.T., Brantôme, 12/08/95: 'I'm 67, and have had arthritis for ten years in the lumbar area, knees and ankles, so I am an invalid and almost completely incapacitated. After two weeks of using Organic Silica , I have recovered 60% of the capacities typical of someone of my age. I now have a lot less pain and am regaining some flexibility in my joints. I hope to complete this success by continuing the treatment. So this letter is a testimony, which I am ready to authenticate if necessary.' Mrs G., St Loubes, 4/01/96: 'I take Organic Silica 3 times a day and my hands are getting better, I can write better and hold things, which I couldn't do before in spite of the doctors. My headaches are less frequent and my cervical arthritis is much better. I can't believe how effective it is; because of being ill all the time I'd lost 11 kilos in 4 months, but now since taking the Organic Silica I eat better, I've regained 2 kilos and I sleep better. I don't know how to thank you, but I think of you in my heart.' Herpes Mrs G., Bègles, 3/01/96: 'After hearing about Organic Silica , I ordered some because my back and knees were very painful. These problems disappeared very quickly. My husband had a small ulcer on his leg which, I put a compress on morning and evening, and it healed. I also had herpes on the lip, and with some compresses night and morning the pimples disappeared in three days.' Arthritis – Headaches – Digestive Problems Mrs M.M.F., 23/01/96: 'I had arthritis in my shoulders, feet and hands, and muscular pain in many other places, and after lots of medical treatments each one as ineffective as the last, I was imprisoned in my suffering. Then I heard about Organic Silica from friend and decided to try it. It was a total success after a few days of taking it orally (a soup spoon a day for a month). My pain is now only a bad memory, my suffering is over and I feel fit again. But the most extraordinary case is that of my son, who had a serious car crash on 4 September 1995; 8 days in coma, 2 months in Limoges hospital and then nursing home and physio-therapy, with a broken shoulder, broken teeth and cranial injury. On my advice, he started using Organic Silica especially for his headaches which were getting worse, and he was always taking lots of pills, antidepressants and so on. After a few days of applying compresses on the back of his neck and on his liver and drinking Organic Silica , we could see a great 93

improvement; no more headaches and the stomach, liver and gut back to normal, while he completely stopped the medical treatment. Digestive Problems - Herpes – Arthritis Mrs J.L., Parempuyre, 1/12/95: 'For the last three weeks my husband and I have been using Organic Silica . I had problems with my liver, pancreas, intestines, plus herpes and cervical arthritis. My husband had serious arthritis in his left knee. We've had very positive results. In my case, my neck pain has gone, I can move my head more easily and my general state of health is much better. As for my husband, the pain in his knee has gone, the joint is easier and he can get about more safely. Organic Silica has done wonders for us both. We used compresses for two weeks, and this last week we have been taking a soup spoonful morning and night.' Arthritis – Blood Pressure – Digestive Problems - Headaches Mrs J.L., St Astier, 8/01/96: 'I bought three liters of Organic Silica for the three of us, and started the treatment immediately, since I had serious arthritis in my left knee, high blood pressure, genetic cholesterol problems, stomach trouble, etc. That day I also had a big patch of herpes beneath my nose, which was healed right away with a few compresses. Within a few days my blood pressure dropped, and so did my husband's. As for the cholesterol, I don't know yet as I have to go for another test. The arthritis in my knee is so much better, I hardly feel it now. My son has got rid of his headaches by using compresses.' Burns Mrs C., pharmacist, March l996: 'After seeing its spectacular results on a burn, I am very interested in Organic Silica Dr Denis G., Bordeaux, November 1995: 'I, the undersigned, certify that I have examined Mr René A., 80 years old, who had third degree burns on his left forearm. I saw him first on 14 November 1995, just after the burn. One minute after the application of Organic Silica he said the pain had completely gone. Moreover the skin healed very satisfactorily with the application of compresses. The patient was seen again on 17 November: no problem. Seen again on 21 November: we decided to leave the bandage off. Seen again on 27 November: cicatrisation complete with some scabs but without any pain.' Digestive Problems – Poor Circulation Mrs P.B., Thenac, 29/07/95: 'I have had serious digestive problems following a gallbladder operation in July 1994. I couldn't keep down what I ate, and vomited a lot of bile. Since starting the treatment with 94

Organic Silica all these problems have completely vanished! I can eat anything and digest very well. I also had edema in my legs and very swollen ankles, but now everything has been healed.' Herpes - Shingles -Rheumatism – Arthritis Mrs A.D., pharmacist, 12/08/91: 'I, the undersigned, certify that in the last 18 months I have recommended to my patients the use of Organic Silica for the treatment of herpes (about 100 cases). Since I and my relatives have used Organic Silica, I can say that no other product presently on the market is as effective for this problem. I have also recommended it for shingles (5 cases with good results), and for rheumatism and arthritis (about 20 cases). Most of the people concerned came back completely recovered and asking for more of the product.' Psoriasis Mrs D.S., Neuil-sur-Mer, 9/04/96: 'I have had very good results on psoriasis of the scalp which I have suffered from for 40 years.' Dr C.M., Ste-Colombe, 8/06/88: 'I, the undersigned, doctor of medicine, certify that my patient Mrs. J.L. whom I have treated for coetaneous psoriasis is now completely clear of it, after using exclusively organic silica.'

95

Frequently Asked Questions
1. What is the source of liquid EOT Organ Dietary Supplements? Liquid EOT Organ Dietary Supplements are processed in Europe, from the finest organic embryonic porcine (pig). Each animal processed is checked and tested by the Agriculture Department and given an actual numbered document with a government seal guaranteeing that this particular animal is free and clear of all diseases, parasites, fungus, bacteria and/or virus. 2. What, specifically, is in the bottle of the liquid EOT Organ Dietary Supplements? Liquid EOT Organ Dietary Supplements contain only the specific gland, or organ extracts and is stored in sterile physiological saline. The specific anatomical constituent is dissected, liquefied, filtered, and then suspended in sterile water. The product is then transferred to sterile single use bottles The entire manufacturing process is performed under strict sterile conditions that meet and or exceed the requirements mandated by the FDA and other government agencies. 3. How do the EOT Organ Dietary Supplements taste? Bland, certainly not offensive. 4. Are there any negative side effects associated with consuming the EOT Organ Dietary Supplements? No. Regardless of which EOT Supplements you decide to use, all are formulated to help improve your quality of life, as well as, help maintain and strengthen body structure and body function. 5. Are there any special requirements for shipping the EOT Organ Dietary Supplements? The supplements are typically shipped overnight with cooling materials. The laboratory arranges late afternoon pickup, 4:00 to 5:00 p.m. and they are shipped priority-overnight, so that they will be delivered by 10:00 am the next morning. Customers should immediately unpack and place them in the refrigerator, where they should be kept until used. No dry ice is needed as these products, are the standard dietary supplement and should never be frozen. 6. How much is in a bottle ? Each bottle contains 0.09 fluid ounces (3ml's) of a specific organ (7.ml's in the case of Combination products) and should be completely consumed at one time. 7. How do patients orally take the Organ Dietary Supplements at home? Place the bottle to be consumed on the bedside table prior to going to bed. Take the entire bottle either before going to bed or first thing in the morning. Complete directions for consuming Organ Dietary Supplements can be obtained from the supplying physician. 96

8. What kind of results can I expect? And how soon can I expect to feel results? Everyone is different and everyone assimilates their EOT Organ Dietary Supplements differently. Some may feel or see changes immediately, while others may take a number of supplements and still not feel that they have experienced any changes. Even if your patients do not feel any change, or difference, the EOT Organ Dietary Supplements are constantly working to maintain your body at its' best possible condition. 9. How long will these results last? And how often, will I need to use them? Again, everyone is different and responds differently to any type of supplement. Like all supplements, some people digest and assimilate better than others. Age and your patients general condition can affect the results and how long they last. Generally, if your patient is over 40 and in good health, *programs should be taken once or twice a year: If your patient is over 60 and in fairly good health, *programs should be taken two to four times a year; people of any age and in poor health may need to take *programs more often: some patients also take maintenance *programs in between standard *programs. You should make these decisions as you know your patients better than anyone. EOT Organ Dietary Supplements may be taken weekly, or less often, for as long as you feel they are beneficial. Depending on your patients condition and what you wish to accomplish, it may take weeks before you get the changes you wish. *Programs are designed using combinations of the 32 Individual Organs and/ or the 12 Combos to help maintain, improve and rebuild different body functions and body structure. Many of these basic programs can be found in Program Section of the manufacturers literature. All programs are designed with a target organ, or organs, and takes into consideration the homeostasis of other support organs. If the target organ is deficient and under stress, all of the support organs are also under stress and not operating efficiently, as they increase their "work-load" to compensate for functions the target organ is unable to do. A target organ will never achieve maximum performance, if the support organs (the target's base) are not also taken into consideration. 10. How does this compare to taking other vitamins, minerals or protein supplements? EOT Organ Dietary Supplements are easily assimilated, and used by the body so that the body will benefit in many ways in maintaining body function and body structure. 11. Can EOT Organ Dietary Supplements be taken if someone has a serious disease? These supplements, as well as any supplement on the market, must be taken with caution and on your physician’s advice. EOT Organ Dietary Supplements are not recommended for, or sold, for any pathology or disease, and anyone with a serious condition should not take these, or any supplement, unless they consult a physician. It is not suggested, or implied, that EOT Organ Dietary Supplements will cure, treat, or help any disease or medical condition. 12. Are there any contraindications for using these products?

97

As a natural dietary supplement, it is the same as consuming a food product in concentrated form. The food in our EOT Organ Dietary Supplements is porcine, which is pork. Anyone who is allergic to pork should not take these supplements. These products should not be taken by pregnant or lactating women. 13. Can EOT Organ Dietary Supplements be shipped to other countries? They can be shipped easily to any country. Appropriate shipping documents apply. 14. What is the difference in the benefits of taking EOT liquid Organ Dietary Supplements compared to taking the frozen product available in foreign clinics throughout the world? EOT liquid Organ Dietary Supplements give all of the same benefits as the frozen products available in foreign countries and possibly more. Most of the foreign products, especially frozen, are lyophilized, which is freeze-dried into a powder, and there is nothing still active that remains. Also, liquid EOT organ supplements are taken from organic embryo porcine tissues and are processed into what is considered to be the leading technology in the Organotherapy industry. This manufacturing process is considered more effective, and delivers a safe finished product. There is also a big difference in the administration. Four to six different frozen extracts are administered at the same time as injections. Normally, a local pain-killer is given with the injections, as the frozen product is very painful to inject. With the EOT Organ Dietary Supplements, individual extracts are taken orally. Since proprietary manufacturing processes are quite common in this industry, products having the same named designation are in reality, quite different from each other with regards to efficacy 15. What is the shelf life of . liquid EOT Organ Dietary Supplements and do they have to be kept cold? EOT liquid Organ Dietary Supplements must be kept cold, and should never be frozen. In a good refrigerator, shelf life is up to two years. If need be, when traveling, it is safe to keep the refrigerated EOT Organ Dietary Supplements out for a few days. Place them in a refrigerator whenever available in your hotel. DO NOT put EOT Organ Dietary Supplements through the x-ray* security check at the airport. Inform security that they are dietary supplements needed for your health. Check before flying and if you are not certain, it is best to take the cooling packs used in shipping the product to you, place with the EOT Organ Dietary Supplements into a small, soft children’s lunch bag and put in your checked suitcase. Children's nylon lunch bags found in drug stores; are inexpensive, easy to carry and they work well. 16. Who could benefit from this type of dietary supplement? Any one of any age, for EOT Organ Dietary Supplements help maintain body function and body structure, thereby, improving quality of life. 17. Are there any scientific studies available on organ dietary products? There are many papers from studies that were conducted in Europe on the frozen products and lyophilized (freeze-dried) products available in the European clinics. We believe these 98

results also apply to EOT non-frozen liquid Organ Dietary Supplements. There is a continual bibliography found at the www.miamimedicalfoundation.com site. NOTE: And, also, we expect to conduct studies allowed by the FDA on Specific Conditions for Dietary Supplements. We will send an email asking anyone if they wish to be included in these specific studies. At present, we are filling our appointments of Medical Director and Advisory Board. These physicians will conduct and be contributing doctors to these studies. 18. What other forms of cell therapy are there and in what countries? There are many different types of general cell therapy. More technically called, Organotherapy. It is the type most people think of as revitalizing, or, improving health conditions. The major users of ORGANOTHERAPY are the nations of Germany, Switzerland and France. Cell Therapy, which was the forerunner of Embryo Organo therapy, uses extracts from living organs taken during the embryo stage of the animal, mixed with physiological serum, in an effort to stimulate, strengthen and help to rebuild the body of the receiver. This technique is widely used in Switzerland. The embryos harvested in Europe are from porcine/pig. Porcine is the animal which resembles most closely the human body. The majority of heart valves used in transplants to humans are harvested from pigs, as well as, many other products for human use. In Germany, Opotherapy enjoys greater favor (use of weighted doses of animal organs). German Opotherapy products have been altered by a sterilization process, lyophilization, pasteurization etc., which is required by German national laws. Their effect is substitutional in nature, working at the tissue level without bringing about intrinsic strengthening and stimulation of the organ that is treated, itself. Thus, they cannot really be said to “revitalize”. The Homeopathic Organotherapy, which was in widespread use in France, prior to the introduction of Embryo Organotherapy, has the effect of restoring functional balance. Embryo Organotherapy which is the method of choice, both because of the nature of the procedure and the results, represents an indisputable improvement on all previous cell therapy products. This new generation of treatment, derived from embryos, which is through the second month of the gestation period, is the only one that deserves to be described as, "revitalization" The living-embryo cell-filtrate undergoes no alteration and therefore retains atomic charges which, by sympathetic vibration, revive intra-cellular activity, by providing the appropriate quantum factor required for organ revitalization.

99

AUTHORS’ NOTES
Cellular therapy has often been criticized for the lack of basic information and research here in the United States. To the contrary, there were many studies conducted beginning in the 20’s that demonstrate its efficacy. Due to the power of “Big Pharma” and so many pharmaceuticals, the natural organotherapy fell out of favor. Recently, many alternative doctors have sought a more natural, less toxic, avenue for the body to heal itself and we have observed a resurgence in interest in cell therapy. Studies in Germany in the early years were conducted primarily utilizing whole cell preparations, and later, due to German regulatory issues, researchers were forced to switch to lyophilized preparations. To this day, due to German Law, only lyophilized or pasteurized preparations are available.. Technically, this is still called “Opotherapy”, the altered process that is sterilized either by lyophilization or pasteurization. Neither process results in an active product and the effect is actually substitutional in nature, working at the tissue level, without bringing about intrinsic regeneration of the organ treated. Thus, it cannot be said that these altered German cellular preparations revitalize. Therefore, lyophilized, cellular preparations even though effective to a degree, are not as efficacious as the embryo organotherapy process produced in Europe today. Based on this premise, it is our opinion, that embryo organotheraphy would be more effective, than the studies listed in this bibliography involving lyophilized preparations. It is of great interest, that much of the basic research, beginning in the 1920’s, involving cell therapy and tissue transplantation, was performed in the United States. As opposed to tissue and organ transplantation, cell therapy is much less traumatic to the recipient. Embryonic xenograft cell preparations are available ALL of the time, on very short notice and immunogenicity is not usually an issue. It seems to be a much better choice; especially, when whole organs are not available. It is our opinion, that organotherapy should be administered first, and certainly, it should be used if whole organs are not available. In the 1920’s and 30’s, Dr. Henry R. Harrower, wrote many papers about the use of “organotherapy and gland therapy” and demonstrated that oral administration of organotherapy preparations were efficacious. One of his articles states the following: “There was a time when it was fashionable to believe that no glandular product, ‘with the exception of thyroid’, of course, was effective by mouth. To take this position now will be to ignore hundreds of excellent clinical and experimental reports to the contrary. This misconception is typical of other mental attitudes that have frequently delayed the acceptance and application of therapeutic advances. A rather amusing example of this was confessed recently by Sir W. Langdon-Brown in his address, ‘The Dead Hand in Medical Science.’ Sir Walter tells of his own original inability to believe that liver feeding could be an effective treatment of so serious a disease as pernicious anemia.”

100

Dr. Harrower continues, “Prof. A. V. Hill wrote from the United States to tell me of the extraordinary results which were just beginning to be obtained from oral liver treatment, which to my shame, I had difficulty in believing. But a Nobel Prize in medicine was awarded in 1934 for this outstanding organotherapeutic attainment. This was the second Nobel Prize for accomplishments in endocrine therapy.” Dr. Harrower’s strong belief in Organotherapy and gland therapy, both oral and injectible, was demonstrated by his forming the Harrower Laboratory, Inc., which produced, in California, some of the very first organ products anywhere in the world, both for oral use and via injection. Throughout his papers, he speaks of “the derogatory statements and unfortunate misconceptions about Organotherapy.” This negativity did not dissuade him, and he continued to produce many of the very first endocrine organotherapy products in the world. It is interesting to note that as early as 1956, in Nature magazine, authors Billingham, Brent and Medawar, published the article "The Autogenic Stimulus in Transplantation Immunity".1 They established in a series of immunological studies, that during the process of freeze drying, (lyophilization) the cells lose their antigenicity. The question usually asked by health care professionals and scientists, when they find out about the use of cellular therapy is: "This is implanting a foreign substance into the body. Will there not be an immune reaction?.... will there not be an allergic reaction?" Again, please refer back to the above article. Cellular therapy, by Medawar and his co-workers, is the injection of freeze dried or Iyophilized cells, and in basic research, they prove that these cells treated in this way lose their antigenicity, a fact known by experimental embryologists for years. In his book, "The Uniqueness of the Individual", Medawar further states that if a living tissue is frozen solid and then dried under a high vacuum in the frozen state (lyophilization) it loses its power to provoke immunity. He goes on to further state that this treatment "kills cells but in the humanist possible way, in the way that does the least possible unnecessary damage to their fine structure". 2 Homeopathic Organotherapy, which was widespread in Europe prior to the introduction of Embryo Organotherapy, has the effect of restoring functional balance. In the beginning, fresh cell therapy used in early years at LaPrairie in Switzerland, utilized fetal and some baby animals. This type of process eventually evolved, while constantly improving, into fetal and eventually, embryonic organotherapy used today in Europe. This process, in various stages, has been used in famous clinics of Europe for over 70 years, frequented by the so-called, “rich and famous”. Embryo organotherapy, which is the method of choice both because of the nature of the procedure and the results, represents an indisputable improvement on cell therapy. In the study “Restoration of the Responsiveness to Growth Factors in Senescent Cells by an Embryonic Cell Extract, Eberhard Amtmann, Experinental Cell Research 189, 202-207 ( 1990 ), states that “In senescent fibroblast cell cultures which have approached a postmitotic stage in vitro, responsiveness to growth factors is restored upon exposure to an embryonic sheep cell extract….mitotic activity is resumed, and the cells keep dividing over several passages. Many attempts have been made to restore the growth capacity of 101

aged cells, but failed to do so in old cultures. Only the embryonic cell extract restored the ability of repeated mitotic divisions.” If this is true, neither fetal nor baby animal extracts actually revitalize. At this time, to our knowledge, only one laboratory guarantees embryonic extract. Some Historical Facts: The idea that a cure could be effected by the incorporation of animal, or human organs, into the body is as old as medical history itself. As early as 360 B.C., the Greek philosopher and scientist, Aristotle, named a series of healing preparations which were obtained from animal or human organs. Paracelsus, the noted 16th century physician, declared, "The heart heals the heart, the kidney heals the kidney". At the beginning of the twentieth century, surgeons were transplanting complete glands, such as testicles or ovaries. The Russian surgeon Prof. Voronoff, achieved particular fame through his implantation of apes testicles in aging men. The modern method of treatment, called Cellular Therapy, was discovered by the Swiss surgeon, Dr. Paul Niehans. Even Niehans at first transplanted whole glands in patients surgically. Later, he changed to embedding fine slivers of organic tissue into the muscle pocket. Niehans subsequently replaced the existing method of surgical implantation of organs and parts of organs with an injection of cell suspensions. The advantage of this method is that the transplanted individual cells and small cell unions are brought into close contact with the tissues and liquids of the recipient, enabling them to take effect more rapidly. The first cell injection by Niehans in 1931 was a convincing success. A woman suffering from severe convulsions was transferred to Niehans' care by Prof. De Quervain following an unsuccessful operation on her thyroid gland. Her life was saved by injection of a suspension of animal parathyroid glands. The significance of Niehans' contribution lies not so much in the introduction of this technical modification, as in the fact that, from that point forward, he consistently transplanted not only glands which were customary in this branch of therapy, but, in addition, all other types of tissue found in the body, such as heart, liver, brain cells etc. Niehans was also the first to use various types of cells from unborn donor animals, recognizing quite early that fetal tissues were more easily tolerated by the recipient and had a stronger therapeutic effect. Thus Niehans intuitively anticipated, and utilized in practical therapy, findings which were not scientifically corroborated until many years later by the 1960 Nobel Prize winners, Medawar and Burnet. I. 2. R.E. Billingham, L. Brent and P.B. Medawar, Nature, 178, p 514, 1956. Medawar, P.B. : The Uniqueness of the Individual. London: Methuen & Co. (1957).

One last thought. The most quoted statement concerning organotherapy is, “ Like goes to Like”. Dr. F. Schmid wrote “Experimental Fundaments, in ‘Cell Therapy’ A New Dimension of Medicine”, Ott Publisher Thoune, Switzerland, 1983, 65-104.

102

While Dr. Schmid is describing experiments in Cell Therapy using intact xenogenic fetal cells, we believe that there is a definite correlation between what Dr. Schmid is writing about and their modern porcine embryonic organ preparation equivalents. The Authors believe that modern embryonic porcine cellular preparations accelerate the process of reconstruction of defective cell structures. This belief is based on hundreds of testimonials and antidotal evidence presented by practicing clinicians. In addition, many clients, who take modern organ preparations, not only experience specific results with regard to health symptoms, but also report an overall sense of well-being, after taking this type of product. Dr. Schmid’s article is well worth the time to read and is noted in the General Bibliography. The complete collection of all literature and papers dedicated to cellular research and therapy would be too voluminous to include in this compilation. Only articles which are historically important, clinically significant and generally informative from a scientific point of view, have been included in the following General Bibliography. I am certain that many important and interesting papers have not been included. We would be very grateful if you would forward by mail, fax or e-mail, any article you find that is not in our collection, to the authors of this book. A complete and continually increasing list is featured on www.miamimedicalfoundation.com Thank you. The Authors Jean Berry, Founder Celllife Forever LLC 12460 Equine Lane Wellington, Florida 33414 Office 561/ 204-4670 Fax 561/ 204-4662 Cell 305/ 774-0330 Frederick Kalfon, Consultant Celllife Forever LLC 12460 Equine Lane Wellington, Florida 33414 Office 561/ 204-4670 Fax 561/ 204-4662

103

Recommended Web Sites - Health Related
http://www.wrightnewsletter.com/
Dr. Jonathan V. Wright, M.D. author of numerous articles over the years beginning in Prevention Magazine and the Let’s Live series, ‘The Book of Nutritional Therapy’ and ‘Guide to Healing with Nutrition’ considered classics in this field. He developed the Bio-Identical Hormone Replacement Therapy for Women and now regularly teaches seminars for doctors on this important addition to their practice. He is also the first doctor to be interviewed in Susanne Sommers latest book, “Breakthrough”.

http://www.miamimedicalfoundation.com

MMF lists many scientific studies and papers, articles, testimonials from doctors and patients, and general information about natural health products and health therapies, including Cell Therapy. Donations to MMF, a 501(C)(3) tax free corporation, are tax deductible and help to continue the work they are doing. In the future, they will have an extensive bibliography on Cell Therapy and will start simple studies in the use of natural products and therapies on specific conditions. If you would like to be included in any of these studies, click on the above link, click on Future Studies and fill out the questionnaire.

http://www.celllifeforever.com/ http://www.mercola.com/ http://www.emofree.com http://www.bottomlinesecrets.com/

Recommended Pet and Animal Web Sites
http://www.drmarty.com Dr. Martin Goldstein, DVM, Author of ‘The Nature of ANIMAL
HEALING’. Recipes for home-made food for dogs and cats: possibly cheaper than what you are now buying. Also, health treatments and general info you should know, etc. for your animals, on his site and in the book. Impressive is his insistence to provide your animals with pure, clean water; no chlorine, fluoride and other impurities. He is not only the vet to celebrities, including consulting to Oprah, but is ‘Martha Stewarts Veterinarian’ on her radio channel, regularly each Tuesday night.

http://www.whole-dog-journal.com/ An informative article on what is in commercial pet foods. You will be amazed and appalled. Continual, general health info and things you should know. Printed newsletter is worth-while. http://www.ahvma.org American Holistic Veterinary Medical Ass.

Recommended Websites to Donate
http://www.smiletrain.com.
Children in third-world countries are given a new beginning with free surgery to correct facial disfigurements, such as cleft pallets, etc. Doctors, nurses, staff, etc., time and services, is donated free and they spend weeks in one location changing the lives of these children from ridicule, shame, even abuse or abandonment, to being normal and having hope. All monies collected is used just for the operations. No salaries or general costs.

104

DISCLAIMER It is the hope of the authors that this text book gives you a background on the miracle of embryonic organotherapy, EOT. The statements contained in this book have not been evaluated by the F.D.A. No products, or information in this book is intended to diagnose, treat, cure, or prevent, mitigate or cure any disease. Pregnant or lactating woman and persons with serious conditions, such as; cancer, cirrhosis of the liver, congestive heart failure, COPD or any other serious chronic condition, or anyone allergic to pork, beef or lamb should not take EOT Organ Extracts from the meat source they are allergic to, without the advice of your doctor. Consumers are cautioned to read all labels and follow all of your doctors directions. You should always consult with your physician before using these or any other such products. Each person is different and one person may get very satisfactory results in a short time and one may get the desired results in a longer period. Also, another person may not get any results, or see changes, at all. None of this information is given as medical advice and is not meant to take the place of your physician's or healthcare professional's advice. EOT organ products are not meant to be, nor implied, in any way, for any medical purpose. It is a dietary supplement sold with the intention to maintain or improve body structure and body function and, therefore, improve quality of life, at any age.

105

Glossary of Terms

106

Adsorption is a process that occurs when a gas or liquid solute accumulates on the surface of a solid or a liquid (adsorbent), forming a molecular or atomic film (the adsorbate). It is different from absorption, in which a substance diffuses into a liquid or solid to form a solution. The term sorption encompasses both processes, while desorption is the reverse process. Adsorption is indicative in most natural physical, biological, and chemical systems, http://en.wikipedia.org/wiki/Adsorption Alzheimer's disease (AD), also called Alzheimer disease or simply Alzheimer's, is the most common cause of dementia, afflicting 24 million people worldwide. Alzheimer's is a progressive and terminal disease for which there is currently no cure. In its most common form, it occurs in people over 65 years old although a less-prevalent early-onset form also exists.[1] The disease can begin many years before it is eventually diagnosed. In its early stages, short-term memory loss is the most common symptom, often initially thought to be caused by aging or stress by the sufferer.[2] Later symptoms include confusion, anger, mood swings, language breakdown, long-term memory loss, and the general withdrawal of the sufferer as his or her senses decline.[2][3] Gradually the sufferer loses minor, and then major bodily functions, until death occurs.[4] Although the symptoms are common, people commonly experience them in a unique way.[5] The duration of the disease is estimated as being between 5 and 20 years.[6][7] The symptoms of Alzheimer's disease are generally reported to a doctor when memory-loss causes concern, and on suspecting Alzheimer’s disease, the physician or healthcare specialists will confirm the diagnosis with a behavioral assessment and cognitive tests, often followed by a brain scan.[8] http://en.wikipedia.org/wiki/Alzheimer%27s_disease Amino Acid In chemistry, an amino acid is a molecule that contains both amine and carboxyl functional groups. In biochemistry, this term refers to alpha-amino acids with the general formula H2NCHRCOOH, where R is an organic substituent.[1] In the alpha amino acids, the amino and carboxylate groups are attached to the same carbon, which is called the "–carbon. The various alpha amino acids differ in which side chain (R group) is attached to their alpha carbon. They can vary in size from just a hydrogen atom in glycine through a methyl group in alanine to a large heterocyclic group in tryptophan.Alpha-amino acids are the building blocks of proteins. Amino acids combine in a condensation reaction which releases water and the new "amino acid residue" which is held together by a peptide bond. Proteins are defined by their unique sequence of amino acid residues; this sequence is the primary structure of the protein. Just as the letters of the alphabet can be combined to form an almost endless variety of words, amino acids can be linked in varying sequences to form a huge variety of proteins. Twenty standard amino acids are used by cells in protein biosynthesis, and these are specified by the general genetic code. These 20 amino acids are biosynthesized from other molecules, but organisms differ in which ones they can synthesize and which ones must be provided in their diet. The ones that cannot be synthesized by an organism are called essential amino acids.

Phenylalanine is one of the standard amino acids. http://en.wikipedia.org/wiki/Amino_acid 107

Alternative medicine includes practices that differ from conventional medicine. Some alternative medicine practices are homeopathy, naturopathy, chiropractic, and herbal medicine. A typical definition is "every available approach to healing that does not fall within the realm of conventional medicine".[1] Alternative medicine practices may be based on unconventional belief systems or philosophies; biological data and observations or biochemical principles;[2] and some may not follow the scientific method. They may incorporate spiritual, metaphysical, or religious underpinnings, untested practices, pre-modern medical traditions, or newly developed approaches to healing. If an alternative medical approach, previously unproven according to orthodox scientific or regulatory methodologies, is subsequently shown to be safe and effective, it may then be adopted by conventional practitioners and no longer considered "alternative". "Alternative medicine" is often categorized together with complementary medicine using the umbrella term Complementary and alternative medicine or CAM. http://en.wikipedia.org/wiki/Alternative_Medicine Aorta (pronounced "ay-OR-tuh") is the largest artery in the human body, originating from the left ventricle of the heart and bringing oxygenated blood to all parts of the body in the systemic circulation. The aorta is usually divided into seven segments/sections[1] [2] : • • • • • Ascending aorta — the section between the heart and the arch of aorta Arch of aorta — the peak part that looks somewhat like an inverted "U" Descending aorta — the section from the arch of aorta to the point where it divides into the common iliac arteries Thoracic aorta — the half of the descending aorta above the diaphragm Abdominal aorta — the half of the descending aorta below the diaphragm

108

The thoracic aorta, heart and other great vessels.

Gray's Branches MeSH

subject #142 thoracic aorta Aorta aorta, abdominal

http://en.wikipedia.org/wiki/Aorta Anti-aging addresses how to prevent, slow, or reverse the effects of aging and help people live longer, healthier, happier lives. It includes scientific research and applications in genetic engineering, tissue engineering, and other medical advances, e.g., finding treatments and cures for Alzheimer’s disease. It includes anti-aging psychology, e.g., coping skills for resiliently handling change, stress, and aging. Life extension is the part of anti-aging focused on living as long as possible. The anti-aging marketplace includes nutrition, physical fitness, skin care, hormone replacements, vitamins, supplements, and herbs. Alternative medicine and holistic approaches have often been an incubator for approaches initially shunned by traditional medicine. Leading sources of anti-aging information include the Life Extension Foundation (focusing on research and supplements), the American Academy of Anti-Aging Medicine (focusing on anti-aging physicians and cutting edge treatments), Andrew Weil (focusing on alternative medicine, holistic health, and herbal supplements), the Chopra Center for 109

Wellbeing (focusing on mind-body medicine and integrating Eastern and Western medicine), and the Ageless Lifestyles Institute (focusing on anti-aging psychology). http://en.wikipedia.org/wiki/Anti-aging Biological Age Whereas your CHRONOLOGICAL AGE is the number of years you have been alive, your BIOLOGICAL AGE (or "REAL AGE") is the age that most normal people would be when their physical state was the same as your own is right now. Biological Age is figured by asking about various health factors including hereditary disease in your family, your personal habits (smoking, overeating, alcohol, or not), and some other basics. Then, an age is arrived at that is relevant by comparison with your chronological age. That is, if you're 44 and your biological age is 57, your health could stand improvement, because you would be a 44-year-old with the body of a 57-year-old. Of course, it can go the other way as well. On the Internet, there are sites that calculate your Biological Age; if you Google "Real Age," you'll find them. Cell membrane (also called the plasma membrane, plasmalemma or "phospholipid bilayer") is a semipermeable lipid bilayer found in all cells.[1] It contains a wide variety of biological molecules, primarily proteins and lipids, which are involved in a vast array of cellular processes such as cell adhesion, ion channel conductance and cell signaling. The plasma membrane also serves as the attachment point for both the intracellular cytoskeleton and, if present, the cell wall.

Illustration of a cell membrane The cell membrane surrounds the cytoplasm of a cell and, in animal cells, physically separates the intracellular components from the extracellular environment, thereby serving a function similar to that of skin. In fungi, some bacteria, and plants, an additional cell wall forms the outermost boundary; however, the cell wall plays mostly a mechanical support role rather than a role as a selective boundary. The cell membrane also plays a role in anchoring the cytoskeleton to provide shape to the cell, and in attaching to the extracellular matrix to help group cells together in the formation of tissues.The barrier is selectively permeable and able to regulate what enters and exits the cell, thus facilitating the transport of materials needed for survival. The movement of substances across the membrane can be either passive, occurring without the input of cellular energy, or active, requiring the cell to expend energy in moving it. The membrane also maintains the cell potential.Specific proteins embedded in the cell membrane can act as molecular signals that allow cells to communicate with each other. Protein receptors are found ubiquitously and function to 110

receive signals from both the environment and other cells. These signals are transduced into a form that the cell can use to directly effect a response. Other proteins on the surface of the cell membrane serve as "markers" that identify a cell to other cells. The interaction of these markers with their respective receptors forms the basis of cell-cell interaction in the immune system. http://en.wikipedia.org/wiki/Cell_membrane Chelation Therapy is used as a treatment for acute mercury, iron (including in cases of thalassemia), arsenic, lead, uranium, plutonium and other forms of toxic metal poisoning. The chelating agent may be administered intravenously, intramuscularly, or orally, depending on the agent and the type of poisoning.One example of successful chelation therapy is the case of Harold McCluskey, a nuclear worker who became badly contaminated with americium in 1976. He was treated with diethylene triamine pentaacetic acid (DTPA) over many years, removing 41 MBq (1.1 mCi) of americium from his body. His death, 11 years later, was from unrelated causes.Several chelating agents are available, having different affinities for different metals. Common chelating agents include: Alternative medicine uses chelation therapy in the treatment of heart disease.[2] Some alternative practitioners use chelation to treat hardening of the arteries. The use of EDTA chelation therapy as a treatment for coronary artery disease is currently being studied by the National Center for Complementary and Alternative Medicine, but no claims or findings are expected before 2009. http://en.wikipedia.org/wiki/Chelation_therapy Chronic Fatigue Syndrome (CFS) is one of several names given to a poorly understood, variably debilitating disorder of uncertain cause/causes. Based on a 1999 study of adults in the United States, CFS is thought to affect approximately 4 per 1,000 adults.[1] For unknown reasons, CFS occurs more often in women, and adults in their 40s and 50s.[2][3] The illness is estimated to be less prevalent in children and adolescents, but study results vary as to the degree.[4]CFS often manifests with cognitive difficulties, chronic mental and physical exhaustion, often severe, and other characteristic symptoms in a previously healthy and active person. Despite promising avenues of research, there remains no assay or pathological finding which is widely accepted to be diagnostic of CFS. It remains a diagnosis of exclusion based largely on patient history and symptomatic criteria, although a number of tests can aid diagnosis.[5] Whereas there is agreement on the genuine threat to health, happiness, and productivity posed by CFS, various physicians' groups, researchers, and patient activists champion very different nomenclature, diagnostic criteria, etiologic hypotheses, and treatments, resulting in controversy about nearly all aspects of the disorder. Even the term chronic fatigue syndrome is controversial because a large part of the patient community believes the name trivializes the illness.[6] http://en.wikipedia.org/wiki/Chronic_fatigue_syndrome DHA; Docosahexaenoic acid (commonly known as DHA; 22:6(#-3), all-cis-docosa4,7,10,13,16,19-hexaenoic acid; trivial name cervonic acid) is an omega-3 essential fatty acid. In chemical structure, DHA is a carboxylic acid with a 22-carbon chain and six cis double bonds; the first double bond is located at the third carbon from the omega end. (C22H32O2) DHA is most often found in fish oil. Most of the DHA in fish and other more complex organisms originates in various photosynthetic and heterotrophic microalgae, and concentrates in organisms as it moves up the food chain. DHA is also commercially manufactured from microalgae; Crypthecodinium cohnii and another of the genus Schizochytrium.[1] Most animals make very little DHA through metabolism; however small 111

amounts are manufactured internally through the consumption of "-linolenic acid, an omega-3 fatty acid found in chia, flax, and many other seeds and nuts. DHA is metabolized to form the docosanoids—several families of potent hormones. DHA is a major fatty acid in sperm and brain phospholipids, and especially in the retina. Dietary DHA may reduce the risk of heart disease by reducing the level of blood triglycerides in humans. Low levels of DHA result in reduction of brain serotonin levels[2] and have been associated with ADHD, Alzheimer's disease, and depression, among other diseases, and there is mounting evidence that DHA supplementation may be effective in combating such diseases (see external links at the end of this article) Mesenchyme (also known as embryonic connective tissue) is the mass of tissue that develops mainly from the mesoderm (the middle layer of the trilaminar germ disc) of an embryo. Viscous in consistency, mesenchyme contains collagen bundles and fibroblasts. Mesenchyme later differentiates into blood vessels, blood-related organs, and connective tissues. Embryonic connective tissue (mesenchyme):
• • • •

Derives from the embryonic mesoderm Consists of loosely-packed, unspecialized cells set in a gelatinous extracellular matrix Develops into other types of tissues: connective, bone, cartilage Develops into other types of structures and systems: blood cells, endothelial cells, smooth muscle cells, circulatory system, lymphatic system. All organs in the body contain mesenchyme. http://en.wikipedia.org/wiki/Mesenchyme

human mesenchyme. Chronic Obstructive Pulmonary Disease (COPD), also known as chronic obstructive airway diseases (COAD), is a group of diseases characterized by the pathological limitation of airflow in the airway that is not fully reversible. COPD is the umbrella term for chronic bronchitis, emphysema and a range of other lung disorders. It is most often due to tobacco smoking,[1] but can be due to other airborne irritants such as solvents, as well as congenital conditions such as alpha-1-antitrypsin deficiency. It is the 4th leading cause of death in the U.S.[2] The main symptoms of COPD include dyspnea (shortness of breath) lasting for months or perhaps years, possibly accompanied by wheezing, and a persistent cough with sputum production.[3] It is possible the sputum may contain blood (hemoptysis) and become thicker, usually due to damage of the blood vessels of the airways. Severe COPD could lead to cyanosis (bluish decolorization usually in the lips and fingers) caused by a lack of oxygen in the blood. In extreme cases it could lead to cor pulmonale due to the extra work required by the heart to get blood to flow through the lungs.[4] 112

COPD is particularly characterised by the spirometric measurement of a ratio of forced expiratory volume over 1 second (FEV1) to forced vital capacity (FVC) being < 0.7 and the FEV1 < 80% of the predicted value [5] as measured by a plethysmograph. Other signs include a rapid breathing rate (tachypnea) and a wheezing sound heard through a stethoscope. Pulmonary emphysema is NOT the same as subcutaneous emphysema, which is a collection of air under the skin that may be detected by the crepitus sounds produced on palpation.[6]
• • • •

Shortness of breath (dyspnea) persisting for months to years Wheezing Decreased exercise tolerance Cough with or without phlegm[7] http://en.wikipedia.org/wiki/COPD

Dalton or unified atomic mass unit (u), is a small unit of mass used to express atomic and molecular masses. It is defined to be one twelfth of the mass of an unbound atom of 12C at rest and in its ground state. 1 u = 1/NA gram = 1/ (1000 NA) kg (where NA is Avogadro's number) 1 u $ 1.660538782(83) × 10%27 kg $ 931.494028(23) MeV/c2 See 1 E-27 kg for a list of objects which have a mass of about 1 u. http://en.wikipedia.org/wiki/Atomic_mass_unit Dermis is the lower layer of skin; contains main blood vessels. The dermis is tightly connected to the epidermis by a basement membrane, and harbors many nerve endings that provide the sense of touch and heat. It contains the hair follicles, sweat glands, sebaceous glands, apocrine glands, and blood vessels. The blood vessels in the dermis provide nourishment and waste removal to its own cells, as well as the Stratum basale of the epidermis.The dermis is structurally divided into two areas: a superficial area adjacent to the epidermis, called the papillary region, and a deep thicker area known as the reticular region. http://en.wikipedia.org/wiki/Dermis

Detox, short for detoxification, in general is the removal of toxic substances from the body. It is one of the major functions of the liver, lower gastrointestinal tract and kidneys. In conventional medicine, detoxification can also be achieved artificially by techniques such as dialysis and (in a very limited number of cases) chelation therapy. There is a firm scientific base in evidence-based medicine for this type of detoxification. Many alternative 113

medicine practitioners promote various http://en.wikipedia.org/wiki/Detoxification

other

types

of

detoxification.

Ectoderm is the start of a tissue that covers the body surfaces. It emerges first and forms from the outermost of the germ layers. What forms from it (general)?
• •

Nervous system Outer part of integument

In vertebrates, the ectoderm has three parts: external ectoderm (also known as surface ectoderm), the neural crest, and neural tube. The latter two are known as neuroectoderm. http://en.wikipedia.org/wiki/Ectoderm

Organs derived from ectoderm.

Section through embryonic disk of Vespertilio murinus.

Gray's Days MeSH

subject #6 48 16 Ectoderm

Endoderm, (sometimes called Entoderm) is one of the germ layers formed during animal embryogenesis. Cells migrating inward along the archenteron form the inner layer of the gastrula, which develops into the endoderm. The endoderm consists at first of flattened cells, which subsequently become columnar. It forms the epithelial lining of the whole of the digestive tube except part of the mouth, pharynx and the terminal part of the rectum 114

(which are lined by involutions of the ectoderm), the lining cells of all the glands which open into the digestive tube, including those of the liver and pancreas, the epithelium of the auditory tube and tympanic cavity, of the trachea, bronchi, and air cells of the lungs, of the urinary bladder and part of the urethra, and that which lines the follicles of the thyroid gland and thymus. http://en.wikipedia.org/wiki/Endoderm

The following graph represents the products produced by the endoderm. Germ Layer Category Product Endoderm Endoderm Endoderm General General General Gastrointestinal tract Respiratory tract Endocrine glands and organs (liver and pancreas)

Endoderm

Endocrine system is an integrated system of small organs that involve the release of extracellular signaling molecules known as hormones. The endocrine system is instrumental in regulating metabolism, growth, development and puberty, tissue function, and also plays a part in mood.[1] The field of medicine that deals with disorders of endocrine glands is endocrinology, a branch of the wider field of internal medicine. The Endocrine system is an information signal system much like the nervous system. However, the nervous system uses nerves to conduct information, whereas the endocrine system mainly uses blood vessels as information channels. Glands located in many regions of the body release into the bloodstream specific chemical messengers called hormones. Hormones regulate the many and varied functions of an organism, e.g., mood, growth and 115

development, tissue function, and metabolism, as well as sending messages and acting on them. http://en.wikipedia.org/wiki/Endocrine_system Enzymes are proteins that catalyze (i.e. accelerate) chemical reactions.[1] In enzymatic reactions, the molecules at the beginning of the process are called substrates, and the enzyme converts them into different molecules, the products. Almost all processes in a biological cell need enzymes in order to occur at significant rates. Since enzymes are extremely selective for their substrates and speed up only a few reactions from among many possibilities, the set of enzymes made in a cell determines which metabolic pathways occur in that cell. Like all catalysts, enzymes work by lowering the activation energy (Ea or &G‡) for a reaction, thus dramatically accelerating the rate of the reaction. Most enzyme reaction rates are millions of times faster than those of comparable uncatalyzed reactions. As with all catalysts, enzymes are not consumed by the reactions they catalyze, nor do they alter the equilibrium of these reactions. However, enzymes do differ from most other catalysts by being much more specific. Enzymes are known to catalyze about 4,000 biochemical reactions.[2] Although almost all enzymes are proteins, not all biochemical catalysts are enzymes, since some RNA molecules called ribozymes also catalyze reactions.[3] Synthetic molecules called artificial enzymes also display enzyme-like catalysis.[4] . http://en.wikipedia.org/wiki/Enzyme

Human glyoxalase I. Embryo (from Greek: !!"#$%&, plural !!"#$', lit. "that which grows," from en- "in" + bryein "to swell, be full") is a multicellular diploid eukaryote in its earliest stage of development, from the time of first cell division until birth, hatching, or germination. In humans, it is called an embryo from the moment of fertilisation until the end of the 8th week of gestational age, whereafter it is instead called a fetus. http://en.wikipedia.org/wiki/Embryo Epidermis is the outermost layer of the skin. It forms the waterproof, protective wrap over the body's surface and is made up of stratified squamous epithelium with an underlying basal lamina. The epidermis is avascular (contains no blood vessels) and is nourished by diffusion from the dermis. The main type or the four principal types of cells which make up the epidermis are keratinocytes, melanocytes, Langerhans cells and Merkels cells. It is a keratinized stratified squamous epithelium. http://en.wikipedia.org/wiki/Epidermis_%28skin%29

116

Cross-section of all skin layers Essential Minerals & Dietary Minerals: Dietary Minerals are the chemical elements required by living organisms, other than the four elements carbon, hydrogen, nitrogen, and oxygen which are present in common organic molecules. The term "mineral" is archaic, since the intent of the definition is to describe ions, not chemical compounds or actual minerals. Furthermore, once dissolved, so-called minerals do not exist as such, sodium chloride breaks down into sodium ions and chloride ions in aqueous solution. Some dietitians recommend that these heavier elements should be supplied by ingesting specific foods (that are enriched in the element(s) of interest), compounds, and sometimes including even minerals, such as calcium carbonate. Sometimes these "minerals" come from natural sources such as ground oyster shells. Sometimes minerals are added to the diet separately from food, such as mineral supplements, the most famous being iodine in "iodized salt." Dirt eating, called pica or geophagy is hypothesized to be a means of supplementing the diet with elements, but this has not been verified [1]. The chemical composition of soils will vary depending on the location.Vitamins, which are not considered minerals, are organic compounds, some of which contain heavy elements such as iodine and cobalt. The dietary focus on "minerals" derives from an interest in supporting the biosynthetic apparatus with the required elemental components.[2] Appropriate intake levels of certain chemical elements is thus required to maintain optimal health. Commonly, the requirements are met with a conventional diet. Excessive intake of any element (again, usually as an ion) will lead to poisoning. For example, large doses of selenium are lethal. On the other hand, large doses of zinc are less dangerous but can lead to a harmful copper deficiency (unless compensated for, as in the Age-Related Eye Disease Study).Dietary minerals classified as "macromineral" are required in relatively large amounts. Conversely "microminerals" or "trace minerals" are required relatively in minute amounts. There is no universally accepted definition of the difference between "large" and "small" amounts. Essential Minerals; At least seven minerals are required to support biochemical processes, many playing a role as electrolytes or in cell structure and function.[3] In human nutrition, the dietary bulk "mineral elements" (RDA > 200 mg/day) are in alphabetical order (parenthetical comments on folk medicine perspective):
•

Calcium (for muscle, heart and digestive system health, builds bone, neutralizes acidity, supports synthesis and function of blood cells) 117

• • • • •

Chloride (for production of hydrochloric acid in the stomach and in cellular pump functions) Magnesium is required for processing ATP and related reactions (health, builds bone, increases alkalinity) Phosphorus is a component of bones (see apatite) and energy processing and many other functions (bone mineralization)[4] Potassium is a systemic electrolyte and is essential in coregulating ATP with sodium Sodium is a systemic electrolyte and is essential in coregulating ATP with potassium

http://en.wikipedia.org/wiki/Dietary_mineral FATS: polyunsaturated fat is an abbreviation of polyunsaturated fatty acid. That is a fatty acid in which more than one double bond exists within the representative molecule. That is, the molecule has two or more points on its structure capable of supporting hydrogen atoms not currently part of the structure. Polyunsaturated fatty acids can assume a cis or trans conformation depending on the geometry of the double bond. The lack of the extra hydrogen atoms on the molecule's surface typically reduces the strength of the compound's intermolecular forces, thus causing the melting point of the compound to be significantly lower. This property can be observed by comparing predominately unsaturated vegetable oils, which remain liquid even at relatively low temperatures, to much more saturated fats such as butter or lard which are mainly solid at room temperature. Trans fats are more similar to saturated fat than are cis fats in many respects, including the fact that they solidify at a lower temperature.

Chemical structure of the polyunsaturated fat linoleic acid.

3D representation of linoleic acid in a bent conformation. 118

A fatty acid has a carboxylic acid at one end and a methyl group at the other end. Carbon atoms in a fatty acid are identified by Greek letters on the basis of their distance from the carboxylic acid. The carbon atom closest to the carboxylic acid is the alpha carbon, the next adjacent carbon is the beta carbon, etc. In a long-chain fatty acid the carbon atom in the methyl group is called the omega carbon because omega is the last letter of the Greek alphabet. Omega-3 fatty acids have a double bond three carbons away from the methyl carbon, whereas omega-6 fatty acids have a double bond six carbons away from the methyl carbon. Polyunsaturated fat, along with monounsaturated fat are "healthy fats," the amount of which in one's daily diet should be near 25 g (in a 2000 calorie-per-day diet).[citation needed] Polyunsaturated fat can be found mostly in grain products, fish and sea food (herring, salmon, mackerel, halibut), soybeans, and fish oil. Foods like mayonnaise and soft margarine may also be good sources, but nutritional facts can vary by style and brand. Omega-3 fatty acids in fish oil, fish and seafood lower the total amount of fat in the blood, which can lower blood pressure and decrease the risk of cardiovascular diseases.[1] Omega-6 fatty acids in sunflower oil and safflower oil also reduce the risk of cardiovascular disease, but can contribute to allergies and inflammation.[citation needed] Some Examples of Foods containing polyunsaturated fat fish cereal whole grain wheat peanuts butter margarine

Saturated fat is fat that consists of triglycerides containing only saturated fatty acids.Fat that occurs naturally in living matter contains varying proportions of saturated and unsaturated fat. Foods that contain a high proportion of saturated fat are butter, ghee, suet, tallow, lard, coconut oil, cottonseed oil, and palm kernel oil, dairy products (especially cream and cheese), meat, chocolate, and some prepared foods[1].There are several kinds of naturally occurring saturated fatty acids, their only difference being the number of carbon atoms - from 1 to 24. Saturated fatty acids have no double bonds between the carbon atoms of the fatty acid chain; hence, they are fully saturated with hydrogen atoms. While nutrition labels usually lump them together, the saturated fatty acids appear in different proportions among food groups. Lauric and myristic acids are most commonly 119

found in "tropical" oils (e.g. palm kernel, coconut) and dairy products. The saturated fat in meat, eggs, chocolate and nuts is primarily palmitic and stearic acid. saturated fat profile of common foods (percentage of total fat)[2] Lauric Myristic Palmitic Stearic Food acid acid acid acid Coconut oil 47% 18% 9% 3% Butter 3% 11% 29% 13% Ground beef 0% 4% 26% 15% Dark chocolate 0% 0% 34% 43% Salmon 0% 1% 29% 3% Eggs 0% 0% 27% 10% Cashews 2% 1% 10% 7% Soybean oil 0% 0% 11% 4% Some common examples of fatty acids are: butyric acid with 4 carbon atoms (contained in butter), lauric acid with 12 carbon atoms (contained in coconut oil, palm oil and breast milk[citation needed] , myristic acid with 14 carbon atoms (contained in cow milk and dairy products), palmitic acid with 16 carbon atoms (contained in palm oil, hence the name, and meat), stearic acid with 18 carbon atoms (also contained in meat and cocoa butter). The relationship between dietary fats and CVD, especially coronary heart disease, has been extensively investigated, with strong and consistent associations emerging from a wide body of evidence accrued from animal experiments, as well as observational studies, clinical trials and metabolic studies conducted in diverse human populations...Saturated fatty acids raise total and low-density lipoprotein (LDL) cholesterol...The most effective replacement for saturated fatty acids in terms of coronary heart disease outcome are polyunsaturated fatty acids, especially linoleic acid. This finding is supported by the results of several large randomized clinical trials, in which replacement of saturated and trans fatty acids by polyunsaturated vegetable oils lowered coronary heart disease risk. – World Health Organization, Population nutrient intake goals for preventing diet-related chronic diseases,5.4.4 Diets high in saturated fat are correlated with an increased incidence of atherosclerosis and coronary heart disease according to a number of studies, both African green monkeys[3] and human.[4][5][6][7] Some studies have suggested that diets high in saturated fat increase the risk of heart disease and stroke. Epidemiological studies have found that those whose diets are high in saturated fatty acids, including lauric, myristic, palmitic, and stearic acid, had a higher prevalence of coronary heart disease.[8][9][10][11] Additionally, controlled experimental studies have found that people consuming high saturated fat diets experience negative cholesterol profile changes.[4][12][13][14] A 2003 meta-analysis published in the American Journal of Clinical Nutrition concluded that diets high in saturated fat 120

negatively affected cholesterol profiles — predictors of a heart attack and other cardiovascular diseases.[15] Experiments in which subjects were randomly assigned to either a control or Mediterranean diet (which replaces saturated fat with mono and polyunsaturated fat) showed a significantly decreased likelihood of suffering a second heart attack, cardiac death, heart failure or stroke.[16][17] Epidemiological studies of heart disease have implicated the four major saturated fatty acids to varying degrees. The World Health Organization has determined that there is "convincing" evidence that myristic and palmitic acid intake increases the probability, "possible" risk from lauric acid, and no increased risk at all from stearic acid consumption.[18] In a study published in 2001, erythrocyte membrane oleic and monounsaturated fatty acid content was positively associated with breast cancer risk in postmenopausal women, while no association was shown between saturated fatty acids and breast cancer risk. Enzyme &9-desaturase catalyzes the conversion of stearic acid to oleic acid: there is a negative correlation between erythrocyte membrane oleic acid and dietary polyunsaturated fatty acids. Inverse relationship between Saturation Index (ratio of membrane stearic to oleic acid) and breast cancer risk could also be related to hormonal and metabolic factors and to interactions between them, as well as to dietary factors.[19] Trans Fat is the common name for a type of unsaturated fat with trans- isomer fatty acid(s). Trans fats may be monounsaturated or polyunsaturated. Most trans fats consumed today are industrially created by partially hydrogenating plant oils — a process developed in the early 1900s and first commercialized as Crisco in 1911. The goal of partial hydrogenation is to add hydrogen atoms to unsaturated fats, making them more saturated. These more saturated fats have a higher melting point, which makes them attractive for baking and extends their shelf-life. Another particular class of trans fats, vaccenic acid, occurs naturally in trace amounts in meat and dairy products from ruminants. Unlike other dietary fats, trans fats are neither essential nor salubrious[1] and, in fact, the consumption of trans fats increases one's risk of coronary heart disease[2] by raising levels of "bad" LDL cholesterol and lowering levels of "good" HDL cholesterol. [3] Health authorities worldwide recommend that consumption of trans fat be reduced to trace amounts. Trans fats from partially hydrogenated oils are more deleterious than naturally occurring oils.[4] Chemically, trans fats are made of the same building blocks as non-trans fats, but have a different arrangement. In trans fatty acid molecules, the hydrogen atoms bonded to pairs of doubly bonded carbon atoms (characteristic of all unsaturated fats) are in the trans rather than the cis arrangement. This results in a straight, rather than kinked, shape for the carbon chain, more like the straight chain of a fully saturated fat. Fibromyalgia (FM) is a disorder classified by the presence of chronic widespread pain and tactile allodynia.[1] Fibromyalgia patients are also typically affected by a number of symptoms other than pain, including debilitating fatigue, abnormal sleep architecture,[2] 121

functional bowel disturbances[3] and a variety of neuropsychiatric problems including cognitive dysfunction,[4] anxiety and depressive symptoms[5]. While the criteria for such an entity have not yet been thoroughly developed, the recognition that fibromyalgia involves more than just pain has led to the frequent use of the term “fibromyalgia syndrome.” It is not contagious, and recent studies suggest that people with fibromyalgia may be genetically predisposed.[6] It affects more females than males, with a ratio of 9:1 by American College of Rheumatology (ACR)criteria.[7] Fibromyalgia is seen in about 2% of the general population.[8] It is most commonly diagnosed in individuals between the ages of 20 and 50, though onset can occur in childhood.The disorder is not directly lifethreatening. The degree of symptoms may vary greatly from day to day with periods of flares (severe worsening of symptoms) or remission; however, the disorder is generally perceived as non-progressive.[9]The validity of fibromyalgia as a unique clinical entity is a matter of some contention among researchers in the field. For example, it has been proposed that the pathophysiology responsible for the symptoms that are collectively classified as representing "fibromyalgia" is poorly understood, thereby suggesting that the fibromyalgia phenotype may result from several different disease processes that have global hyperalgesia and allodynia in common, [10][11][12] an observation that has led to the proposition that current diagnostic criteria are insufficient to differentiate patient groups from each other.[13] Alternatively, there is evidence for the existence of differing pathophysiological abnormalities within the greater fibromyalgia construct[14][15], which may be interpreted to represent evidence for the existence of biologically distinct "sub-types" of the disorder akin to conditions such as epilepsy, schizophrenia and major depressive disorder. In a January 14, 2008 article in the New York Times, the controversy of the reality of the disease and its proposed cures are discussed, while citing that the American College of Rheumatology, the Food and Drug Administration and insurers recognize fibromyalgia as a diagnosable disease. Drug companies are aggressively pursuing fibromyalgia treatments, seeing the potential for a major new market.[16] http://en.wikipedia.org/wiki/Fibromyalgia Gestation is the carrying of an embryo or fetus inside a female viviparous animal. Mammals during pregnancy can have one or more gestations at the same time (multiple gestations). The time interval of a gestation is called gestation period, and the length of time the offspring have spent developing in the uterus is called gestational age.Human pregnancy can be divided into three trimesters, each three months long. The third trimester begins at about 28 weeks. The 23rd week is the first week when a preterm fetus is considered viable. Before this age major developmental events that would allow the fetus to survive outside the womb have not yet occurred. This division is somewhat arbitrary as children born before this point have survived, but only with significant medical assistance.In humans, birth normally occurs at a gestational age of 37 to 42 weeks. Childbirth occurring before 37 weeks of gestation is considered preterm, childbirth after 25 weeks is usually considered"viable". [1] Preterm and low birth weight babies make up the second leading cause of infant death at about 17%.[citation needed] Preterm births solely consist of 12% of infant deaths with an 84% majority within the 32-36 week period. [2] It is estimated that two million babies worldwide die annually within 24 hours of birth.In mammals, pregnancy begins when a fertilized zygote implants in the female's uterus and ends once it leaves the uterus. http://en.wikipedia.org/wiki/Gestation Below are average and approximate values ordered by gestation period:

122

Animal

Average gestation period (days) 33 62 65 108 115 150 259-294 283 336

Rabbits Cats Dogs Lions Pigs Sheep Humans Cattle Horses

Elephants 600-660

Gland
A gland is an organ in an animal's body that synthesizes a substance for release such as hormones or breast milk, often into the bloodstream (endocrine gland) or into cavities inside the body or its outer surface (exocrine gland).

Types
Glands can be divided into two groups: Endocrine glands — are glands that secrete their product directly onto a surface rather than through a duct.
123

Exocrine glands — secrete their products via a duct, the glands in this group can be divided into three groups: Apocrine glands — a portion of the secreting cell's body is lost during secretion. Apocrine gland is often used to refer to the apocrine sweat glands, however it is thought that apocrine sweat glands may not be true apocrine glands as they may not use the apocrine method of secretion. Holocrine glands — the entire cell disintegrates to secrete its substances (e.g., sebaceous glands) Merocrine glands — cells secrete their substances by exocytosis (e.g., mucous and serous glands). Also called "eccrine." The type of secretory product of an Exocrine gland may also be one of three categories: Serous glands — secrete a watery, often protein-rich product. Mucous glands — secrete a viscous product, rich in carbohydrates (e.g., glycoproteins). Sebaceous glands — secrete a lipid product.

Formation
Every gland is formed by an in-growth from an epithelial surface. This in-growth may from the beginning possess be a tubular structure, but in other instances glands may start as a solid column of cells which subsequently becomes tubulated. As growth proceeds, the column of cells may divide or give off offshoots, in which case a compound gland is formed. In many glands the number of branches is limited, in others (salivary, pancreas) a very large structure is finally formed by repeated growth and subdivision. As a rule, the branches do not unite with one another, but in one instance, the liver, this does occur when a reticulated compound gland is produced. In compound glands the more typical or secretory epithelium is found forming the terminal portion of each branch, and the uniting portions form ducts and are lined with a less modified type of epithelial cell. Glands are classified according to their shape.

If the gland retains its shape, as a tube throughout, it is termed a tubular gland. In the second main variety of gland the secretory portion is enlarged and the lumen variously increased in size. These are termed alveolar or saccular glands.

Specific glands
A list of human exocrine glands is available here. 124

A list of human endocrine glands is available here.

Section of submaxillary gland of kitten. Duct semidiagrammatic.

Section of pancreas of dog. X 250.

Dissection of a lactating breast.

Section of portion of mamma.

Apocrine

Methods of secretion

Good Manufacturing Practice or GMP (also referred to as 'cGMP' or 'current Good Manufacturing Practice') is a term that is recognized worldwide for the control and management of manufacturing and quality control testing of foods and pharmaceutical products.In the US, the phrase "current good manufacturing practice" appears in 501(B) of the 1938 Food, Drug, and Cosmetic Act (21USC351). US courts may theoretically hold that a drug product is adulterated even if there is no specific regulatory requirement that was violated as long as the process was not performed according to industry standards. The World Health Organization version The World Health Organization (WHO) version of GMP is used by pharmaceutical regulators and the pharmaceutical industry in over one hundred countries worldwide, primarily in the developing world. The European Union's GMP (EU-GMP) enforces more compliance requirements than the WHO GMP, as does the Food and Drug Administration's version in the US. Similar GMPs are used in other countries, with Australia, Canada, Japan, Singapore and others having highly developed/sophisticated GMP requirements. In the United Kingdom, the Medicines Act (1968) covers most aspects of GMP in what is commonly referred to as "The Orange Guide", because of the colour of its cover, is officially known as The Rules and Guidance for Pharmaceutical Manufacturers and Distributors.Since the 1999 publication of GMPs for Active Pharmaceutical Ingredients, by the International Conference on Harmonization (ICH), GMPs now apply in those countries and trade groupings that are signatories to ICH (the EU, Japan and the US), and applies in other countries (e.g., Australia, Canada, Singapore) which adopt ICH guidelines to the manufacture and testing of active raw materials.GMP is designed to help assure the quality of drug products by ensuring several key attributes, including correctness and legibility of recorded manufacturing and control documentation. Data transfers must be performed in specific ways to avoid mistakes (e.g., writing down a reading on a balance and requiring a second person to also check the balance reading to assure accuracy). Methods have been developed to make this process 125

easier (e.g., links between equipment and central data storage facilities for direct transfer of important data). http://en.wikipedia.org/wiki/Good_manufacturing_practice Growth hormone (GH) is a hormone that stimulates growth and cell reproduction in humans and other animals. It is a 191-amino acid, single chain polypeptide hormone which is synthesized, stored, and secreted by the somatotroph cells within the lateral wings of the anterior pituitary gland. The hormone is also known as somatotrophin when referring to growth hormone produced by recombinant DNA technology, and is abbreviated "rhGH".Growth hormone has a variety of functions in the body, the most noticeable of which is the increase of height throughout childhood, and there are several diseases which can be treated through the therapeutic use of GH.There are many controversies around the claims, products, and businesses related to the use of growth hormone as an antiaging therapy. Most of this controversy falls into two categories: 1. Claims of exaggerated, misleading, or unfounded assertions that real growth hormone treatment slows or reverses the effects of aging 2. The sale of products that fraudulently or misleadingly purport to be growth hormone or to increase the user's own secretion of natural human growth hormone to a beneficial degree. Following a study in 1990 by Rudman[1] which showed fat loss, muscle mass increase and maintenance of healthy skin from the administration of growth hormone in elderly men, there has been a burgeoning industry surrounding the sale and administration of GH and its purported anti-aging effects. As is common with such therapies, the literature is now dominated by advocacy from pharmaceutical companies. Solid medical evidence is harder to find, and appears to indicate mixed results. It is likely that there is some advantage, but it is also evident that benefits are being exaggerated by some for commercial gain[2].Some of the side effects reportedly seen in previously healthy mature patients after taking HGH include:
• • • • • •

Edema (retention of fluids) in extremities[3] Arthralgia (joint pain)[3] Carpal tunnel syndrome[3] Hypertension Diabetes and other glucose metabolism imbalances[3] Gynecomastia (enlargement of male mammary glands)[3]

Chronic use of HGH is not well studied, except when used in children for acute growth deficiencies. A long term increase in colon cancer and Hodgkin's Disease has been observed in these cases.[4] http://en.wikipedia.org/wiki/HGH_controversies High-density lipoproteins (HDL) form a class of lipoproteins, varying somewhat in their size (8–11 nm in diameter), that carry fatty acids and cholesterol from the body's tissues to the liver. About thirty percent of blood cholesterol is carried by HDL.[1] It is hypothesized that HDL can remove cholesterol from atheroma within arteries and transport it back to the liver for excretion or re-utilization—which is the main reason why HDL-bound cholesterol is sometimes called "good cholesterol", or HDL-C. A high level of HDL-C seems to protect against cardiovascular diseases, and low HDL cholesterol levels (less than 40 mg/dL) increase the risk for heart disease.[1] When measuring cholesterol, 126

any contained in HDL particles is considered as protection to the body's cardiovascular health, in contrast to "bad" LDL cholesterol. HDL are the smallest of the lipoproteins. They are the densest because they contain the highest proportion of protein. They contain the A class of apolipoproteins.[2] The liver synthesizes these lipoproteins as complexes of apolipoproteins and phospholipid, which resemble cholesterol-free flattened spherical lipoprotein particles. They are capable of picking up cholesterol, carried internally, from cells they interact with. A plasma enzyme called lecithin-cholesterol acyltransferase (LCAT) converts the free cholesterol into cholesteryl ester (a more hydrophobic form of cholesterol) which is then sequestered into the core of the lipoprotein particle eventually making the newly synthesized HDL spherical. They increase in size as they circulate through the bloodstream and incorporate more cholesterol molecules into their structure. Thus it is the concentration of large HDL particles which more accurately reflects protective action, as opposed to the concentration of total HDL particles.[3] This ratio of large HDL to total HDL particles varies widely and is only measured by more sophisticated lipoprotein assays using either electrophoresis (the original method developed in the 1970s), or newer NMR spectroscopy methods (See also: NMR and spectroscopy), developed in the 1990s. In the stress response, serum amyloid A, which is one of the acute phase proteins and an apolipoprotein, is under the stimulation of cytokines (IL-1, IL-6) and cortisol produced in the adrenal cortex and carried to the damaged tissue incorporated into HDL particles. At the inflammation site, it attracts and activates leukocytes. In chronic inflammations, its deposition in the tissues manifests itself as amyloidosis. Men tend to have noticeably lower HDL levels, with smaller size and lower cholesterol content, than women. Men also have an increased incidence of atherosclerotic heart disease. Historically, beginning in the late 1970's cholesterol and lipid assays were promoted to estimate total HDL-cholesterol because such tests used to be far less expensive, by about 50 fold, than measured lipoprotein particle concentrations and subclass analysis. Over time, with continued research, decreasing costs, greater availability and wider acceptance of other "lipoprotein subclass analysis" assay methods, including NMR spectroscopy, human studies have continued to show a stronger correlation between human clinically obvious cardiovascular events and quantitatively measured large HDL-particle concentrations. Epidemiological studies have shown that high concentrations of HDL (over 60 mg/dL) have protective value against cardiovascular diseases such as ischemic stroke and myocardial infarction. Low concentrations of HDL (below 40 mg/dL for men, below 50 mg/dL for women) are a positive risk factor for these atherosclerotic diseases. Data from the landmark Framingham Heart Study showed that for a given level of LDL, the risk of heart disease increases 10-fold as the HDL varies from high to low. Conversely, for a fixed level of HDL, the risk increases 3-fold as LDL varies from low to high. Even people with very low LDL levels are exposed to some increased risk if their HDL levels are not high enough. (HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events; Philip Barter, M.D., September 27, 2007; NEJM[1]) 127

Recommended rangeThe American Heart Association, NIH and NCEP provides a set of guidelines for male fasting HDL levels and risk for heart disease. Level mg/dL <40 40–59 >60 Level mmol/L <1.03 1.03–1.52 >1.55 Interpretation Low HDL cholesterol, heightened risk for heart disease, <50 is the value for women Medium HDL level High HDL level, optimal condition considered protective against heart disease

Homeopathy (also homœopathy or homoeopathy; from the Greek "!%(%), hómoios, "similar" + *+,%), páthos, "suffering" or "disease") is a form of alternative medicine first defined by Samuel Hahnemann in the 18th century.[1] Homeopathic practitioners contend that an ill person can be treated using a substance that can produce, in a healthy person, symptoms similar to those of the illness. According to homeopaths, serial dilution, with shaking between each dilution, removes the toxic effects of the remedy while the qualities of the substance are retained by the diluent (water, sugar, or alcohol). The end product is often so diluted that materially it is indistinguishable from pure water, sugar or alcohol.[2][3][4] Practitioners select treatments according to a patient consultation that explores the physical and psychological state[5] of the patient, both of which are considered important to selecting the remedy.[6]Hydrogen Peroxide Drip http://en.wikipedia.org/wiki/Homeopathy Homocysteine is a chemical compound with the formula HSCH2CH2CH(NH2)CO2H. It is a homologue of the naturally-occurring amino acid cysteine, differing in that its side-chain contains an additional methylene (-CH2-) group before the thiol (-SH) group. Alternatively, homocysteine can be derived from methionine by removing the latter's terminal C' methyl group. The "extra" (relative to cysteine) one carbon methylene group allows this molecule to form a five-membered ring, homocysteine thiolactone. The facility of this reaction precludes the formation of stable peptide bonds. In other words, a protein containing homocysteine would tend to cleave itself. The 4 carbon homocysteine is (only) made from the 5 carbon methionine, an essential amino acid, in a multi step reaction via S-adenosyl methionine. Homocysteine can be recycled back into methionine or it can be permanently converted to cysteine via the transsulfuration pathway. Homocysteine is not obtained from the diet; it is a normal temporary and chemically reactive reaction product that can be measured in blood.[1] Due to its high reactivity to proteins, it is almost always bound to proteins, 'thiolating' (and thus degrading) most notably the lysine and cysteine components thereof. This can permanently affect protein function. In blood, it is found bound to albumin and to hemoglobin. It affects enzymes with cysteine-containing active sites, for example, it inhibits lysyl oxidase a key enzyme in the production of collagen and elastin, two main structural proteins in artery, bone and skin. As a consequence of the biochemical reactions in which homocysteine is involved, deficiencies of the vitamins folic acid (B9), pyridoxine (B6), or B12 (cyanocobalamin) can 128

lead to high homocysteine levels.[2] Supplementation with pyridoxine, folic acid, B12 or trimethylglycine (betaine) reduces the concentration of homocysteine in the bloodstream.[3] [4] Increased levels of homocysteine are linked to high concentrations of endothelial asymmetric dimethylarginine. Elevations of homocysteine also occur in the rare hereditary disease homocystinuria and in the methylene-tetrahydrofolate-reductase polymorphism genetic traits. The latter is quite common (about 10% of the world population) and it is linked to an increased incidence of thrombosis and cardiovascular disease and that occurs more often in people with above minimal levels of homocysteine (about 6 (mol/L). Common levels in Western populations are 10 to 12 and levels of 20 (mol/L are found in populations with low B-vitamin intakes (New Delhi) or in the older elderly (Rotterdam, Framingham). Women have 10-15% less homocysteine during their reproductive decades than men which may help explain the fact they suffer myocardial infarction (heart attacks) on average 10 to 15 years later than men. A high level of blood serum homocysteine is a powerful risk factor for cardiovascular disease. Unfortunately, one study which attempted to decrease the risk by lowering homocysteine was not fruitful.[5] This study was conducted on nearly 5000 Norwegian heart attack survivors who already had severe, late-stage heart disease. No study has yet been conducted in a preventive capacity, on subjects who are in a relatively good state of health. Studies reported in 2006 have shown that giving vitamins [folic acid, B6 and B12] to reduce homocysteine levels may not quickly offer benefit, however a significant 25% reduction in stroke was found in the HOPE-2 study [6] even in patients mostly with existing serious arterial decline although the overall death rate was not significantly changed by the intervention in the trial. Clearly, reducing homocysteine does not quickly repair existing structural damage of the artery architecture. However, the science is strong supporting the biochemistry that homocysteine degrades and inhibits the formation of the three main structural components of the artery, collagen, elastin and the proteoglycans. Homocysteine permanently degrades cysteine [disulfide bridges] and lysine amino acid residues in proteins, gradually affecting function and structure. Simply put, homocysteine is a 'corrosive' of long-living [collagen, elastin] or life-long proteins [fibrillin]. These long-term effects are difficult to establish in clinical trials focusing on groups with existing artery decline. The main role of reducing homocysteine is likely in 'prevention' but with a slow but probable role in 'cure'. Low-density lipoprotein (LDL) belongs to the lipoprotein particle family. Its size is approx. 22 nm and its mass is about 3 million daltons; but, since LDL particles contain a changing number of fatty acids, they actually have a mass and size distribution. Each native LDL particle contains a single apolipoprotein B-100 molecule (Apo B-100, a protein with 4536 amino acid residues) that circles the fatty acids, keeping them soluble in the aqueous environment. In addition, LDL has a highly-hydrophobic core consisting of polyunsaturated fatty acid known as linoleate and about 1500 esterified cholesterol molecules. This core is surrounded by a shell of phospholipids and unesterified cholesterol as well as a single copy of B-100 large protein (514 kD)[1]. In general, LDL transports cholesterol and triglycerides from the liver to peripheral tissues. LDL also regulate cholesterol synthesis at these sites. 129

Because LDLs transport cholesterol to the arteries and can be retained there by arterial proteoglycans starting the formation of plaques, increased levels are associated with atherosclerosis, and thus heart attack, stroke, and peripheral vascular disease. For this reason, cholesterol inside LDL lipoproteins is often called "bad" cholesterol. This is a misnomer. The cholesterol transported on LDL is the same as cholesterol transported on other lipoprotein particles. The cholesterol itself is not "bad"; rather, it is how and where the cholesterol is being transported, and in what amounts over time, that causes adverse effects. Increasing evidence has revealed that the concentration and size of the LDL particles more powerfully relates to the degree of atherosclerosis progression than the concentration of cholesterol contained within all the LDL particles[citation needed] . The healthiest pattern, though relatively rare, is to have small numbers of large LDL particles and no small particles. Having small LDL particles, though common, is an unhealthy pattern; high concentrations of small LDL particles (even though potentially carrying the same total cholesterol content as a low concentration of large particles) correlates with much faster growth of atheroma, progression of atherosclerosis and earlier and more severe cardiovascular disease events and death. LDL is formed as VLDL lipoproteins lose triglyceride through the action of lipoprotein lipase (LPL) and become smaller and denser, containing a higher proportion of cholesterol. A hereditary form of high LDL is familial hypercholesterolemia (FH). Increased LDL is termed hyperlipoproteinemia type II (after the dated Fredrickson classification). LDL poses a risk for cardiovascular disease when it invades the endothelium and becomes oxidized, since the oxidized form is more easily retained by the proteoglycans. A complex set of biochemical reactions regulates the oxidation of LDL, chiefly stimulated by presence of free radicals in the endothelium. Nitric oxide down-regulates this oxidation process catalyzed by L-arginine. In a corresponding manner, when there are high levels of asymmetric dimethylarginine in the endothelium, production of nitric oxide is inhibited and more LDL oxidation occurs.Citations required for this paragraph Because LDL appears to be harmless until oxidized by free radicals [2], it is postulated that ingesting antioxidants and minimizing free radical exposure may reduce LDL's contribution to atherosclerosis, though results are not conclusive. [3] When a cell requires cholesterol, it synthesizes the necessary LDL receptors, and inserts them into the plasma membrane. The LDL receptors diffuse freely until they associate with clathrin-coated pits. LDL particles in the blood stream bind to these extracellular LDL receptors. The clathrin-coated pits then form vesicles that are endocytosed into the cell. After the clathrin coat is shed, the vesicles deliver the LDL and their receptors to early endosomes, onto late endosomes to lysosomes. Here the cholesterol esters in the LDL are hydrolysed. The LDL receptors are recycled back to the plasma membrane. In the USA, the American Heart Association, NIH, and NCEP provide a set of guidelines for fasting LDL-Cholesterol levels, estimated or measured, and risk for heart disease. As of 2003, these guidelines were: 130

Level mg/dL

Level mmol/L

Interpretation

<100

<2.6

Optimal LDL cholesterol, corresponding to reduced, but not zero, risk for heart disease Near optimal LDL level Borderline high LDL level High LDL level Very high LDL level, corresponding to highest increased risk of heart disease

100 to 129 2.6 to 3.3 130 to 159 3.3 to 4.1 160 to 189 4.1 to 4.9

>190

>4.9

These guidelines were based on a goal of presumably decreasing death rates from cardiovascular disease to less than 2% to 3% per year or less than 20% to 30% every 10 years. Note that 100 is not considered optimal; less than 100 is optimal, though it is unspecified how much less. Over time, with more clinical research, these recommended levels keep being reduced because LDL reduction, including to abnormally low levels, has been the most effective strategy for reducing cardiovascular death rates in large double blind, randomized clinical trials[citation needed]; far more effective than coronary angioplasty/stenting or bypass surgery. For instance, for people with known atherosclerosis diseases, the 2004 updated American Heart Association, NIH and NCEP recommendations are for LDL levels to be lowered to less than 70 mg/dL, unspecified how much lower. It has been estimated from the results of multiple human pharmacologic LDL lowering trials[citation needed] that LDL should be lowered to about 50 to reduce cardiovascular event rates to near zero. For reference, from longitudinal population studies following progression of atherosclerosis-related behaviors from early childhood into adulthood[citation needed], it has been discovered that the usual LDL in childhood, before the development of fatty streaks, is about 35 mg/dL. However, all the above values refer to chemical measures of lipid/cholesterol concentration within LDL, not LDLipoprotein concentrations Mesoderm forms in the embryos of animals more complex than cnidarians, making them triploblastic. Mesoderm forms during gastrulation when some of the cells migrating inward to form the endoderm form an additional layer between the endoderm and the ectoderm.This key innovation evolved hundreds of millions of years ago and led to the evolution of nearly all large, complex animals. The formation of a mesoderm led to the formation of a coelom. Organs formed inside a coelom (body cavity) can freely move, 131

grow, and develop independently of the body wall while fluid cushions and protects them from shocks. General Note: Not all triploblasts produce all of the items listed.
• • • • • • • • •

bones most of the circulatory system, including the heart and major blood vessels connective tissues of the gut and integuments mesenchyme mesothelium muscles peritoneum (lining of the coelom) reproductive system urinary system, including the kidneys

http://en.wikipedia.org/wiki/Mesoderm The oral mucosa is the mucous membrane epithelium of the mouth. It can be divided into three categories.
• • •

Masticatory mucosa - keratinized stratified squamous epithelium, found on the dorsum of the tongue, hard palate and attached gingiva. Lining mucosa - non-keratinized stratified squamous epithelium, found almost everywhere else in the oral cavity. Specialized mucosa - specifically in the regions of the taste buds on the dorsum of the tongue.

http://en.wikipedia.org/wiki/Special:Search?search=oral+mucosa&fulltext=Search

Organ: In biology, an organ (Latin: organum, "instrument, tool", from Greek -#.'&%& - organon, "organ, instrument, tool") is a group of tissues that perform a specific function or group of functions. Usually there is a main tissue and sporadic tissues. The main tissue is the one that is unique for the specific organ. For example, main tissue in the heart is the myocardium, while sporadic are the nerves, blood, connective etc. Animal organs Animal organs include the heart, lungs, brain, eye, stomach, spleen, bones, pancreas, kidneys, liver, intestines, skin (the largest human organ), urinary bladder, and the sex organs (uterus in female animals, testicles in male). The internal organs collectively are often called viscera, the plural of the rarely-used term viscus. Organ systems A group of related organs is an organ system. Organs within a system may be related in any number of ways, but relationships of function are most commonly used. For example the urinary system comprises organs that work together to produce, store, and carry urine. 132

The functions of organ systems often share significant overlap. For instance, the nervous and endocrine system both operate via a shared organ, the hypothalamus. For this reason, the two systems are combined and studied as the neuroendocrine system. The same is true for the musculoskeletal system, which involves the relationship between the muscular and the skeletal system.

List of major human organ systems
There are typically considered to be eleven major organ systems of the human body.

Digestive system - Absorption of nutrients and excretion of waste. Skeletal system - Support and movement, lymphocyte production Muscular system - Support and movement, production of heat Nervous system - Integration and coordination through electrochemical signals Endocrine system - Integration and coordination through hormones Cardiovascular system - Internal transport Respiratory system - Elimination of CO2 and absorption of O2 Reproductive system - Production of offspring. Integumentary system - Body covering Lymphatic system - Regulate fluids and immunity Urinary system - Excretion of nitrogenous waste, and maintain homeostasis of electrolytes

Gland
A gland is an organ in an animal's body that synthesizes a substance for release such as hormones or breast milk, often into the bloodstream (endocrine gland) or into cavities inside the body or its outer surface (exocrine gland).

Types
Glands can be divided into two groups: Endocrine glands — are glands that secrete their product directly onto a surface rather than through a duct.
133

Exocrine glands — secrete their products via a duct, the glands in this group can be divided into three groups: Apocrine glands — a portion of the secreting cell's body is lost during secretion. Apocrine gland is often used to refer to the apocrine sweat glands, however it is thought that apocrine sweat glands may not be true apocrine glands as they may not use the apocrine method of secretion. Holocrine glands — the entire cell disintegrates to secrete its substances (e.g., sebaceous glands) Merocrine glands — cells secrete their substances by exocytosis (e.g., mucous and serous glands). Also called "eccrine." The type of secretory product of an Exocrine gland may also be one of three categories: Serous glands — secrete a watery, often protein-rich product. Mucous glands — secrete a viscous product, rich in carbohydrates (e.g., glycoproteins). Sebaceous glands — secrete a lipid product.

Formation
Every gland is formed by an in-growth from an epithelial surface. This in-growth may from the beginning possess be a tubular structure, but in other instances glands may start as a solid column of cells which subsequently becomes tubulated. As growth proceeds, the column of cells may divide or give off offshoots, in which case a compound gland is formed. In many glands the number of branches is limited, in others (salivary, pancreas) a very large structure is finally formed by repeated growth and subdivision. As a rule, the branches do not unite with one another, but in one instance, the liver, this does occur when a reticulated compound gland is produced. In compound glands the more typical or secretory epithelium is found forming the terminal portion of each branch, and the uniting portions form ducts and are lined with a less modified type of epithelial cell. Glands are classified according to their shape.

If the gland retains its shape, as a tube throughout, it is termed a tubular gland. In the second main variety of gland the secretory portion is enlarged and the lumen variously increased in size. These are termed alveolar or saccular glands.

Specific glands
A list of human exocrine glands is available here. 134

A list of human endocrine glands is available here.

Section of submaxillary gland of kitten. Duct semidiagrammatic.

Section of pancreas of dog. X 250.

Dissection of a lactating breast.

Section of portion of mamma.

Apocrine

Methods of secretion

Osteoporosis is a disease of bone that leads to an increased risk of fracture. In osteoporosis the bone mineral density (BMD) is reduced, bone microarchitecture is disrupted, and the amount and variety of non-collagenous proteins in bone is altered. Osteoporosis is defined by the World Health Organization (WHO) in women as a bone mineral density 2.5 standard deviations below peak bone mass (20-year-old healthy female average) as measured by DXA; the term "established osteoporosis" includes the presence of a fragility fracture.[1] Osteoporosis is most common in women after the menopause, when it is called postmenopausal osteoporosis, but may also develop in elderly men, and may occur in anyone in the presence of particular hormonal disorders and other chronic diseases or as a result of medications, specifically glucocorticoids, when the disease is called steroid- or glucocorticoid-induced osteoporosis (SIOP or GIOP). Given its influence on the risk of fragility fracture, osteoporosis may significantly affect life expectancy and quality of life. Osteoporosis can be prevented with lifestyle advice and sometimes medication, and in people with osteoporosis treatment may involve lifestyle advice, preventing falls and medication (calcium, vitamin D, bisphosphonates and several others). http://en.wikipedia.org/wiki/Osteoporosis Ozone (O3) is a triatomic molecule, consisting of three oxygen atoms. It is an allotrope of oxygen that is much less stable than the diatomic O2. Ground-level ozone is an air pollutant with harmful effects on the respiratory systems of animals. Ozone in the upper atmosphere filters potentially damaging ultraviolet light from reaching the Earth's surface. It is present in low concentrations throughout the Earth's atmosphere. It has many industrial and consumer applications. Ozone, the first allotrope of a chemical element to be recognized by science, was proposed as a distinct chemical compound by Christian Friedrich Schönbein in 1840, who named it after the Greek word for smell (ozein), from the peculiar odor in lightning storms.[1][2] The formula for ozone, O3, was not determined until 135

1865 by J.L.Soret and confirmed by Schönbein in 1867.[1] The odor from a lightning strike is from ions produced during the rapid chemical changes, not from the ozone itself.[3] Ozone Therapy Some people, including a number of doctors and biochemists, believe ozone has remarkable healing properties.[1][2][3] Others argue that it is nonscientific and has no proven benefits.[4][5][6][7] For many years ozone's medical value or non-value has been the subject of controversial and emotional debate.[8] The advent of precise medical ozone generators has only recently allowed the mechanisms, action and possible toxicity of ozone to be evaluated by clinical trials.[9] Ozone has a capacity to oxidize organic compounds,[10] and has well-known toxic effects on the respiratory tract when present in smog.[11][12] In medical use the gas — produced from medical grade oxygen — is administered in precise therapeutic doses, and never via inhalation, and advocates claim it has holistic health benefits.[13] Therapeutic use of ozone is not endorsed by health authorities or medical associations in any English speaking country, and most US states prohibit the marketing of ozone generators, its medical use, and even research and clinical trials of ozone therapy, so that doctors risk losing their medical licenses by administering or prescribing ozone therapies. There is anecdotal evidence of ozone therapy having caused remission in a variety of diseases,[14] but only a few of these life saving administrations have been verified.[15] http://en.wikipedia.org/wiki/Ozone_therapy Peptides (from the Greek */*012(', "small digestibles") are short polymers formed from the linking, in a defined order, of "-amino acids. The link between one amino acid residue and the next is known as an amide bond or a peptide bond. Proteins are polypeptide molecules (or consist of multiple polypeptide subunits). The distinction is that peptides are short and polypeptides/proteins are long. There are several different conventions to determine these, all of which have caveats and nuances. http://en.wikipedia.org/wiki/Peptide Stem cells are cells found in all multi-cellular organisms. They retain the ability to renew themselves through mitotic cell division and can differentiate into a diverse range of specialized cell types. Research in the stem cell field grew out of findings by Canadian scientists Ernest A. McCulloch and James E. Till in the 1960s.[1][2] The two broad types of mammalian stem cells are: embryonic stem cells that are found in blastocysts, and adult stem cells that are found in adult tissues. In a developing embryo, stem cells can differentiate into all of the specialized embryonic tissues. In adult organisms, stem cells and progenitor cells act as a repair system for the body, replenishing specialized cells, but also maintain the normal turnover of regenerative organs, such as blood, skin or intestinal tissues. As stem cells can be grown and transformed into specialized cells with characteristics consistent with cells of various tissues such as muscles or nerves through cell culture, their use in medical therapies has been proposed. In particular, embryonic cell lines, autologous embryonic stem cells generated through therapeutic cloning, and highly plastic adult stem cells from the umbilical cord blood or bone marrow are touted as promising candidates.[3]

136

The classical definition of a stem cell requires that it possess two properties:
• •

•

Self-renewal - the ability to go through numerous cycles of cell division while maintaining the undifferentiated state. Potency - the capacity to differentiate into specialized cell types. In the strictest sense, this requires stem cells to be either totipotent or pluripotent - to be able to give rise to any mature cell type, although multipotent or unipotent progenitor cells are sometimes referred to as stem cells. http://en.wikipedia.org/wiki/Stem_cell

Mouse embryonic stem cells with fluorescent marker. Sublingual, literally 'under the tongue', from Latin, refers to a pharmacological route of administration in which certain drugs are entered directly into the bloodstream via absorption under the tongue. Many pharmaceuticals are prepared for sublingual administration. These commonly include cardiovascular drugs, steroids, barbiturates, some enzymes and increasingly frequently, certain vitamins and minerals http://en.wikipedia.org/wiki/Sublingual

The underside of a human tongue Vein is a blood vessel that carries blood toward the heart. The majority of veins in the body carry low-oxygen blood from the tissues back to the heart; the exceptions being the pulmonary and umbilical veins which both carry oxygenated blood.Veins function to return deoxygenated blood to the heart, and are essentially tubes that collapse when their lumens are not filled with blood. The thick, outer-most layer of a vein is made of collagen, wrapped in bands of smooth muscle while the interior is lined with endothelial cells called intima. Most veins have one-way flaps called venous valves that prevent blood from back flowing and pooling in the lower extremities due to the effects of gravity. The precise location of veins is much more variable from person to person than that of arteries. They are one step lower then arteries. http://en.wikipedia.org/wiki/Vein

137

Cross section of a vein showing a valve which prevents backflow A vitamin is an organic compound required as a nutrient in tiny amounts by an organism.[1] A compound is called a vitamin when it cannot be synthesized in sufficient quantities by an organism, and must be obtained from the diet. Thus, the term is conditional both on the circumstances and the particular organism. For example, ascorbic acid functions as vitamin C for some animals but not others, and vitamins D and K are required in the human diet only in certain circumstances.[2] Vitamins are defined by their biological activity, not their structure. Thus, each "vitamin" actually refers to a number of vitamer compounds, which form a set of distinct chemical compounds that show the biological activity of a particular vitamin. Such a set of chemicals are grouped under an alphabetized vitamin "generic descriptor" title, such as "vitamin A," which (for example) includes retinal, retinol, and many carotenoids. [3] Vitamers are often inter-convertible in the body. The term vitamin does not include other essential nutrients such as dietary minerals, essential fatty acids, or essential amino acids, nor does it encompass the large number of other nutrients that promote health but that are not essential for life.Vitamins have diverse biochemical functions, including function as hormones (e.g. vitamin D), antioxidants (e.g. vitamin E), and mediators of cell signaling and regulators of cell and tissue growth and differentiation (e.g. vitamin A) [4]. The largest number of vitamins (e.g. B complex vitamins) function as precursors for enzyme cofactor bio-molecules (coenzymes), that help act as catalysts and substrates in metabolism. When acting as part of a catalyst, vitamins are bound to enzymes and are called prosthetic groups. For example, biotin is part of enzymes involved in making fatty acids. Vitamins also act as coenzymes to carry chemical groups between enzymes. For example, folic acid carries various forms of carbon group – methyl, formyl and methylene - in the cell. Although these roles in assisting enzyme reactions are vitamins' best-known function, the other vitamin functions are equally important.[5]Until the 1800s, vitamins were obtained solely through food intake, and changes in diet (which, for example, could occur during a particular growing season) can alter the types and amounts of vitamins ingested. Vitamins have been produced as commodity chemicals and made widely available as inexpensive pills for several decades,[6] allowing supplementation of the dietary intake. http://en.wikipedia.org/wiki/Vitamin

138

The Miracle of Cell Therapy’ References by Number LIST OF SCIENTIFIC STUDIES, ARTICLES from Magazines and Newspapers, and TESTIMONIALS from PHYSICIANS and PATIENTS SS – Scientific Study; A – Article; PT – Physician Testimonial; PL - Patient Letter; LT - Technical Information from Laboratories; ST - Technical Information from Product Sales Companies; W – Wikipedia or other OR M - Merck Definition Many of these are Summaries Only, and will have a Link to the Complete Paper

Regeneration of insulin-producing islets may lead to diabetes cure
1. SS http://www.mgh.harvard.edu/news/releases/111303faustman.htm 2. LT Explanation of Dermal Tissue and Different Stages during the gestation Period. Taber’s CYCLOPEDIC MEDICAL DICTIONARY and personal Communication from a European laboratory that produces EOT products 4. A Heart Muscle Cells Regenerate after a Heart Attack NHLBT Communications office (301-496-4236) NIH/National Heart Lung and blood Institute Girls Heart Regenerates thanks to artificial assists http:/ /www.cbc.ca/canada/calgary/story/2007/08/28/artificial-heart.html Human brain can re-grow cells, study shows http://www.msnbc.msn.com/id/17170672/

5. A 7. A

8. PT Letter about Severe Eye Condition, Walter A. Ward, MD 9. SS Schmid Experimental Fundaments In Cell Therapy, A New Dimension In Medicine, OTT Publisher, Thorne Switzerland 1983, pp 65-104 10. SS Jussek, Roscher, Critical review of Contemporary Cellular Therapy (Cell Therapy) Journal of Gerentology 1970, vol 25, #2, pp-11p-125 11. SS Amtmann, Edde, Sauer, Westphal, Restoration Of The Responsiveness Of Growth factors In Senescent Cells By An Embryonic Cell Extract, Experimental Cell Research, 1990, 189, pp 202-207 14. PT Letter about Knee and other Joint Procedure. Dr. Arthur L. Koch, D.O. January 1999 18. A Patients Contact HIV and Hepatitis C from Organ Transplants. Palm Beach Post, 2008

21. W Information on Stem Cells. http://encyclopedia.thefreedictionary.com/stem+cells 139

BIBLIOGRAPHY OF CELLULAR THERAPY
LEGEND: E. = English - A -

ACKERMANN, G.: Behandlungsversuch bei fortgeschrittenem metastasierendem Prostata-Ca mit Humanplazenta. Munch. med. Wschr., 100,494f.,l959.
ACKERMANN, G.A.: Ultrastructure and Cyto-chemistry of the developing Neutrophil. Lab.Invest. 19,290 (1968).

ADAMIKER, D.: Gerontologische Untersuchungen an Rattenlebermitochondrien. Inaugural-Diss., Tierarztl. Hochschule Wien 1963. AEHNELT, E.: Erfahrungen mit der Trockenzellbehandlung bei Funktionsstorungen der Keimdrusen grober Haustiere. Vortrag anl.d.8. Arbeitstagung der Dt.Ges.f.Zellulartherapie, Bad Homburg, 1960. Berliner Arzteblatt 73.Jg.,Heft 18. E. ALLAN, P.C. und KABAT, E.A.: Persistence of circulating antibodies in human immunized with dextran, levan and blood group substances. J.Immunol. 80,495 (1958) ALTERAUGE, W.: Ober allergische Reaktionen, Abderhaldenschen Reaktion und Zellulartherapie von Niehans in ihren Beziehungen zueinander. Berlinger Munchenertierarztl. Wschr.,70,70-74, 1957. E. ALTMANN, PH.L. und KATZ, D.D.: "Cell-Biology"; 1976 by Feder.of American. Soc. F. Exper. Biology Bethesda, Maryland. AMELUNXEN, F und SPIESS, E.: Untersuchungen zur Struktur der Ribosomen. Ein Beitrag zur Konformation der 80 S-Ribosomen von Pisum sativurn. Cytobiologie 4,293 (1971). E. ANDRES, G.: Embryonic transplantation by the vascular route. Science, 111,456,1950. Experiments on the fate of dissociated embryonic cells (chick) disseminated by the vascular route. Part 11 Terotomas. J. Exper. Zool., Philadelphia, 122, 507-540, 1953. ANDRES, G.: Wachsturnsreaktionen der Urniere und der Leber des Huhnerembryos auf Injektion von Zellbrei in die Blutbahn. Verh. d. Schweiz. Natu rforsch.Ges., Lugano, 99, 1953. ANDRES, G.: Growth reactions of mesonephros and liver to intravascular injections of embryonic liver and kidney suspension in the chick embryo. J. Exper.Zool., Philadelphia, 130, 221-250, 1955. 140

ANDRES, G.: - Wirkungsspezifitat von Zellinoculaten beim embryonalen und heranwachsenden Organismus. Zellforschung und Zellulartherapie, Verlag Huber, Bern 1963,S.241-264. E. ANDRES, G.: - Specific Effectiveness of Cell Inocula in Embryonic and Growing Organism. In F. Schmid und J. Stein. Cell Research and Cellular Therapy. Ott Publishers Thoune, Switzerland, 1967, p. 247-269. ANDRES, G.: Injektion embryonaler Zellen in die Blutbahn der Huhnerembryos. Vortrage beim II. Internationalen Kongreb f. Zell- und Histotherapie. Wiesbaden.1.6-11, 1959. ANDRES, G.: Wirkung von Gewebsinjektionen auf den embryonalen Organismus. Vortrag ani.d.111. Intern. Kongr.fur Zellulartherapie, Paris, 1961. E. AYRES, W.W.: Production of Charcot-Leyden Crystals from eosinophils with aerosol. Blood, 4,595(1949).

- B BABILLOTTE, J.: 1 steine causale Therapie der Depression moglich? Cytobiol. Rev. 2, 31-35 (1978). BABILLOTTE, J.: Die Migrane - Indikation fur eine Zelltherapie? 117-121 (1979). E. BACH, M.K.: Basel 1978. Immediate Hypersensitivity. Cytobiol. Rev. 3,

Marcel Dekker Inc.

New York and

E. BAKER, R.W.R. et al.: Fatty acids-composition of brain lecithins in multiple sclerosis lancet, i. 26-27 (1963). E. BANKER, B.Q., ROBERT; J.T. and VICTOR, M.: Spongy degeneration of central nervous system in infancy. Neurology (Minneapolis) 14, 981-1001 (1964). BARBEAU, A.: Friedreichs Ataxia 1979: An Overview J. Can. Scienc. neurol. 1979. 311-319. BARGMANN, W. und KNOOP, A.: Uber die Morphologie der Milchsekretion. Lichtund elektronenmikroskopische Studien an der Milchdruse der Rafte. Z.Zellforschg. 49,344 (1959). E. BARRETT, A. J.: In Dingle, J.T., ed. Lysosomes; A Laboratory Handbook. North-Holland, Amsterdam 1972. S. 46-135. BARTH, G.: Experimentelle Grundlagen fur die Knochenmarktransplantation nach Ganzkorperbestrahlung. Dtsch. med. Wschr. 86,1331-1333, 1961. 141

BAUER, K.F.: Methodik der Zell- und Gewebezuchtung. 1974.

S. Hirzel Verlag,

Stuttgart

E. BECKER. F.F. and LANE, B. P.: Regeneration of the mammalian liver. Amer. J. Path. 47, 783 (1965). BEHRENS, M.: Uber die Lokalisation der Hefenucleinsauren in pflanzlichen Zellen. Hoppe-Seylers. Z. Physiol. Chem. 253, 185 (1938). E. BELL, G.I., PERELSON, S.S., PIMBLEY, G.H. JR.: Theoretical Immunology. Marcel Dekker. Inc. New York and Basel 1978. BENNHOLD, H. 704-711,1954. Gefahren der Frischzellentherapie. Dtsch. med. Wschr. 79,

BERG, G.: Histologische Labortechnik. J.F. Lehmanns Verlag, Mfinchen 1972. BERNHARD, P.: Decken sich die Wirkungsvorgange bei der Zellulartherapie mit der Genese der Endometriose? Therapiekongreb, 9-11, 1956. Therap. Woche, KarIsruhe, 7, 43-51, 1956. BERNHARD, P.: Merkmale und Behandlung des vorzeitigen und biologischen
Alterns. Med. Mschr., Stuftgart, l0, 361-367, 1956.

BERNHARD, P.: Uber den Einflub der Frisch-zellen-Implantation von Endometrium auf den Kastratenuterus des Kaninchens. Ber.v.d.5. Tagg.d.Forschungskreises fur Zellulartherapie, 45-47,1958. BERNHARD, P.: Ober die Wirkung von Frischzellen- und Trockenzellen-Implantati onen von Kanin-chenendometrium auf den Uterus kastrierter Kaninchen. Vortrage beim II.Intern.Kongr.f.Zell- und Histotherapie,Weisbaden,l,l 1-21,1959. BERNHARD, P. und KRAMPITZ, W.: Ober die Wirkung von Frischzellen- und Trocken-zellen-Implantationen von Kaninchenen-dometriurn auf den Uterus kastrierter Kaninchen.Zschr.Geburtsh.,Stuftgart, 156,1-19,1960. E. BERNHARD, P. und KRAMPITZ, W.: The Organ-Specific Cellular Effect of Implanted Rabbit Endometrium upon the Uterus of Castrated Rabbits. In F. Schmid and J. Stein: Cell Research and Cellular Therapy. Ott Publishers Thoune, Switzerland, 19e7,p.302. BERNHARD, W., BAUER, A., GUERIN, M. et OBERLING, CH.: Lude au microscope 616ctronique de corpuscles d'aspect virusal dans des 6pitheliomas marnmaires de la souris.Bull.Ass.frang.Cancer 32,163 (1955). BERSIN, TH.: Biochemie der Mineral- und S pu renelemente.Akad.Veriagsges. Fran kfu rt 1963. BESSIS, H.: Living Blood Cells and their Ultrastructure, Springer-Verlag, Berl i n-Hei del be rg-New York 1972. 142

BESSIS, M.et LOCQUIN, M.: Sur la pr6sence de mouvements propres de I'aster et des vacuoles contractiles dans les granulocytes.C.R.Soc.Biol.1 44,483(1950). E. BEUTNER, R.: Physical Chemistry of Living Tissues. Williams & Wilkins, Baltimore 1933. BHADURI S., KURRLE, E., ARNOLD, R., LOHRIVIANN, H.P., PFLIEGER,H., KUBANEK, B. und HEIMPEL, H.: Knochenmarktransplantation (KMT).Klinikarzt 9,105-112(1980). BINDER, G.: Untersuchungen Ober die Verteilung und den zeitlichen Verlauf der Aktivitat von L-Lysin-4,5-Tritium in Organen der Ratte nach peroraler Verabreichung. Inaugural-Diss. Tierti rztl. Hoch sch u le Wienj 969. BIRCHER, F.E.: Insuffisance surrenalienne et alimentation. Supplemento della Recerca Scientifica,XXVII, 1 955,36me Journal de Dietique,Rome,22-24 sept. 1955. BIRCHER, F.E.: Therapie cellulaire des troubles circulatoires terminaux. Rapports du 3eme Congres Frangais de Therapeutique cellulaire, Paris. Edit. du Centre-Med. d'Etudes et de Rech.Paris 65-67,1959. BITTAR, E.E.: Membranes and Ion Transport, Wiley-Interscience a division of John Wiley & Sons Ltd. Volume 1,London 1970, Volume 2 London 1970, Volume London 1971. E. BLACK, D.B., KATO, J.G. und WALKER, G.W.R.: A study of improvement in mentally retarded children occuring from Siccacell Therapy. Am J.of mental Deficiency,Jan.1966,Vol.70. Nr.4,S.499. BLASIUS, W.: Vom Wesen des Lebens. Cytobiol.Rev.3,31-37(1979). BLOCK, S.: Erfahrungsbericht aus Ober 30j5hrigen Praxis mit Frischzellentherapie bei Ober 45 000 Patienten.Biol.Med.1 1, 261-266(1982). BLUMENBERG, F.W.: Erste klinische Erfahrungen Ober die Zusatztherapie mit einem Zellprtiparat zur Strahlen-bzw. Cytostatika-Therapie.Ref Blatt Die Zelltherapie,Nr.36,1969. BLUMENBERG, F.W.: Erste klinische Erfahrungen Ober die Zusatztherapie mit einem Zusatzprtiparat zur Strahlen- bzw. Zytostatika-Therapie. Die Heilkunst. 84. Jh.,Heft 10.Okt.1971. BOMS, P.: Inwieweit kann der Schlachthoftierarzt, der Material for die Frischzellentherapie entnimmt, schuldhaft sein? Archiv f.Lebensmiftelhygiene, 7,171-174,1956. Arch iv.f. Lebensm ittel hygiene, 7,276-277,1956. BORSOOK. H., DEASY, C.L., HAAGEN-SMIT, A.J., KEIGHLEY, G.and LOWY, P. 14 Metabolism of C -labelled glycine, 1-histidine, I-leucine and I-lysine. J.Biol.Chem.1 87,519(1950). BOSCH, J.: Zellulartherapie, ja oder nein? Wien,klin.Wschr.,70, 76-80,1958, 143

BOSSE, J.: Kann man der Landarzt,Stuftgart,34,164-168,1958.

vorzeitigen

Alterung

wirksam

begegnen?

BRACHET, J.: Recherches sur la synthese de I'acide thymonucleique pendant le developpement de I'oeuf d'oursin. Arch. Biol.44,51 9(1933). BRACHET, J.:La detection C.R.Soc.Biol.1 33,88(1940). BRAMMER, H.: Neue Cytobiol.Rev.,73-75(1982). histochimique in der des acides von pentosenucldique. Alkoholkranken.

Wege

Behandlung

BRANDIS, H.: Einfohrung in die Immunologie. Gustav Fischer Verlag Stuttgart 1975, BRANDNER, R.: Die Zellulartherapie bei degenerativen Erkrankungen. Fortschr. Med.,76,453f.,1958. E. BRAUN, P.: Speech-Development-Analysis. Cytobiol.Rev.5, 73-75 (1981). BRUECKEL, K.W.: Grundzjge Mfichen-Berlin-Wien(l 975). der Geriatrie. Urban und Schwarzenberg,

BRUNNER, P.: Die Lunge des alten Mannes: Altersver5nderungen und Krankheiten im Alter (im Druck). BURGER, H.: Gerontologische elektronenmikroskopische Untersuchungen an Herzmuskelmitochondrien der Ratte. Inaugural-Diss., Tiertirztl. Hochschule Wien, 1965. E. BURNET, F.M.: The Clonal Selection Theory of Acquired Immunity. Vanderbilt Univ. Press, Nashville/Tenn.,1959. BUSCHA, J.: Zelltherapie bei Asthma bronchiale? Cytobiol.Rev.5,174-178(1981). BUTLER, I.A.V.: Vom Haushalt der Zelle.F.Vieweg u.S. Braunschweig 1958. E. BYERS, B.: Structure and function of ribosome crystals in hypothermic Chick embryo cells. J.Mol.Biol.26,155(1967). CAMERER, W.: Behandlung Karisruhe,7,13,1956. der Infertilitht des Mannes. Therapie-Woche,

CAMERER, W.: Ober die Behandlung von Fertiliftitsstdrungen. Bericht v.d.4.Tagg. d. Forschunghsf. Zellulartherapie,47-50,1957. CAMERER, W.: Behandlung klimakterischer Beschwerden. Bericht v.d.4. Tagg. d. Forschungskreises f. Zellulartherapie.42,1957. CAMERER, W.:Gibt es eine er-folgreiche Behandlung mdnnlicher FertilitMsstdrungen mit Siccacell? M Cinch. med.Wsch r., 100, 1897-1900,1958. 144

CAMERER, W.: Ist die Zellulartherapie schidlich? Landarzt, Stuttgart,37, 251-254, 1961. CAMERER, W.: Infertilitat - Diagnostik und Therapie. Cytobiol. Rev.,12-16(1978). E. CAMITTA, B.M.,THOMAS, E.D.,NATHAN, G. et al.: Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood 48,63-70(1976). E. CARO, L.G. and PALADE, G.E.: Protein synthesis, storage and discharge in the pancreatic exocrine cell. An autoradiographic study. J.Cell Biol.20,473(1964). E. CASPERSSON, T.: The protein metabolism of the cell. Naturwissenschaften 29, 33, (1941). CASTENS, C.E.: Vermeidung von Gefahren bei der Zellulartherapie. Hippokrates, Stuttgart, 28,40-45, 1957. CASTENS, C.E.: Sichere Indikationen und Kontraindikationen der Zellulartherapie. therapie-Woche, Karisruhe,8,34-36, 1957. Therapie-Kongr.6-10, 1957. E. CHAO, F.C.: Dissociation of macromolecular ribonucleoprotein of yeast. Arch. Bio-chem.Biophys.70,426(1957). CHASE, M.W.: The cellular transfer of cutaneous hypersensitivity to tuberculin. Proc.Soc.exp.bioi.(N.Y.)59,134(1945). E. CHERKIN, A., FINCH, C.E., KHARASCH, N., TAKASHI, M., SCOTT,F.L. STREHLER, B.S.: Physiology and cell Biology of Ageing. Raven Press, Basel 1979. E. CLAUDE, A.: Particulate components of cyto-plasm. Cold Spring Harbor Symp. Quant. Biol. 9,263 (1941). E. COGGIN, J.H.a.o.: Tumor immunity in hamsters immunized with fetal tissues. J.Immun. (1971). E. COHEN, S. and PORTER, R.R.: Structure and Biological Activity of Immunglobulins. In Dixon,F.J. and Humphrey,J.H.: Advances in Immunology: Vol.4, Academic Press; New York/ London, 1964. E. CONGDON, C.C., UPHOFF, D. and LORENZ, E.: Modification of acute irradiation injury in mice and guinea pigs by injection of bone marrow. J.Nat.Cancer Inst.,Wash.,l 3,73-93,1952. E. COTTIER, H., ODARTCHENKO, N. and CONGDON, C.C.: Germinal Centers in Immune Response. Springer, Heidelberg/Berlin/New York.1 967. E. CUMINGS.J.N. et al.: Lipid studies in the blood and brain in multiple sclerosis and motor neurons disease. J.Clin.Path.18, 641(1965). DAHMEN, H.: Tierkrankheiten, 145

die gegebenenfalls durch Frischbzw. Trockenzellen auf den Menschen Obertragen werden kennen. Bericht v.d.l.Tagg.d.Arbeitsgem. f.Zellulartherapie, Frankfurt, 31-52, 1953. CUMINGS.J.N. et al.: Arztliche Sorgfaltspflicht bei der Anwendung der Zell ulartherapie. Medizin heute, 5,59-62,1956.

- D E. DALTON, A.J.: A study of the Golgi material of hepatic and intestinal epithelial cells with the electron microscope. Z. Zellforschg. 36, 522(1952), Golgi apparatus and secretion granules. In: The cell, Vol.2 eds. Brachet and Mirsky. New York and London, Academic Press 1961. E. DANIELLI, J.F. and DAVSON, H.: J.Cellular Comp. Physiol,5,495,1935. E. DANIELLI, J.F.: in K.B. WARREN (Ed.),Formation and Fate of Cell Organelles, Academie press, London 1967, 239. DAVID, J.M. und DAVID, AURELIA E.A. DE: Tratamiento de oligofrenias de etiologia diversa con la implantacion de tejidos frescos (Terapeutica celular).Sem-med.,Buenos Aires,1 17,289 u. 329, 1960. E. DAVISON, P.F.: Intermediate Filaments: Intracellular Diversities and Interspecies Homologies. In: Internat. Cell Biol. 1980-1981, p.286-292; ed. H.G. SCHWEIGER. Springer-Verl. Berl i n-Hei delberg-New York 1981. E. DEAN, R.T.: In Dingle, J.T. and Dean, R.T., ed. Lysosomes in Biology and Pathology. North-Holland, Amsterdam 1975, 349-382. E. DE DUVE, C.: The Lyosome.Sci. Am. 208, 64,1963. E. DE DUVE, CHR.: Peroxyomes and related particles in historical perspective Annals New York Acad.Sciences 386,14 (1982). DEGENS, E.T.: Ober die Bedeutung von Metallionen in der biologischen Zelle. Cytobiol.Rev.5,107-113(1981). DELONS, P.E. et COUGOULE, J.: Excitabilitt neuro-musculaire et thdrapie cellulaire. Rapports du 36me Congres Frangais de Therapeutique Cellulaire. Paris.edit.du Centre Mdd.d'Etudes et de Rech.,Paris,52-55, 1959. E. DESTUNIS, G.: The treatment of mental deficiency and encep halo path ies in childhood by means of fresh tissue and Siccacell. Zell ulartherapie bei Debilitat und Encelphalopathie. Ber.v.d.4.Tagg.d.Forschungskreises for Zellulartherapie. 57-60, 1957. CUMINGS.J.N. et al. L'implantation de diencephale comme thdapie de development contre la debilite et 1'encephalopathie des enfants et son importance 146

prophylactique. Rapports du 2eme Congres Frangais de Therapeutique Cellulaire, Tours.Edit. Du Centre Med. d'Etudes et de Rech., Paris, 44-48, 1958. CUMINGS.J.N. et al.: Die drztliche Behandlung der Debilitit und Encephalopathien. Medizinische, Stuttgart, 24, 980-984, 1958. CUMINGS.J.N. et al.: Zell ulartherapie (Zwischenhirn implantation) bei kindlichen Entwicklungsstetungen und Encephalopathien. Jahreskongrea 1958 for ilrztliche Fortbildung, 341-345,VEB Verlag Volk u.Gesundheit, Berlin, 1958. CUMINGS.J.N. et al.: La Terapia cellulare nelle turbe dell'infanzia. Relazioni I-Congresso Scientifico, Milano. Centro Italiano Terapie Istobiologica, Milano, Viale Lunigiana 46, 57-65 (1959). Die Zell- und Histotherapie, 1516, 12-18, 1959. CUMINGS.J.N. et al.: Zwischenhirnimplantationen bei Encephalopathien. Rottdrdamse gesprecken over celtherapie. Ned. Uitgeversmaatschappij N.V.,Leiden, 49-53, 1960. DESTUNIS,.G. und SCHMIDT, E.: Zwischenhirnimplantationen bei kindlichen Encephalopathien und Debilitat verschiedener Genese, Med.-Kiin.,51,768-770, 1956. TherapiekongreB 11-12,1956. DITS, A. TH.: Wurzelspitzenresektion und KnochenwundfCillung mit Osteoblasten "Siccacell-Trockenzellen". Heilkunst, M(Inchen, 70,12-13,1957. DITTMAR, F.: Der Einflug von Zellpraparaten auf Washstum und Kerpergewicht im Tierversuch. In F Schmid und J. Stein: Zellforschung und Zellulartherapie. Verlag Huber, Bern 1963, S.397. DITTMAR, F., GROSS, A. und THOMAS, W.: Ober den Einflug der sogenannten Frischzellen auf Wachstum und K6rpergewicht im Tierversuch. Medizinische, Stuttgart, 47, 1637-1939, 1955. E. DIXON, F.J. and HUMPHREY, J.H.: Advances in Immunology. Vol.4. Academ Press. New York/London. 1964. DIXON, K.C.: Cellular Defects in Disease. Blackwell Scient. Publ.Cambridge 1981. E. DOLER, H.J. und SCHMID, F.: Infantile Cerebralparese. Froherkennung und Frahbehandlung. 3. Auflage. Dr.SchwappachVerl.Gauting 1974. DEDERLEIN, G.: Die Indikation zur Implantation Schweine-Hopophysen. MCinch.med.Wschr.95,969,1953. von Kalbsund

DEDERLEIN, G., FANCONI, G. und NONNENBRUCH, W.: Wie sind Theorie und Leistung der Frischzellen-, Frischdr0sen-, beziehungsweise Serumtherapie nach Niehans, Zajicek und Bogomoletz zu beurteilen? M(inch.med.Wschr.,97,710-712, 1955. DOLCE, G.: Neurophysiologische Untersuchungen zur Wirkung von Pyrithioxin auf das zentrale Nervensystern der Katze. Pharmakopshchiatrie 3, 355-370 (1970). 147

DOLCE, G.: Beeinflussung der akuten alkohol-bedingten Verdnderung des EEG, der evoked potentials sowie des Verhaltens bei der Katze durch Pyrithioxin. Act nerv.su p. (Praha) 16,1(1974) DOMAGK, G.F.: Zur Biochemie des Lernens. In: G. NISSEN: Intelligenz, Lernen und Lernsterungen. Springer-Verlag, Berl i n-Heidel berg-New York 1977. DORNBUSCH, S.: Die Beeinflussunsg der experimentellen Cholesterinsklerose urch Siccacell-Placenta. Zell ulartherapie in Klinik und Praxis. Kuhn, W. DORNBUSCH, S.: Hippokrates-Verlag. Stuttgart, 134-140. 1956. Bericht v. d. 3.Tagg.d. Forsch u ngsgem ei nsc haft f. Zell ulartherapie, 19-20. 1956. DORNBUSCH, S.: Der Einflufvon Placenta-Zellinjektionen auf die experimentelle Cholesterin-Arteriosklerose bei Kaninchen. Medizinische. Stuttgart, 43,1533-1535. 1956. Bericht v.d.5. Tagg d.Arbeitsgemeinschaft for Zellulartherapie, Bad Homburg, 1-2,1956. DORNBUSCH, S.: Die Beeinflussung der Angiopathien der experimentellen Gefdllsklerose durch Placenta-Zellen. In F.Schmid und J. Stein: Zellforschung und Zellulartherapie. Verlag Huber, Bern 1963, S.378. DREIER, H.K.: Aktivithtssverteilung in verschiedenen Organen der Ratte nach s.c. VerabreichungTritium-markierter ganhomogenate.Inaugural-Diss.Tierdrztl.Hochscule Wien, 1972. DUBOIS, A.M. et GONET, A.: Regendration des flots de Langerhans. au cours de [a Correction du Diabete experimental du rat par brephoplastie pancrdatique. Zschr.Zeliforsch,53,481-491,1961. E. DUMONDE, D.C.: The Role of Lymphocytes and Macrophages in the Immunological Response. Springer, Berl in/Heidel berg/New York, 1971. DUNNETT S.B., BJORKLUND 1987, 18 ( 186 ), 334-345. A. Les greffes dans le cerveau. La Recherche,
French

E. DVORAK, ANN M.: Biology and Morphology of basophilic Leukocytes. In: BACH, M.K.: Immediate Hypersentivity. Marcel Dekker Inc. New York and Basel 1978, S.369-406. Editorial: Die Abderhaldensche Reaktion. Cytobiol.Rev.2,44-45 (1978) E. Editorial: Marrow Transplantation for Non-malignant Disorders. New EngI.J.Med. 298, 963 (1978) EHNI, L. und DUVE, G.: Zur Beurteilung und Therapie hypophysar-diencephaler Regulationssterungen im Entwicklungsalter .Medizinische,Stuftgart,38, 1381-1384.1957. 148

ERLICH, P. Und MORGENROTH, J.: Ober 1-1emolysine, Berlin,Klin. Wschr. 36, 1,481, (1899); 37, 453,581 (1900). EICKSCHEN, H.: Fetales Cytobiol.Rev.2,39-40 (1978). Mesenchyrn (Resistocell) bei Osteomyelitis.

EM(5DI, G.: Die Beeinflussung des Immunsystems durch Interferon und klinische Behandlungmeglichkeiten neoplastischer Erkrankungen. Cytobiol.Rev. 1, 27-29 (1977). ENDERLE, E.: Ergebnisse einer prophylaktischen und therapeutischen Anwenclunr von fetalern Mesenchyrn (Resistocell) bei DANA-induzierten Tumoren. 2/3, 7-9 (1979). ERNST, W., KANZOW, U. und OETTGEN, H.: Untersuchungen zur Zellulartherapie. 3. Mitteilung: Ober den Einflull von. Placenta-Zellinjektionen auf die Blutlipoide. Medizinische, 7, 277-281, 1958. FAGRAEUS, A.: The plasma cellular reaction and its relation to formation of antibodies in vitro. J. Immunol. 58,1 (1948) E. GIBSON, G.E., KARK, R.A.P., and CARREL, R.E Antibody production in relation to the development of plasma cells. In vivo P.,.: Ketonic diet in the management of pyruvate dehydrogenase deficiency. Pediatrics 58, 713-721 (1976).

- F FANTON, E. La terapia cellulare nel Mongolismo. Relazioni I.Congresso Scientifico, Milano. Ediz. Centro Italiano Terapia Istobiologica, Milano. Viale Lunigiana 46, 67-69, 1959. E. FAWCETT, P.W.: Structural and functional variations in the membrances of cytoplasm. In: Intracellular membraneous structure. Proc. first Int. Symp. Chemistry 1963, Okayama: Chugoku Press Ltd. 1965. FEDERLIN u.Mitarb.: Inselzell-Transplantation- eine Chance for die Behandlung des Diabetes mellitus? MedWelt 29,535-543 (1978) , FELDMANN, H.S.: A propos du traitement m6dicamenteux des obligophrenes. Revue Suisse dUtilitd Publique, 98,11/2.1959 FELDMANN, H.S. Valeur de la thdrapie cellulaire dans les retards du developpement chez Iinfant. Vortrag ani.d. 111. Intern. Kongresses for Zell u la rtherapie. Paris. 1961. Rev.mdd.Suisse rom.,LXXXI/I 1, 773-796, 1961. E. FELDMAN, H.S.: The value of Cell.therapy for cases of retarded development in children. In: IIIRD International Congress for cellular therapy, Hans Huber,ed.Bern, pp 89-116 (1961). E. FELDMAN, H.S.: Present Drug Treatments for Mental Retardation (A Comparative Longitudinal Study of 100 Cases). Cytobiol.Rev.3, 55-69(1979). 149

FELDWEG, TH.: Die Zuckerkrankheit und ihre biologische Behandlung. Heinr. Schwab, GeInhausen 1965. FEULGEN, R., BEHRENS, M. und MAHDIHASSAN; Darstellung und Identifizierung der in den pflanzlichen Zellkernen vorkommenden Nucleinsaure. Hoppe-Seyler's Z. Physiol.Chem.246,203 (1937). FISCHER, K.J.: Niehans, Arzt des Papstes. Wilhelm Andermann Verlag, MUnchen-Wien 1957. FISHMAN, M. and ADLER, F.L.: Antibody formation in vitro. Immunpathologie Illrd I nternat. Sym pos i u m.S. 79. Basel u.Stuttgart: Benno Schwabe & Co. 1963. E. FREDERICKS, R.E. and MALANEY, W.C,: The basophilic granulocyte. Blood 14, 571(1959). E. FUCHS, G.: Cancer Therapy and Prophylaxis, Teraphia del Cancer y Profilaxia, International Associaton for Cytobiological Therapies, Walldorf (1994) E. FUCHS, G.: Can Organ-Tissue-Ultrafiltrates cause an Allergisation? Med Organica 2/1993 FUENTE CHAOS, DE LA A.: Filosofia de la terapia en el cancer. Cytobiol.Rev.2/1,10-12 (1978). FUENTE-PERUCHO, DE LA A., FUENTE-CHAOS, DE LA A., PAYA-PARDO, J.M., GIANOLI, A.C., MORENO-KOCH, M.C. e PEREZ-CUADRADO: Terapia celular con Resistocell e immunidad en oncologia. Cytobiol.Rev.3,83-104 (1979). FUJIKI, Y., FOWLER, S. HUBBARD, A.L. a LAZAROW, P.B.: Polypeptide and phospholipid composition of the membrane of rat liver peroxysomes. J.Cell.Biol.1982.

- G GARNIER, CH.: Contribution; L’ tude de la structure et du fonctionement des cellules glandulaires sdreuses. Du rele de 1'ergastoplasma dans la sdcrbtion. Thesis Nancy 1899. GEIGER, H.: Krebskrankheit und Placenta-Substrate. Medizinische. 1958, 1099-1103. E. GERSTL, B. et al.: Alterations in myelin fatty acids and plasmalogens in multiple sclerosis. Ann.N.Y.Acad.Sci, 122, 405-416 (1965). GIANOLI, A.C.: Therapie des Morbus Parkinson. Fortschr.Med.87, Nr.35/36 (1969). GIANOLI, A.C.: Neuere Erfahrungen auf dem Gebiet der Zelltherapie. Die Zelltherapie 42,3-18 (1975). 150

GIANOLI, A.C.: Revitalisationsthera pie in Klinik und Praxis. Z.praeklin.Geriatrie 5,186-192 (1975). GIANOLI, A.C.: Der heutige Stand der Organtherapie in Klinik und Praxis. Cytobiologische Revue 1,30-34 (1977). E. GIANOLI, A.C.: Revitalization. Cytobiol. Rev.4,70-74 (1980). GIANOLI, A.C.: 00 en est le traitement cellulaire du point de vue international? Cytobiol.Rev.4,145-146 (1980). GIANOLI, A.C.: Behandlung der Parkinsonschen Krankehit. Cytobiol.Rev.6,184-188 (1982). E. GIANOLI, A.C. a. PEREZ-CUADRATO, S.: Immunmodulation and Restoration with Resistocell. Cytobiol.Rev.6,138-139 (1982). GIESE, H.: Die Zell ulartherapie homosexueller Winner. Nervenarzt, Berlin, 30, 133 ff., 1959. GILKA, L.: Schizophrenia: A Disorder of Tryptophan Metabolism. Acta psych.scand. Suppl. 258, 1975. Parkinson's Disease - A New Approach I Oth I nternat.Congr. Neu rol. Barcelona 1973. GILLHAM, N.W.: Organelle Heredity. Raven Press, Basel 1978. E. GLEICH, G.J., LOEGERING, D.A. and MALDONADO, J.E.: Identification of a major basic protein in guinea pig eosinophil granules. J.exp.Med.137,1459 (1973). E. GOLDSTEIN, H.: Siccacell Therapy in Children. Arch. Pediatr.N.Y., 73, 234-249, 1956.- La terapia "Siccacell" en los ninos afectados de lesiones cerebrales con trastornos de la evolution. Sintesis Medica IV, No. 26, Sept.1959. GOLDSTEIN, H.: Siccacell-Therapie bei hirngesch~kdigten, entwicklungsgesterten Kindern. Zellulartherapie nach Dr. P. Niehans in Wissenschaft und Praxis, Sonder-Nr. 1959. E. GOLDSTEIN, H.: Siccacell Therapy for retarded children. General Practice, Jan 1961. GOLGI, C.: Sur la structure des cellules nerveuses. Arch.ital.Biol. 30,60, (1898). E. GOOD, H.M. The brain injured child; a holistic approach, Med Organica, March 1994 E. GOOD, H.M. Spinal Muscular Degenerations - A Holistic Concept of Treatment, Cytobiological Review, Nr. 1/1988 151

E. GOOD, H.M. Tinnitus; Degeneration of the VIII Cranial Nerve and Hearing Pathway. Cytobiological Review Nr. 3/1987 E. GOOD, R.A.: Immunbiology, Cellular Engineering and Cancer. Pediatric Research Vol. I 2,Nr.4,Part.2.Williams a.Wilkins Co. Baltimore 1978. E. GOOD, R.A. and PAPERMASTER, B.W.: Autogeny and Phylogeny of Adaptive Immunity. In Dixon,F.J., Humphrey,J.H.: Advances in Immunology. Vol.4.Academic Press, New York/ London. 1964. E. GOOD, R., und BACH, F.: Clinical Immunbiology. Academic Press, New York 1974. E. GOOD, R.A., MARTINEZ, C., DALMASSO, A.P., PAPERMASTER, B.W., and GABRIELSON, A.E.: Studies on the role of the thymus in developmental biology, with a consideration of the association of thymus abnormalities and clinical disease. Immunopathogie. Illrd Internat. Symposium. Basel u.Stuftgart:Benno Schwabe & Co. 1963. GORDONOFF, T.: Pharmakologische Unter suchungen einiger S iccacel I-Pra pa rate. Med.Welt,44,2303-2307. 1960. GOSLAR, H.G.: Recherches histophysiologiques sur la realft de I'action de divers extraits d'organes lymphatiques. Rapports du 36me Congres Frangais de Therapeutique Cellulaire, Paris. Edit.du Centre Med.d'Etudes et de Rech., Paris 29-33,1959. GOSLAR, H.G.: Beitrdge zur Korrelation von Thymus, Schilddrase und Nebenniere. Vortrage beim II.Intern.Kongr.f.Zell- und Histother., Wiesbaden,l, 22-24,1959. GOSLAR, H.G.: Morphologische Untersuchungen zur Objektivierung einer differenten Wirkung von Extrakten lymphatischer Organe. Rotterdamse gesprekken over celtherapie. Ned. U itgeversmaatschappij N.V., Leiden 55-57, 1960. E. GOWANS, I.L., and MCGREGOR, D.D.: The origin of antibody-forming cells. Immunpatholigie. Illrd Internat. Symposium. S.89, Basel U.Stuttgart: Schwabe & Co. 1963. GRAUPNER, H.: Die Niehanssche Zel I u lartherapie. J.F. Lehman's Verlag, Manchen, 1955. E. GRIFFEL, A.: The latest developments in Dry Cell Therapy (Siccacell). Arch.Pediatr., N.Y.,74, 325-342,1957. GROBER, H.: Experimentelle Studien mit Trockenzellen bei der Sa Iva rsa n-Neph rose, Berd.v.d.2.Tagg.d. Forsch ungsgem.f Zell u larth. 49f., 1955. GROBER, H.: Die Wirkung tierischer Trockenzellen auf den Arsenobenzoischaden der Tiere. Franf Zsc hr. Path., 66.362-375. 1955.

152

GROBER, H.: Experimentelle Untersuchungen zur Zell u lartherapie. Vortrag auf der Herbsttagg.d. Nord- und Westdtsch. Pathologen in Bad Ems. Sept.1 954.Ref. Blatt "Die Zellulartherapie".Nr.6,7-8.1955. E. GRUMET, F.C., PAYNE, R.O., KONOSHI, J., KRISS, J.P.: HLA-antigens as marker for disease susceptibility and autoimmunity in Graves disease. J.Clin.Endocrinal.Metab.39,1115 (1974). GUTTMANN, G.: Neurospychologie' des Lernens. In Nissen G.: Intelligenz, Lernen und Lernsterungen. Springer-Verlag, Berl i n-Heidelberg- New York 1977.

- H HAGER, D.: Kongregbericht Cytobiol.Rev.5, 212-213 (1981). Ober den Kurs "Lyophilisations technologie".

HAGER, D.: Immunstimulation und Interferon-Induktion in der Tumortherapie. Cytobiol.Rev.5,144-148 (1981). HAGMAIER, W.: Zelltherapie in der post-operativen Phase. Ref. Blatt "Die Zelltherapie" Nr.40. Aug. 1973. HAGMAIER, W.: Erfolgreiche Behandlung von Weichteilverletzungen mit Nekrosen. Eiterungen, osteomyelitischen Vertinderungen und unijberbrackbaren Hautdefekten durch lyophilisiertes Mesenchym (Resistocell). Cytobiol.Rev.2, 36-38 (1978). HAGMAIER, W., HOEPKE, H., LANDSBERGER, A. und RENNER, H.: Erfolgreiche Behandlung Krebskranker durch Immuntherapie mit fetalem Lyophilisat. Cytobiol.Rev.3,10-14 (1979). HAILER, B.Y. u. BRAUNE, J.: Die Blut-Hirnschranke Cytobiol.Rev. 5.166-170 (1981). HALPERN, B.N., BENACERRAF, B. and DELAFRESNAYE, J.F.: Physiopathology of the reticuloendothelial system. Oxford: Blackwell, Paris: Masson & Cie. 1957. HARBERS, E.: Tierexperimentelle Untersuchungen zur Beeinflussung konstlich gesetzter Leberschdden durch Frischund Trockenzellen. Bericht v.d.I.Tagg.d.ForschungsgemeinschaftfUrZellulartherapie. 8-10,1954. HARBERS, E.: Tierexperimentelle Untersuchungen mit radioaktiv markiertem Trokkengewebe. Bericht v.d.3.Tagg.d.Arbeitsgem.f. Zellulartherapie, Frankfurt, 13, 1954. Berichtv.d.2.Tagg.d. Forsch u ngsgemei nsc haft f. Zellulartherapie. 31f., 1955. HARMS, A.: Zelltherapie - Endlich Licht in das Dundel. Gesunde Medizin 1978/12. 54-58. HARTMANN, G.: Quantitative elektronenmikroskopische Studien an Le berm itoch ondrien der Ratte nach Injektionen von Placenta- und Hodengewebe. Inaugural-diss. Tier5rztI. Hochschule Wien, 1964.

153

HARVEN, DE. E. and BERNHARD, W.: Etude au microscope dlectronique de l'ultrastructure du centriole chez les vertebrds. Z.Zellforsch.45, 378 (1956). E. HASHIMOTO, T.: Individual peroxysomal R-oxidation enzymes. Annals of the New York Academy of Sciences, 386, 5-12 (1982). HASSELMANN, H.: Zurn Problem einer Therapie der Keratosis palmaris et plantaris hereditaria. Hippokrates, Stuttgart, 30, 184f, 1959. HAUBOLD, H.: Bisherige Erfahrungen Ober komnbinierte Zellbehandlung bei endokrinen Sterungen. Bericht d.Forschungsgemeinschaft fu'* r Zell u la rtherapie, 29-38,1954. Vitaminund v.d.l.Tagg.

HAUBOLD, H.: Neue therapeutische Meglichkeiten bei Mongolismus. Vorschlag einer Nachreifungsbehandlung. ArztI. Forschung, Monchen, IX, 1/211-1/228.1955, Neue therapeutische Meglichkeiten beim Mongolismus. Therapiekongrer,11 2-15,1954. Therapie-Woche, Karlsruhe, 5,275-282.1955. HAUBOLD, H.: Vergleich zwischen iirztlicher Nachreifungstherapie und heilpadagogischer Behandlung ohne tirztliche Hilfe bei mongoloiden und anderen entwicklungsgehemmten Kindern. Ber.a.d.6.Tagg.d.Arbeitsgemeinschaft f. Zellulartherapie. Bad Homburg, 37-41, 1957. HAUBOLD, H., LOEW, H. und HAEFFELE-NIEMANN, R.: Meglichkeiten und Grenzen einer. Nachreifungsbehandlung entwicklungsgehemmter, insbesondere mongoloider Kinder. Landarzt, Stuftgart,36,378-380,1960. HAUPT, E.: Das Verhalten von Milz und Thymus beirn i ntra peritonea len Yoshida-Aszites-Tumor von Ratten. Medizinische, Stuttgart, 4, 157-160, 1958. E. HAUROWITZ, F.: Immuno-chemistry and the Biosynthesis of Antibodies. New York, 1968. HAUSWIRTH, A.: Die Stellung der Zellulartherapie in der inneren Medizin. Prakt. Arzt, Wien, XII, 352-361, 1958. HAYFLICK, L.: Die cellultire Basis des biologischen Alterns. Verh. Dtsch. Ges. Path. 59, 52-66 (1975). E. HEIDELBERGER, M.: Lectures in Immuno-chemistry. Acad.Press. Publ., New York, 1956. HEINSTEIN, G. u. ENDERLE, E.: Versuch der Prtkvention DANA-induzierter Karzinome durch immunologische Antezedenz. Cytobiol.Rev.5,135-143 (1981). HEINTZ, R.: Die Zellulartherapie bei der chonisch differenzierten Glomerulonephritis, Therapie-Woche, Karlsruhe, 5, 282-284,1954/55.

154

E. HELLSTROM, K.E. and HELLSTREM, I.: The role of cell-mediated immunity in control and growth of tumors. In Good and Bach: Clinical Immunbiology, Bd.II.Academic Press 1974.

- L E. LANE, N.J. and NOVIKOFF, A.B.: Effects of arginine deprivation, ultraviolet radiation and X-radiation on cultured KB cells. A cytochernical and ultrastructural study. J.Cell Biolog. 27, 603 (1965). LANGENDORFF. W. LANGER VON: Die Bedeutung enzymastischer AktivitAten der Placenta in ihrer Beziehung zur Zelltherapie. 5.intern.Kongrea Celltherapie (1 4.Arb.Tagg.dt.Ges.) 5./6.77.69 Referatenblaft Die Zelltherapie Nr.36.Dez.1 969. LANGENDORFF, W. LANGER VON: Vergleichende Versuche zur Revitalisierung von Zellen in vitro. 1 6.Kongreg f.ZT.9./lO.10.1971. Ref. Blatt Die Zelltherapie Nr.39, August 1972. LANGENDORFF, W. LANGER VON: Schutzwirking der Zelltherapie gegen emphysembedingte Lungendegeneration. Re:Blatt Die Zelltherapie Nr.41, 1974. E. LANGENDORFF, W. LANGER VON; The Effect of Fetal Mesenchymal Cells on a Hodgkins-like Lymphoma Culture. Cytobiol.Rev.2/1, 3-6 (1978). E. LANGERDORFF, W. LANGER VON; The Effect of Fetal Mesenchyme Cells on the Morphology Growth Characteristics and Function of an Experimental Wilm's Tumor Culture. Cytobiol.Rev.4,131/134 (1979). LAUBE, H.: Inselzell-Autotransplantation. Ref: Praxis-Kurier 21, 4 (1979):85. Tagung der Deutschen Geselischaft f0r Innere Medizin Wiesbaden, April 1979. LAUDAHN, G.: Grundlagen und tierexperimentelle Untersuchungen zur Frage einer therapeutischen anwendbarkeit isolierter Mitochondrien. Arztl.Forschung.Manchen, 10,1/513-1/524,1956. LAUDAHN, G. und LODERS, C.J.: Die Wirkung isolierter Leberzellmitochondrien auf die akute schedigung der Rattenleben durch Tetrachlorkohlenstoff. Arzneimiftel Forsch.,Aulendorf.10,978-985. 1960. E. LAWRENCE, H.S.: The cellular transfer of cutaneous hypersensitivity to tuberculin in man. Proc.Soc.exp.Biol.(N.Y.)71, 516 (1949). LECHNER, E.: Quantitative elektronenmikroskopische Studien an Herzmitochondrien der Ratte nach Injektionen von oder Hodengewebe. I naug u ral-Diss., Tierd rztI. Hoc hsch u le Wien, 1965. E. LEHNINGER, A.L.: The Mitochondrion, W.A. Benjamin, New York 1964. LEIBIG, A.: Ober die Behandlung von Arthrosen und Arthritiden mit Placenta. Medizinische, Stuttgart, 51, 1823-1825,1956. 155

E. LENDRUM, R., WALKER, G., CUDWORTH, A.G., THEOPHANIDES, C., PYKE, D.A., BLOOM, A. and GAMBLE, D.R.: Islet cell antibodies in diabetes mellitus. Lancet 11.1273 (1976). E. LEPOW, I.H., NAFF, G.B., TODD, E.W., PENSKY, J. and HINZ jr. C.F.: Chromatographic resolution of the first component into three activities. J.exp.Med.1 77,983,(1963). LETTRE, H.: Gewebekulturversuche mit Frisch- und Trockenzellen. Ber.v.d.l.Tagg.der Forschungsgem.f.ZT,1,1 954, Zellkonfrontation in der Gewebekultur. Bericht v.d.2.Tagg.d. Forsch u ngsgem.f.ZT. Frankfurt, 28-30, 1955. LETTRE, H.: Versuche zur Klilrung der Wirksamkeit der Zell u rlartherapie nach Niehans. Umschau in der Wissenschaft u.Technik,23, 708 ff., 1954. LETTRE, H.: Untersuchungen an Frisch- und Trockenzellen. Bericht v.d.l.Tagg d.Forschungsgemeinschaft Zellulartherapie,2-3,1954. LETTRE, H.: Profung der organspezifischen Wirkung von Zellinjektionen. Thera pie-kong reg, 17-19, 1954. Therapy. Woche, Karlsruhe, 5, 152-156, 1955. LETTRE, H.: Experimentelle Studien Ober die Wirkung von Zellfragmenten. Bericht v.d.2.Tagg.d.Forschungsgem.f.ZT.30f.,1 955. LINDER, G.: Untersuchung der Zellatmung von Herz, Niere und Leber bei Hohnern in Beziehung zurn Lebensalter. Inaugural-Diss. TierdrztI. Hochscule Wien. 1961. LINDMARK. D.G. a MOLLER, M.: Hydrogenosome, a cytoplasmic organelle of anaerobic flagellate Trichomonas foetus and its role in pyruvate metabolism. J.Biol.Chem.248,7724-7728 (1973). E. LINTZ, R.M.: Implantation of Placental Tissue in Patients with Rheumatoid Arthritis. Ann.Rheumat.Dis.,London,13,63-66,1954. E. LITTLEFIELD, J-W. and KELLER, E.B.: Incorporation of C amino acids into ribonucleoprotein particles from the Ehrlich mouse ascites tumor. J.Biol.Chem. 224, 13(1957). E. LORENZ, E., UPHOFF, D., REID, T.R. and SHELTON, H.: Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J.of NC1 12, 197 (1951). E. LORENZ, E. and CONGDON, C.C.: Modification of Lethal Irradiation Injury in Mice by Injection of Homologous or Heterologous Bone. J.Nat.Cancer Inst.Wash., 14, 955-961,1954.

156

- M E. MACKENZIE, C.D., RAMALHO-PINTO, F.J., MCLAREN. D.J. and SMITHERS, S.R.: Anti-body irriadiated adherence of rat eosinophils to shistosomula of shistoma mansoni in vitro. Clin.exp.Immunol. 30, 97 (1977). E. MARCOLONGE, R. and DI PAOLA, N.: Fetal Thymic Transplant in Patients with Hodgkins Disease. Blood 41, 625 (1973). MARGRAF, 0.: Minder- und Zwergwuchs, Cytobiol.Rev.3,122-123 (1979). MARQUARDT, P. und FRANZ, G.: Zur Wirkung von Trockenzellpr5paraten bei intraveneser Iniektion. Arzneimiftel-Forschung. Aulendorf, 11, 544f., 1961. E. MARSHAK, A. und WALKER, A.C.: Effect of Liver Fractions on Mitosis in Regenerating Liver. Amer.J.Physiol.,149, 226-2U,1946. MAUGH, TH.H. und MARX, J.L.: Zersterendes Wachstum, G. Thierne Verlag, Stuttgart 1979. E. MCLAREN, D.J., MACKENZIE. C.D. and RAMALHO-PINTO, F.J.: Ultrastructural observations on the in vitro interaction between rat eosinophils and parasitic helminths. Clin.exp.immun.30,105(1977) E. MEDAWAR, P.B.: Immunological tolerance: Nobel lecture. Nature 189,14 (1961). MEHNERT, H.: Stoffwechselkrankheiten. Thieme-Verlag, Stuttgart 1975. MEISS, L., RONIEN, CL. und Dtsch.med.Wschr.981,1179 (1973). SERON, B.: Immuntherapie des Krebses.

MERTELMANN, R., KOCH, G., SCHUMPELICK, V. und TACHEZY, H.: Implantation von fetalem Thymusgewebe bei Patienten mit progredienten besartigen Geschwulstkrankheiten. MCinch.med. Wschr. 166,2063-2066 (1974). E. METCHNIKOFF, E.: Lectures on the Comparative Pathology of Inflammation. London 1893. METSCHNIKOFF, E.: L'inflammation. Paris Infektionskrankheiten. Jena:Gustav Fischer 1902. 1892, Immunitat bei

MEYER, W.: Experimentelle Pan kreastransplantation. Fortschr. Med-97,1280-1284 (1979). MIEHLKE, K.: Hypophysen-Implantation bei chronischer Polyarthritis. ArztI.Praxis, MLnchen,V/37,1953.Ber.v.d.I.Tagg d. Arb.Gem.f.Zellulartherapie, Fran kfurt,9-1 2,1953. MIEHLKE, K.: Zur Behandlung der Arthrosis. Ber.v.d.4.Tagg.d. Arbeitsgem f. Zellulartherapie, Bad Homburg, 22-24,1955. 157

E. MILLER, E.C. and MILLER, A.: Approaches to the mechanisms and control of chemical carcinogenesis. In:Environment and Cancer. Williams and Wilkins, Baltimore 1972. E. MILLER, J.F.A.P.: Immunological function of the thymus: Lancet 1961 11:748. MILLER, I.F.A.P. und DUKOR, P.: Die Biologie des Thymus nach dem Stand der heutigen Forschung. Fran kfurt:Akad.Verlagsges. 1964. E. MILLER, F.: Acid phosphatase localization in renal protein absorption droplets. Proc.Intern. Cong r. Electron. Microscopy. 5th Philadelphia Academic. Press.Inc. New York 1962. MOENCH, A.: Der Einflug heterologer Gewebetrockenzellen auf die experimentelle Nephritis des Kaninchens. Bericht v.d.2.Tagg.d. Forschungem.f.ZT.49,1955. MOENCH, A. und BURCKHARD: Ober die Wirkung von Siccacell und Kaninchentrokkenserum auf die xperimentelle Neosalvarsan Neph rose der weigen Ratte. Bericht v.d.4.Tagg. d.Forchungskreises f.ZT,6-8,1957. MELBERT, E.: Die Orthologie und Pathologie der Zelle.Handb. allgem.Pathol.Band . 238-466. Springer-Verlag, Berlin Heidelberg-New York 1968. MELBERT, F.: Das endoplasmatische Reticulum. In H.W. Altmann u.a.,Handb.allgern. Pathol.11/5.Die Zelle,S.336-403. SpringerVerlag, Berl i n-Heidelberg-New York 1968. MESE, J.R.: Serologische Untersuchungen bei Behandlung mit Iyophilisierten Organzellen oder Organextrakten. Vortrage beim II.Intern.Kongrell f2ell- und Histotherapie, Wiesbaden. 1.54-62,1959. MESE, J.R.: BeeinfluRbarkeit von HeterohAmolysinen und Norma I-Ba kterienAgg I uti n i nen durch Behandlung mit Iyophilisierten Organzellen. Vortrag anl.d. III. Intern. Kongr.f.ZT,Paris, 1961. MESE, J.R.: WENNIG, F. und STEIN, 0.: Anderung des Heterohdmagglutination stiters nach Injektion Iyophilisierter Organzellen. Medizinische,Stuftgart,31/32, 1200-1202,1958. MOMMSEN, H.: Ober die Behandlung des Mongolismus mit Frischzellen. Ber.v.d.4.Tagg.der Arbeitsgem.f.Zel I u larthera pie, Bad Homburg, 25-27, 1955. MOMMSEN, H.: Hippokrates, Stuttgart, 27, 619-623,1956. MOMMSEN, H.: Zellulartherapie bei entwicklungsgesterten Kindern. Ber.v.d.4. Tagg.d.Forschungskreises f. Zellulartherapie, 61 f., 1957. MOMMSEN, H.: Die Zellulartherapie des Mongolismus. Arztl.Praxis.MQnchen, XIII/11,646f., 1961. 158

E. MOORE, F.D.: Transplantation. Springer, Berl i n/Heidel berg/New York. 1970. E. MORGAN, W.T.J. and WATKINS. W.M.: Bio-chemistry of human blood group substances. Brit.med.Bull.1959,112. E. MOUNT, H.T.R.: Multiple Sclerosis and other demyelinating diseases. Canadian Med.Ass.J.108,1356-1358 (1973). MOLLER, 0.: Antikerper- und Autoantikerperbildung nach intraperitonealer Injektion von heterologen Iyophilisierten Zellen. Inaug.-Diss.a.d. Albert-Ludwigs-Univ., Freiburg, 1956. MOLLER, E.A.: Die Anwendung der Frischzellentherapie nach Dr. Niehans bei Endangiitis obliterans. Med.Klin.,48,1294f., 1953. MOLLER, I.: Selbstversuch mit Resistocell. Cytobiol.Rev.2/2, 30 (1978). MOLLER, L.FELIX Thera pievers uc he mit Lebermitochondrien bei experimentellen Tetrachlorkohlenstoff-Schaden des'Hundes. Berliner MUnchener tier ArztI. Wschr.74,130-132, 1961. E. MOLLER-EBERHARD, H.J.: Chemical aspects of human complement components IInd lnternat.Symp.Immunopath. p.23. Basel u.Stuftgart, Benno Schwabe & Co. 1962.

- N NEUBERT, H.: Frischzellentherapie beim Diabetes mellitus. V. Wissen.Kongrer Monchen 1978, Kong rellbericht S.25-48. NEUBERT, H.: Wissenswertes Ober langjAhrige Frischzellentherapie. Biolog.Medizin 8, 436-447 (1979). Erfahrungen stationarer

NEUBERT, H.: Einsatz derZelltherapie bei Diabetes mellitus. Cytobiol.Rev.6,22-27 (1982). NEUMANN, K.H.: Versuche zur therapeutischen Wirksamkeit von Frisch- und Trokkenzellen, getestet an ovariektornierten Wusen. Ber. v.d.l. Tagg.d. Forschungsgem.f.ZT, 10f.,1 954. NEUMANN, K.H.: Konservierungsverfahren, Herstellung und Eigenschaften von Trockengewebe. In F.Schmid und J.Stein:Zeliforschung und Zell ulartherapie Verlag Huber,Bern 1963, S.72-99. NEUMANN, K.H.: Pharmakologische Grunduntersuchungen zur Zellulartherapie. In F.Schmid und J.Stein: Zellforschung und Zell u lartherapie. Verlag Huber,Bern 1963,S.1 01 -124. -124. 159

E. NEUMANN, K.H.: Methods of Conservation and Preparation of Desiccated Tissues and their Properties. In F.Schmid and J.Stein: Cell Research and Cellular Therapy. Ott Publishers Thoune, Switzerland, 1967 p.83-108. E. NEUMANN, K.H.: Basic Pharmacological Studies concerning Cellular Therapy. In F.Schmid and J.Stein: Cell Research and Cellular Therapy. Ott Publishers Thoune, Switzerland. 1967, p. 110-132. NEUMANN, K.H.: Gefriertrocknung und ihre Leistungen fOr die Konservierung von Organ pril pa raten. Zellulartherapie in Klinik u. Praxis, Kuhn, W.Hippokrates-Verlag, Stuttgart,39-69, 1956. NEUMANN, K.H.: Untersuchungen Ober die therapeutische Wirksamkeit von Injektionen von Nierengewebe bei experimentell erzeugter Nephrose Ber. v.d.6. Tagg. d. Arbeitsgem.f.ZT,Bad Homburg, 1-3 1957. NEUMANN, K.H.: Ober die Wirkung von Trockenzelleninjektionen auf Gewicht und Bau einzelner Organe der Maus. Bericht von der 5.Tagg.d.Forschungskreises f.ZT,54-59, 1958. NEUMANN, K.H.: Induktion des Organwachstums durch Implantation von homologen Geweben. In F.Schmid und J.Stein: Zellforschung und Zellulartherapie. Verlag Huber,Bern 1963, 328-335. NEUMANN, K.H.: Beeinflussung experimenteller Leberschadigung durch Gewebeinjektionen'. In F.Schmid und J.Stein: Zellforschung und Zellulartherapie, Verlag Huber, Bern 1963, S.366-376. E. NEUMANN, K.H.: Induction of Growth in Organs by the Implantation of Homologous Tissues. In F.Schmid und J.Stein: Cell Research and Cellular Therapy. Ott Publishers Thou ne,Switzeriand, 1967, p.331-337. E. NEUMANN, K.H.: The Influence of Tissue Injections on Experimental Liver Damage. In F.Schmid and J.Stein: Cell Research and Cellular Therapy. Ott Publishers, Thoune, Switzerland, 1967 p.368-377. NEUMANN, K.H.: Gefriertrocknung und ihre Leistungen fOr die Konservierung von Organ pril pa raten. Zellulartherapie in Klinik u. Praxis, Kuhn, W.Hippokrates-Verlag, Stuttgart,39-69, 1956. NEUMANN, K.H.: Untersuchungen Ober die therapeutische Wirksamkeit von Injektionen von Nierengewebe bei experimentell erzeugter Nephrose Ber.v.d.6.Tagg.d.Arbeitsgem.f.ZT,Bad Homburg, 1-3 1957. NEUMANN, K.H.: Ober die Wirkung von Trockenzelleninjektionen auf Gewicht und Bau einzelner Organe der Maus. Bericht von der 5.Tagg.d.Forschungskreises f.ZT,54-59, 1958.

160

NIEDERMOLLER, H.: Untersuchungen an der Ratte Uber die Resorption, Verteilung und Ausscheidung von Penicillin V in AbhAngigkeit vorn Lebensalter und nach Revitalisierung. Inaugural-Diss. TierdrztMockschule, Wien 1972. NIEHANS, P.: Die endokrinen DrOsen und die Methoden der Verjungung. Vortrag am XV. Schweiz. Chirurgen-Kongreg. Verlag Benno Schwabe, Basel, 1928. NIEHANS, P.: Les glandes endocrines et les methodes de rajeunissement. Verlag Benno Schwabe, Basel 1930. NIEHANS, P.: Krebs und endokrine Drosen. Benno Schwabe, Basel 1933. NIEHANS, P.: Das Alter, seine Beschwerden und die VerjUngung. Hans Huber, Bern 1936. NIEHANS, P.: Die endokrinen Dr Usen des Gehirns. Hans Huber, Bern 1938. NIEHANS, P.: Krebs-Krankheit. Hans Huber, Bern 1945. NIEHANS, P.: Biologische Behandlung kranker Organe bei Menschen und Tieren. Hans Huber, Bern 1948. NIEHANS, P.: Biologische Behandlung kranker Organe durch Einspritzen lebender Zellen. Verlag A.Schmid & Co., Bern 1949. NIEHANS, P.: Manchen 1954. Die Zellulartherapie (Lehrbuch). Verlag Urban & Schwarzenberg,

NIEHANS, P.: Einfohrung in die Zellulartherapie. Hans Huber, Bern 1957. E. NIEHANS, P.: Introduction to Cellular Therapy. Coopers Square Publ., New York 1960. NIETHAMMER, D., BIENZLE, U., KLEIHAUER, E.: Knochenmarktransplantation. Erg.Piediatrik. Onkologie 1,70-73 (1977). NIETHAMMER, D.: Behandlung mit immunologisch kompetenten Zellen und Zellextrakten. Monatsschr.Kinderheilk. 127, 381-388 (1979). NIKOLOWSKI, W.: Behandlung mannlicher Potenzstbrungen. Therapie-Wo'che, Karlsruhe, Kong rega,usgabe, 604-608,1956. E. NOMURA, M., TISSIERES, A. and LENGYEL, P.: Ribosomes. Cold Spring Harbor Laboratory, 1974. E. NOMURA, M. and HELD, W.A.: Reconstitution of Ribosomes: Studies of Ribosome Structure, Function and Assembly. In Nomura, Tissieres and Lengyel: Ribosomes. Cold Spring Harbor Laboratory 1974, SA 93-224. 161

E. NOSSAL, G.I.V. and MITCHELL, JUDITH: The nature of RNA synthesis in immune induction. Immunpathologie. Illrd Internat.Symposium.S.1 13.Basel u.Stuttgart, Benno Schwabe & Co. 1963.

- O E. OBERLING, CH. : The structure of cytoplasm. Int.Rev.Cytol.8, 1 (1959). OETZMANN, H.J.: La therapeutique cellulaire dans les maladies hepatiques. Rapports due 26me Congres Frangais de Therapeutique Cellulairejours. Edit.de Centre Med. d'Etudes et de Rech., Paris 49-53, 1958. OETZMANN, H.J.: Kritisches zur Zellulartherapie chronischer Lebererkrankungen. Vortrege beim ll.lntern.Kongref Zell- und Histotherapie, Wiesbaden 1,69-73,1959. OHNISHI, T.: Peroxidbildung im Gewebe, zit. Gann 49, 233 (1958) Bersin. OLBRISCH, R.R.: Plastische Chirurgie bei mongoloiden Kindern. Fortschr.Med. 97, 1475-1477 (1979). OPITZ, H. und SCHMID, F.: Handbuch der Kinderheilkunde, BdAV, Springer-Verlag, Berlin-Heidelberg-New York 1965. E. OPPERDOES, F.R. a.BORST, P.: Localization of nine glycolytic enzymes in microbodylike organelle in Trypanosoma brucei The glycosome. FEBS Lett. 80, 360-364 (1977). ORTIZ, R.F.: Evaluacion de la Citoterapie en los Retrasos del Desarrallo fisico e intelectual del nirlo. Mexico 1973.- Sinopsis de terapeutica celular. Mexico 1971.Citaterapie en las Enfermedades reumaticas. Mexico 1974: Cytobiol.Revue 4,H.3 (1980). E. PALADE, G.E.: A small particulate component of the cytoplasm. J.Biophys. Biochem. Cytol.1,59 (1955). E. PALADE, G.E.: A study of fixation for electron microscopy. J.exp.Med.95,285 (1952). E. PALADE, G.E.: Studies on the endoplasmatic reticulum. 11-Simple dispositions in cells in situ. J.biophys.biochem.Cytol.1,567 (1955). PALADE, G.E.: Relations between the endoplasmatic reticulum and the plasma membrance in macrophages. Anat.Rec.1 21,445 (1955). E. PAPPENHEIMER, A.M.: The Golgi apparatus: personal observations and a review of the literature. Anat.Rec.1 1,107 (1916).

162

PARADE, G.W.: Somatophysische Wirkungen der Epithelkerperchenober pflanzung. Beitrage zur Zell u lartherapie. Festschrift zurn 70. Geburtstag von P.Niehans. Verlag Urban & Schwarzenberg, Minchen/Berlin, 34-43,1952. PARAT, M.: Appareil de Golgi, vacoume, colorations vitales pH intracellulaire, Arch.exp.Zeliforschg.6,109 (1928). E. PARKMANN, R., RAPPOPORT, J., CASSADY, R., LEVEY, R., NATHAN, D.G., and ROSEN, R.S.: Correction of the Wiskoft-Aldrich-Syndrome by Bone-Marrow-Transplantation. New Engi.J.Med.298,921-927 (1978). PEDRERO, A. e SCHMID, F.: Down-Syndrom (span) Cytobiol.Rev.5,197-211 (1981). PETERMANN, M.L., HAMILTON, M.G. and MIZEN, N.A.: Elektrophoretic analysis of the macromolecular nucleoprotein particles of mammalian cytoplasm. Cancer Res. 14,360 (1954). PFEIFFER, I.: Die lebende Zelle, Time-Life, International (Nederland) 1965. PICOURET, A.: La therapeutique cellulaire dans les arterites des membres inferieurs. Rapports du 26me Congres Frangais de Therapeutique Cellulaire, Tours. Edit.du Centre Med.d'Etudes et de rech., Paris, 36-43, 1958. PICOURET, A.: La therapeutique cellulaire dans les; affections vasculaires des membres; inferieurs. Rapports, du 36me Congres Francais de Theapeutique Cellulaire, Paris. Edit.du Centre Med.d'Etudes et de Rech., Paris, 41-51, 1959. PISCHINGER, A.: Schicksal und Wirkung kerperfremden Gewebes im Organismus. Stuttgart, 23, 767-771, 1953. PISCHINGER, A.: Frischzellentherapie. Zur Kritik der Theorie und zurn Wesen der Frischzellentherapie nach Niehans. Wien, med. Wschr., 105, 952-957,1955. PLICARD, A. et BESSIS, M.: Etude surlement vivant en pathologie cellulaire l'emploi de la microcindmatographie en contraste de phase. Rev.1-16mat.8, 5 7(1953). POLICARD, A., BESSIS, M., BRETON-GONUS, J. et THIERY, J.P.: Polaritd de la centrosphere et des corps de Golgi dans Exp.Cell Res. 14, 221 (1958). E. POLLISTER, A.W. and POLLISTER, P.F.: The structure of the Golgi apparatus. Int. Rev.Cytol.6, (1957). E. PORTER, K.R.: The fine structure of cells. Fed.Proc.14, 673 (1955). E. PORTER, K.R.: Current views of the cytoskeleton. Pediatric Research Vol.1 2, NA, Part 2. Williams & Wilkins Co., Baltimore 1978. PORTER, K.R. und BONNEVILLE, M.A.: Einfahrung in die Feinstruktur von Zellen und Geweben, Springer-Verlag, Berl in Heidel berg-New York 1965. 163

E. PREHN, R.: Immunological surveillance: pro and contra. In: GOOD and BACH. Clinical Immunbiology,Bd.11, Academic Press, New York 1974.

-Q OUADBECK G., LANDMANN, H.R., SACHSSE, W. und SCHMIDT, J.: Der Einflull von Pyrithioxin auf die Bluthirnschranke. Medicina experim. 7, 144-154 (1962).

- R RANSWEILER, V.: Tierexperimentelle Untersuchungen Ober die therapeutische Wirksamkeit von Trockenzellen. lnaugural-Dissertation,Med.Fakultat der Universitat Heidelberg, 1960. E. RAPP, F.: Herpes virus and cancer. Advance. Cancer Res.19,265 (1974). RAPPOLD: Erfordern die Gefahren der Zellulartherapie im Lande NRW gesetzliche Schutzvorschriften? sterr.Zschr.Kinderheilk., 19, 204-206, 1957. READING, CH.H., MCLEAY, A. and NOBILE, S.: Down's Syndrome and Thiamine Deficiency. Journ. Orthomol. Psych.8, 4-12 (1979). REITZ, W. und SCHOOP, W.: Ein tedlich verlaufener anaphylaktischer Schock nach Trockenzelliniektion. Medizinische Stuttgart 13, 4161., 1957. RENNER, H.: Onko-fetale antigene und Tumor-Immuntherapie. Fortschr.Med.92,Nr.5 (1974). RENNER, H.: Immunologische Wirkung fetaler Zellen. Cytobiol.Rev. 1, 24-26 (1977). RENNER, H.: Klinische Aspekte einer Tumor-Immuntherapie mit Iyophilisierten fetalen Zellen. Cytobiol. Rev.3, 3-6 (1979). RENNER, K.H., RUNGE, T. u. ZEINZ, M.: Erfahrungen mit Resistocell als Zusatztherapie beim metastasierenden MammaCarcinom. Cytobiol. Rev.4, 109-114 (1980). E. REVEL, J.P. and HAY, E.D.: An autographic and electron microscopic study of collagen synthesis in differentiating cartilage. Z. Zellforschg. 61, 110 (1963). E. REZEPECKI, R.M., LUKASIEWICZ, M., ALEKSANDROWICZ, J., SNAGIEL, Z., SKOTNICKI, A. and LISIEWICZ, J.: Thymus Transplantation in Leukemia and malignant Lymphogranulomatosis. Lancet 1973/1,508. E. RIEKKINEN, P.J. and CLAUSEN, J.: Proteinase Activity of Myelin. Brain Research 15, 413-430 (1969). RIES, W. et al: Methodische Probleme bei der Ermittlung des biologischen Alters. Innere Medizin 4,109 (1976). 164

RIESEN, W.F. Und BARANDUN, S.: Struktur und Funktion von Antikbrpern. Allergologie 2,153-159 (1979). RIETSCHEL, H.G.: Problematik und Klinik der Zelltherapie, Verlag Urban and Schwarzenberg, Mijnchen-Berlin (1957). RIETSCHEL, H.G.: Frischzellentherapie med.Wschr.105/46,1955. und ihre Gefahren. Wien,

RIETSCHEL, H.G.: Nutzen und Gefahren der Frischzellentherapie. Therapiekingrea 9-12, 1954. Therapie-Woche,Karlsruhe,5,161-170,1955. RIETSCHEL, H.G.: Ein Zwischenfail bei der Zellulartherapie. Erfahrungsheilkunde 5, 177-180, 1956. E. ROBERTS, A.N. and HAUROWITZ, F.: Intracellular localization and quantitation of tritated antigens in reticuloendothelial tissues of mice during secondary and hyperimmunune responses. J.exp.Med. 116, 4 (1962). E. ROBERTS, R.B.: Microsomal particles and protein synthesis. Pergammon Press. New York 1958. ROBINSON, D.: Enzyme 18,114-134 (1974). ROCHELS, R.: Anthropometrische Untersuchungen zum Down-Syndrom, Cytobiol.Rev.5, 65-74,129-134,179-183 (1981). RODEMANN, H.P. und BAYREUTHER, Ks.: Die Zellteilungskapazitdt von menschlichen diploiden Fibroblasten und Gliazellen in quantitativen Gewebekultursystemen unter dem Einflull von Centrophenoxin. In Kugler, J.: Hirnstoffwechsel und Hirndurchblutung. Schnetztor-Verlag. Konstanz 1976, S.32. ROEDER, F.: Ober die maximale Behandlung des Parkinsonsyndroms. Wiss.Beiblaft zur Materia Medica Nordmark.Nr.59, April 1967. ROEDER, K.H.: Behandlung eines Falles von chronischer Nephritis mit hochgradiger Nephrose mit Trockenzellsubstanz nach Dr. P. Niehans, Med.Kiin.47,1572,1962. ROITT, I.: Immunologie, Dr.Dietrich Steinkopff, Darmstadt 1977. ROMEIS, B.: Mikroskopische Technik. R.Oldenbourg Verlag, MOnchen 1978. ROTHER, CL.: Experimentelle immunbiologische Studien nach der Verwendung von Niehans-Trockenzelien. Ber.v.d.3.Tagg.d.Forschungsgemeinschaft f.ZT.3-34, 1955. ROTHER, CL.: Sensibilisierungsvorgdnge nach Niehans-Zellulartherapie. Bericht v.d.3. Tagg. d. Forschungsgemeinschaft f.ZT.3-5,1956. ROTHER, K.: Komplement. Dr.Dietrich Steinkepff Verlag, Darmstadt 1974.

165

ROTHER, K.: Schaden durch direkte Bindung von Antikerpern am Gewebe. Allergologie 2, 160-167 (1979). ROMELIN, K.: Zur Prophylaxe und Therapie allergisch-anaphylaktisc her Reaktionen. 5. Intern. Kong r.f.Zel Itherapie (1 4,Arb.Tagg.Dt. Ges.) 5./6.7.1969.Ref.Blaft Die Zelltherapie Nr-37,1969. RUMPF, K.D.: Methoden zur Funktionskontrolle transplantierter Langerhansscher Inseln. Langenbecks Arch.Chir.343, 293-305 (1977). RUMPF, K.D.: Transplantation isolierter Langerhansscher Diabetes-Behandlung. Fortschr. Med.96,1227-1232 (1978). RUPP, J.: Kritisches zur Frischzelientherapie,Arztl.Praxis. Arzti. Mitt., KbIn,40-47, 1955. Inseln zur

Munchen. VII/47,1955.

- S SCHAFFER, J.: Ober das Vorkommen eosinophiler Zellen im menschlichen Thymus. Zbl. Med.Wiss.29, 401 (1891). SCHEIB, D.: Properties and role of acid hydrolases of the Mallerian ducts during sexual differentiation in the male chick embryo in A.V.S.de Reuck and M.P. Cameron (eds.), Ciba Found, Symp.Lysosomes, J. and A. Churchill, Ltd. London 1963 p.264. SCHLANGE, H.: Die passive Obertragung der Tuberkulinempfindlichke it durch Blutaustauschtransfusionen und due Obertragung der erworbenen Tuberkulinnegativitht. Arch. Kinderheilk. 148,2 (1954) SCHMID, F.: Schicksal und Wirkung injizierter Fremdgewebe. Vortrage beirn II. Intern. Kongrer f Zell- und Histotherapie, Wiesbaden,1,85-88,1959. SCHMID, F.: Rotterdamse gesprekken over celtherapie. Ned.Uitgeversmaatschappij N.V.,Leiden, 97-194, 1960. SCHMID, F.: Aufnahme und Verteilungsprinzipien injizierter Fremdgewebe. Vortrag anidglich d. Ill. Intern. Kongr.f.ZT, Paris 1961. SCHMID, F und Stein J.: Nachweis biochemischer Substanzen in frischentnommenen und Iyophilisierten fetalen Geweben. Zellforschung und Zell ulartherapie, Verlag Huber, Bern 1963,S. 126. E. SCHMID, F und Stein J.: Demonstration of Biochemical Substances in Fresh and Lyophilized Tissues. Cell Research and Cellular Therapy.Ott Publishers Thoune, Switzerland, l 967,p.1 34. SCHMID, F.: Tierexperimentelle Untersuchungen Uber die OrganspeziMt von injizierten Zellsuspensionen. Bericht v.d.5.Tagg.d.Forschungskreises f.ZT.41-44, 1958.

166

SCHMID, F.: Les cellules frafches et seches ont-elles une action specifique aux organes? Rapports du 36me Congres Frangais de Therapeutique Cellulaire, Paris.Edit-du Centre Med.d'Etudes et de Rech., Paris,3-10,1959. E. Schmid F. and J. Stein: - Action of Placenta Cells in Experimental Arteriosklerosis. InCell Research and Cellular Therapy. Ott Publishers Thoune, Switzerland, 1967, p.380. SCHMID, F und Stein J.: Wirkung und Wirkungsspezifitht auf leukdmische Blutbildverschiebungen. Zellforschung und Zell u lartherapie. Verlag Huber,Bern 1963, S.275. SCHMID, F und Stein J.: Aufnahme und Verteilungsprinzipien injizierter Fremdgewebe. Zellforschung und.Zellulartherapie. Verlag Huber,Bern 1963,S.135-145. E. SCHMID, F und Stein J.: Effect and Specific Effectiveness on the Change of the Blood Picture in Leukemia. Cell Research and Cellular Therapy. Ott Publishers Thoune,Switzerland,l 967,p.280. E. SCHMID, F und Stein J.: Acceptance and Distribution-Patterns of Injected Foreign Tissues. Cell Research and Cellular Therapy. Ott Publishers Thoune, Switzerland, 1967, p.143-152. SCHMID, F.: Biologische Asperkte der Leukose-Behandlung. KinderdrztI.Praxis, Leipzig, 26, 485-493,1958. SCHMID, F.: Experimentelle Grundlagen der Therapie Gewebsfraktionen. Die Therapiewoche 12,11, 1962. mit Geweben und

SCHMID, F und Stein J.: Wachsturnsimpulse heterologer Gewebe in der Gewebekultur. Zellforschung und Zell u lartherapie. Verlag Huber, Bern 1963,S.386-396. E. SCHMID, F und Stein J.: Growth-stimulation of Heterologous Tissues in Tissue Cultures. Cell Research and Cellular Therapy. Ott Publishers Thoune, Switzerland, 1967, p.388-397. SCHMID, F und Stein J.: Der immunologische Mechanismus der Zelle. Zellforschung und Zellulartherapie. Verlag Huber, Bern 1963, S.219-231. E. SCHMID, F und Stein J.: The Immunological Mechanism of the Cell. Cell Research and Cellular Therapy. Ott Publishers Thoune, Switzerland, 1967, p.226-235, E. SCHMID, F und Stein J.: Fundamental Immunological Principles. Cell Research and Cellular therapy. Ott Publishers Thoune, Switzerland, 1967, p.1 57-203. SCHMID, F.: Prof. Med.86.J.,Nr.24,1968. Dr. Paul Niehans (Aktuelle Obersicht). Fortschr.

SCHMID, F.: Zelitherapie: Analyse und Aspekte. Selecta Nr. 19 Jg.XIV v.8.5. 1972. 167

SCHMID, F.: Das Mongolismus-Syndrom. Hansen u.Hansen, Monsterdorf 1976. SCHMID, F.: Das Mongolismus-Syndrom. Sammeisonderdruck aus Fortschr .d. Med., Jg.87, 29:1185, 1204; 30:1248,1252,31:1324,1969. SCHMID, F.: Mehrschichtige Therapie bei Mehrfachbehinderten. Ref. Blaft Die Zelltherapie Nr.40,Aug.1973 und Phys.Med. und Rehabilitation,3.Jg. Juni 1972, Heft 6. SCHMID, F.: Therapeutischer Nihilismus beim Mongolismus ist heute nicht mehr zu verantworten. Medical Tribune, Jg. 9, Nr.10 vom 8.3.1974. SCHMID, F.: Das apallische Syndrome, Cytobiol.Rev.1,10-16(1977). SCHMID, F.: Die Zelle als biologische Elementareinheit. Cytobiol.Rev. 1, 40-42 (1977). SCHMID, F.: Fetaler Hautextrakl: - ein neues therapeutisches Prinzip. Cytobiol. Rev. 1, 35-3'9 (1977). E. SCHMID, F: Down's Syndrome. Treatment and Management. 25-32 (1978). Cytobiol. Rev. 2,

SCHMID, F.: Zelltherapie - Experimentelle Grundlagen und Klinik. Cytobiol. Rev.2, 3-11 (1978). SCHMID, F.: Cytomembranen. Cytobiol. Rev.2, 20-23 (1978). SCHMID, F: Mitochondrien. Cytobiol. Rev. 2.17-19 (1978). SCHMID. F.: Ribosomen. Cytobiol. Rev.2, 28-32 (1978). SCHMID. F.: Lysomen. Cytobiol. Rev. 2. 23-30 (1978). SCHMID. F.: Der Golgi-Apparat, Cytobiol. Rev. 3, 70-74 (1979). SCHMID. F.: Centriolen, Cytobiol. Rev.3 , 105-107 (1979). SCHMID. F.: Geistige und Mehrfachbehinderungen: Behandlungs-Systematik. Cytobiol.Rev. 2, 3-22 (1978). SCHMID. F.: Antigene. Fortschr. Med. 82, 475 (1964). SCHMID. F.: Antigene Determinanten. Fortschr. Med. 82, 684-685 (1964). SCHMID. F.: Antikerper. Fortschr. Med. 82, 644-645 (1964). SCHMID. F.: Antigen-Antikerper-Be; ziehungen. Fortschr. Med. 82, 774-775 (1964). SCHMID. F.: Das Immunsystem. In Mikroekologie und Therapie. Voi.7,1977, S.20-31. Instut.for Mikreokologie D-6348 Herborn. 168 Konzept einer

SCHMID. F.: Die generalisierten Tuberkulosen, Literaturzusammenstellung "RES und ImmunitAt". Stuttgart: Georg Thieme 1951. SCHMID. F.: Klinische Aspekte des Mesenchymproblems. Med. Welt 1960, 1207. SCHMID. F.: Immunobiologie. In Handbuch der Kinderheilkunde.Bd.V,S.646. Berlin-Geftin gen-Heidel berg: Springer 1963. SCHMID. F.: Das "alktive" Mesenchyme, Fortschr. Med. 82, 446 (1964). SCHMID. F.: Lebensprofil der Immunabwehr. Mkurse iirztI. FortbiId. 15,76 (1965); Selecta 1965. SCHMID, F.: Staffelung der immunologischen Abwehrvorgtinge. Dtsch. Arzteblaft, 63, 3009 (1966). SCHMID. F.: Immunmangelzustende. Pediatr. Praxis 14, 555 (1974). SCHMID. F.: Cytobiologie der Immunocyten. Die gelben Hefte 12, 481 (1966). SCHMID, F.: Konstitutionsanornalien des Skelettes. Handb. Inn. Med. VI/1 B, 981-1055. Herausgeb. Kuhlencordt, F.und Bartelheimer, H.Springer Verlag Berlin-Heidelberg-New York 1980. SCHMID, F.: Immunbiologische Synopsis. Cytobiol. Rev. 4, 3-44 (1980) E. SCHMID. F.: Cell Therapy-Experimental Basis and Clinics. Cytobiol. Rev. 4, 63-69, (1980). SCHMID. F.: Zelltherapie - die Medizin der Zukunft. Cytobiol. Rev. 4, 141-143 (1980). SCHMID, F.: Das Gehirn; Entwicklung,Morphogenese und Function. Cytobiol. Rev. 5, 51-64 (1981). SCHMID, F.: Elemente als Determinanten biologischer Strukturn. Cytobiol. Rev. 5, 122-128 (1981). SCHMID, F.: Down-Syndrom: Situationsanalyse (Situation analysis) Cytobiol. Rev. 5, 184-196 (1981). SCHMID, F.: Down-Syndrom: Behandlung und Betreuung - Treatment und Care (deutsch u.englisch); Cytobiol. Rev. 6, 28-41 (1982). SCHMID, F.: Down-Syndrorn - Grundlagen-forschung. Cytobiol Rev. 6, 140-152 (1982). SCHMID, F.: Mineralien und Spurenelemente in Iyophilisierten Geweben. Cytobiol. Rev. 6, 89-95 (1982). SCHMID. F.: Die degenerativen Krankheiten der weiRen Gehirnsubstanz; The degenerative diseases of the white brain matter. Cytobiol. Rev. 6, 189-197 (1982). 169

SCHMID, F, et al.: Beinflussung der mongoloiden Dyszephaiie durch Injektionsimplantationen fetaler, heterologer Gehirngewebe. Fortschr. Medj 181-1186 (1972). SCHMID, F. und HAGGE, W.: Beinflussung unspezifischer Zellreaktionen durch die Tuberkulose-Allergie. Beitr. Klin. Tuberk. 109, 139-142 (1953). SCHMID, F., SCHUSTER, W. und KREBS, H.: Haben Frisch- und Trockenzellen eine organ-spezifische Wirkung? Med. Kiin. 54, 1202-1206,1959. SCHMID, F. und STEIN, J.: Zellforschung und Zelltherapie, Verlag H. Huber. Bern-Stuttgart 1963. E. SCHMID, F. und STEIN, I.: Cell Research and Cellular Therapy; Ott Publishers Thoune, Switzerland 1967. SCHMID, R.G.: Cytochemischer Vergleich fetaler und maternaler Gewebe. Cytobiol. Rev. 2, 2-10 (1978). SCHMID, R.G.: Stoffwechselsterungen. Cytobiol. Rev. 3, 151-154(1979) SCHMID, F.: Diagnostisch-therapeutische Probleme in der Betreuung cerebraler Anfallsleiden. Cytobiol. Rev. 5, 76-78 (1981). SCHMID, F und Stein J.: Die bei Zellulartherapie in Betracht kommenden immunologischen Reaktionen. Zellforschung und Zellulartherapie. Verlag Huber, Bern 1963, S. 199-206. E. SCHMID, F und Stein J.: The Immunological Reactions in Cellular Therapy. Cell Research and Cellular Therapy. Ott Publishers Thoune, Switzerland, 1967, p.206. SCHMID, F und Stein J.: Spezielle immunbiologische Probleme der Heterologen Gewebei m plantation. Zellforschung und Zellulartherapie. Verlag Huber,Bern 1963, S.207-218. E. SCHMID, F und Stein J.: Special Immunological Problems in the Implantation of Heterologous Tissues. Cell Research and Cellular Therapy. Ott Publishers Thoune, Switzerland, l967, p. 214. SCHMID, F und Stein J.: Die Implantation ematopoetischer Gewebe als Therapie der Strahlensch Aden. Zellforschung und Zellulartherapie. Verlag Huber, Bern 1963, S. 505. SCHMID, F und Stein J.: Grundlagen und Technik der Zelltherapie. Die Fleilkunst, 84. Jg. Heft 1 O, Okt.1971. SCHMID, F und Stein J.: Grundlagen und Entwicklung der Zelltherapie. Der Dt Apotheker, 23. Jg. Heft 6, Juni 1971. 170

SCHMID, F und Stein J.: Erfahrungen mit Zelltherapie. Ein -Kongregbericht Haut-Verlag 1971. - Technik der Zelltherapie. Ref.Blaft:Die Zelltherapie Nr.38, 1971. SCHMID, F und Stein J.: Gibt es etwas Neues in der Frischzellentherapie? Fragen aus der Praxis. Selecta Nr. 44, 1972. -Zeiltherapie. Annabelle Enzykioptidie .Nr. 38, Okt. 1972. SCHMID, F und Stein J.: Der Mensch und Arzt Paul Niehans. Bayrischer Rundfunk, Abt. Kirchenfunk, Titel: Besuch am Krankenbeft, Febr. 1973. E. SCHMID, F und Stein J.: Specific Effect of Implanted Endocrine Tissues. Cell Research and Cellular Therapy. Ott Publishers Thoune, Switzerland, 1967, p. 340. SCHNEIDER, H.: Immunreaktion, 1. Pathomechanismen. Cytobiol. Rev. 3, 139-148 (1979) II.Kiinik. Cytobiol. Rev. 4, 45-54 (1980). SCHNEIDER, H.: Die Oberlebenszeit lebenswichtiger Organe. Cytobiol. Rev. 2,19, (1978). SCHNEPPENHEIM, P. und GRONBERG, H.: Experimentelle Untersuchungen Ober die Wirkung von Nebennierenrinden-Trokkenzellen. Zschr. exper. Med., Berlin, 126, 319-333, 1955. SCHNITZER, A.: Untersuchungen mit fetalen Zellen beim chemisch induzierten Haut-carcinom des Kaninchesn. Vortr. ani. d. 13. Arb. Tagg. d. Gt. Ges. f.ZT. 15.9.1968. SCHNITZER, A.: Wirkungsmechanismen bei der Zelftherapie. Cytobiol. Rev. 2, He. ft 4, 33-37 (1978). SCHOLZ, K.: Zur Therapie des Morbus-Down-Syndroms im ersten und zweiten Le bensjah r. Ref. Blatt: Die Zel Itherapie N r. 40. Aug. 1973. SCHOLZ, K.: Erfahrungen mit der Zelltherapie beim Morbus-Down-Syndrom. Ref. Blatt: Die Zelltherapie Nr.41, 1974. SCHREIBER, A.: Einflasse von Injektionsimplantationen auf cerebrale Anfallsleiden. Ref. Blatt: Die Zelltherapie Nr. 41,1964. SCHREIER, K.: Die angeborenen Stoffwechselanomalien. ThiemeVerlag, Stuttgart 1979. SCHUBERT, E.v.: Zur Therapie des Mongolism us. Ber. v.d .6 Tagg. d. Arbeitsgem. f. Zellulartherapie, Bad Homburg, 9-12,1957, Medizinische, Stuttgart, 40, 1452-1454, 1957. SCHUCK, W.: Biologische Behandlung von Verbrennungen und Verbrohungenim. Kindesalter. Cytobiol. Rev. 6, 10-14 (1982). SCHULTEN, H.: Wissenschaft als Gewissen des Arztes, dargestellt am Beispiel der Zellulartherapie. Mts. Kurse f. d. arztl. Fortbildung 9 .378-385, 1957. 171

SCHULTZE, H.E.: Immunitatsiehre. Klin. Gegenw. IX, 423 (1960). SCHOTZE, E.: Wesen, Wert und Gefahren der Zellulartherapie. Arztl. Forschg. Monchen, X, 1/431-1/441, 1956. E. SCOTT, R.B. et al.: Hypoplastic Anaemia treated by Transfusion of Foetal Haernopoietic Cells. Brit. Med. J., 2, 1385-1 388,1961. Referiert: Selecta, IV/9,11, 1962. SEIDL, W.: Zellulartherapie bei neurologischen psychiatrischen Erkrankungen. Sammelmanuskriptd. Referate d. I. Fortbildungskurses f.Zellulartherapie in Osterr. 1, 30-32, 1957. SEIDL, W.: Die Pathobiologie der Schizophrenie und die Zelltherapie. Vortrag anl. d. l. intern. Symp. f. Zell- und Histotherapie. Bad Ischl. Die Zell- und Histotherapie, 1, 5/6, 21-26, 1959. SHELDON,, W.H. und CALDWELL, I.B.H.: Die mononucleare Zellphase in der Entzijndengsreaktion des Neugeborenen. Bull. Johns Hopk. Hosp.1 12, 258 (1963). E. SHELDON, H. and KIMBALL, F.B.: Studies on cartilage. 111. The occurence of collagen within vacuoles of the golgi apparatus. J.Cell Biol. 12, 599 (1962). SIEGMUND, H.D.: Reticulo-Endothel und aktives Mesenchym. Beitr. klin. Med. 1927 1. E. SISTRAND, F.S. and HANZON, V.: Membrane structures of cytoplasma and Mitochondria in exocrine cells of mouse pancreas as revealed by high resolution electron microsopy. Exp. Cell Res. 2, 393 (1954). SPITZNAGEL, J.K.: Die Gefahren der Zell ulartherapie. In Cell Biology 1976, s. ALTMANN und KATZ. SPRADO, K.: Dtsch.med.Wschr. 80,1262-1264, 1955. SPRADO, K.: Die Frischzellentherapie, der Prilgelknabe unter den umstrittenen Heilmethoden. Landarzt, Stuftgart. 34, 161-164, 1958. SPRADO, K.: Kombinationsbehandlung peripherer Durchblutungssterungen. Hess. Arzteblatt, 11, 1 0-12, 1958. Landarzt, Stuttgart, 33, 452-456, 1957. E. STEIN, J.: Immunological Reactions after Cellular Therapy. Cellular Therapie. Cairo. 1960. Symposium on

STEIN, J.: Die Objektivierung organspezifischer Wirkung zellularer Proparate. F.Schmid und J.Stein: Zellforschung und Zellulartherapie. Verlag Huber, Bern 1963, S.289. STEIN, J.: Vital it; M, VitaIitetsei n buIle und Revitalisierungstherapie. Die Heilkunst, Heft 11, Nov. 1972, 85J. STEIN, J.: Vita I itat-Chara kteris ieru ng eines biologischen Phanomens. Cytobiol. Rev. 3, 38-43 (1979). 172

STEIN, J.: Zell implantationen bei Diaabetes mellitus. Cytobiol. Rev. 6, 15-21 (1982). STEIN, J.: Die Zelltherapie endokriner Dysfunktionen. Cytobiol. Rev.6,134-137 (1982). STEINERT, P.M., IDLER, W.W. WANTZ, M.L.: Biochem. J. 1 87, 913-916 (1980). STEININGER, U. und THEILE, H.: Funktionsdiagnostik im Kindesalter. Thieme-Verlag Stuftgart 1974. STEPANTSCHITZ, G. und SCHREINER, B.: Erfahrungen mit der Siccacell-Therapie bei Gefegerkrankungen. Therap. Umschau 10, 1956. STEPANTSCHITZ, G. und SCHREINER, B.: Erfahrungen mit der Schildd rosenim plantation bei Gelenkerkrankungen. Wien.Klin. Wschr. 981,1952, Ref. Blaft Die Zelltherapie 6, 10-11, 1955. STICKL, H. und SCHMID, F.: Improbleme Problem-Impfungen. Dtsch. Arzteveriag, Kbln, 1975. E. STOBB, R., THOMAS, E.D., BUCKNER, D. et al: Marrow transplantation in untransfused patients with severe aplastic anemia. Blood 50: Suppi. 1, 316 (1977). STOWER, P.: Untersuchungen Ober die Einwirkung von NiehansTrockenzellen auf regenerierendes Leber-Gewebe. lnaugurai Dissertation. Justus- Liebig- Hochschule, Giepien, Pharmakologisches Institut der Akademie for medizinische Forschung und Fortbildung 1956. STOHLINGER, H.: Erfahrungsbericht Ober 30 Jahre Zelltherapie. Cytobiol. Rev. 5, 171-173 (1981). E. STUBBLEFIELD, E. and BRINKLEY, B.R.: Architecture and function of the mammalian centriole. In Warren, K. B. ed.: Formation and fate of cell organeiles. Symp. internat. Soc. Cell Biol. 6, 175 (1967), Acad. Press, New York. STURM, A.: Einflug von Thyreoidea-Siccacellen auf den Jodstoffwechsel der Schilddrase. Medizinische, Stuttgart 47. 1634-1637, 1955. SULMAN, F.G.: Objektivierung des Erfolges der Zelltherapie durch Neurohormon-Analyse vor und nach der Behandlung. Die Zelitherapie 43, 3-11 (1976). SULMAN, F.G.: Neue Methoden zur Behandlung der Migrane. 108-116 (1979). Cytobiol. Rev. 3,

E. SUZUKI, K. et. al: Myelin and Multiple Sclerosis. Arch. Neurol. 28, 293-297 (1973).

173

- T E. TEIR, H. and RAVENTI, K.: Mitotic Activity and Growth Factors in the Liver of the white rat. Exper. Cell. Res. 5, 500-507, 1953. TIBURTIUS, H. und EHLING, U.: Ein Beitrag zur experimentellen Profung der Zellulartherapie bei einer erblichen Katarakt des Kaninchens. KIin. Mb. F Qr Augenheilkunde. Stuftgart 134, 687-692, 1959. TIBURTIUS, H. und KROKOWSKI, E.: Ober Versuche,die Entstehung der Rentgenkatarakt des Kaninchens auf zellulartherapeutischem Wege zu beeinflussen. Graefes Arch. f. Ophth., 163, 572-546, 1961. E. TISSIERES, A.: Ribosome Research: Historical Background. In Nomura, Tissieres and Lengyel: Ribosomes. Cold Spring Harbor Laboratory 1974.. E. TODARO, G.J. and HUEBNER, R.J.: The viral oncogene hypothesis. Proc. nat. Acad. Sci. (Wash.) 69, 1009 (1972). TOURAINE, J.L., MALIK, M.C., PERROT, H., MAIRE, I., REVILLARD, J.P., GROSSHANS, E. and TRAEGER, J.: Maladie de Fabry: deux malades ameliores par la greffe de cellules de foie foetal. Nouv. Presse Med. 8, 1499-1503 (1979). TRINCHER, K.: Das Krebsproblem in struktur-thermodynamischer Sicht. Cytobiol. Rev. 5, 1 Ir 4-121 (1981). E. TROTSKY, J.: Side-effects and contra-indications of <<Siccacel>> Preparations. Cytobiologische Revue Nr. 2. 1985 1

- U UHLENBRUCK, P.: Die Stoffwechseltherapie des Herzens. Manch. med. Wschr., 102, 859-864, 1960. E. UHLENBRUCK, P.: Introduction. In F.Schmid and J.Stein: Cell Research and Cellular Therapy. Ott Publishers Thoune, Switzerland 1967, p. 19. ULLRICH, K.: Diabetes insipidus beim Hund. Deutsches Tiertirzteblaft, 6/5, 78, 1958. UHRICH, K.: Bektimpfung des Alterns mit Injektionen von Aufschwernmungen tierischer Embryonen. Arztl. Praxis. Manchen, XI/43, 1529-1532, 1959.

- V E. VALLS CONFORTO, A.: The Dependency of Immunological Reactions on the Blood Content of Implants. In F.Schmid and J.Stein: Cell Research and Cellular Therapy. Ott Publishers Thoune, Switzerland, 1967, p.239. 174

E. VAN HOLDE, K.D. and HILL, W.E.: General Physical Properties of Ribosomes. In: NOMURA, TISSIERES and LENGYEL; Ribosomes. Cold Spring Harbor Laboratory 1974, S.53-92. VELLEY, G.C.: Effects des injections de suspensions cellulaires et endocellulaires sur les organes grefts dans la chambre antdrieure de I'oeil. Bericht v.d. 5. Tagg. d. Forschungskreises f. ZT, 52-54,1958. VIDAL SAPRIZA, C. und GAYOSO, M.: Resultado de la implantacion de placenta en las arteriopatias obstructivas de los miembros interiores. Biol. Soc. cir Uruguay, XXVII/6, 1956. VORSTER, R.: Zur Siccacell-Behandlung Hippokrates, Stuttgart, 29, 565f., 1958. von Amenorrhoe und Sterilitet.

VORLANDER, K.O.: Gefahren der Zellulartherapie. Fortschr. d. Med. 76, 239-241, 1958. VORLANDER, K.O., FITTING, W. und GIERLICH, G.: Der Einflub heterologer Gewebszellen (Nierentrockenzellen nach Niehans) auf die Masugi-Nephritis der Ratte. Klin. Wschr., 32,1065-1073, 1954. VOYNOW, P. and KURLAND, C.G.: Stoichiometry of the 30 S ribosomal proteins of Escherichia coli. Biochemistry 10, 517, (1971).

- W WACKER, A.: Interferon-Induktion durch xenogenes Gewebe (Resistocell) Cytobiol. Rev. 6, 182-183 (1982). E. WAKSMAN, B.H., ARNASON,'B.G. and JANKOVIC, B.D.: Role of the thymus in immune reactions in rats. III.Changes in the lympoid organs of thymectornized rats. J. exp. Med. 1 16,187 (1962). E. WALDMANN, T.A., STROBER, W. and BLAESE, R.M.: Immundeficiency disease and malignancy. Ann. intern. Med. 77, 605 (1972). WALLNEFER, E.: Das Verhalten der Spontanaktivitat und des Kollagens von Ratten nach s.c. Injektionen von Hertzmuskelzellkernen oder Herzmitochondrien. Inaugural-Diss. TierdrztI. Hochschule Wien, 1973. WARNATZ, H.: Immunsystem. ln: Siegenthaler, Klinische Pathophysiologie. G. Thieme-Verlag, Stuttgart 1979. E. WARNER, N.L., SZENBERG, A.: The Thymus in Immunbiology. Eds: R. A. Good, A. E. Gabrielson, Harper & Row, New York 1964.

175

E. WEISS, P. and TAYLOR, A.C.: Reconstitution of complete organs from single-cell suspensions of chick embryos in advanced stages of differentiation. Proceedings of the National Academy of Sciences, Sciences, 46, 1177-1185, 1960. WESTPHAL, 0.: Immunchemie. Springer, Berlin/Heidelberg/New York, 1965. WIETEK, H.F. und TAUPITZ, E,: Der EinfluB Iyophilisierter Placenta auf die experimentelle Arteriosklerose von Ratten. Arzneimift.-Forsch., Aulendorf, 7, 479-485, 1957. WIETEK, H.F. und TAUPITZ, E,: Der EinfluB von Siccacell-Placenta auf die experimentelle Arteriosklerose von Ratten. Bericht v. d. 4. Tagg. d. Forschungskreises f. Zellulartherapie 26-30, 1957. WILHELM, J.: Das Verhalten von Hydroxyprolin, Succinodehydrogenase und Lipofuscin in verschiedenen Organen der Rafte nach s.c.Injektion von Herzmuskelzellkernen und Herzmitochondrien. Inaugural-Diss. Tierdrztl. Hochschule Wien, 1973. WITTE, S.: Klinische Erfahrungen mit der Knochenmarktransfusion. Dtsch. med. Wschr. 86, 1334-1337, 1961. WITTE, S.: Die Behandlung der zytostatisch bedingten htimatologischen Nebenwirkungen durch Knochenmarktransfusion. Mijnch. med. Wschr. 102, 1251-1253, 1960. WOLF-JURGENSEN, P.: The basophilic leukocyte. Series haemat. l. Nr A, (1968).

WOLF, N.: Zellulartherapie bei hirnatrophischen Prozessen des mittleren und reife Lebensalters. Psychiatria et Neurologica, Basel. 152. 230-245, 1966. Meglichkeiten und Erfolge der Zelltherapie bei hirnatrophischen Prozessen. Fortschr. Med. 87, H. 1 (1969). WOLF, N.: Zelltherapie bei cerebralen Krankheitsprozessen. Die Heiikunst, 84. Jg., Nr. 10. Oktober 1971. WOLF, N.: Klinische Ergebnisse der Zelltherapie bei hirnatrophischen Prozessen des mittleren und reifen Lebensalters. Akftuelle Gerontol. 6, 635-639 (1976). WOLF, N.: Klinische Ergebnisse der Zelltherapie bei hirnatrophischen Prozessen des mittleren und reiferen Lebensalters. Cytobiol. Rev. 1, 21-23 (1977). WOLF, N.: (1978). Der Begriff Vitalitat aus psychiatrischer Sicht. Cytobiol. Rev. 2, 13-16

WOLF, N.: Bestdtigung und Reprocluzierbarkeit therapeutischer Ergebnisse. Cytobiol. Rev. 3, 18-20 (1979). WOLF, N.: Behandlungsergebnisse der Zelltherapie bei Patienten mit fortgeschrittenen cerebralen Abbauerscheinungen. Cytobiol. Rev. 4, 128-132 (1980). 176

WOLF,N. und HENNING, W.: Heterologe Injektionsimplantationen bei hirnatrophischen Prozessen des mittleren und reifen Lebensalters. Verlaufsbeobachtungen aus psychologischer Sicht. Ref. Blatt Die Zelltherapie Nr. 36, 1969. WORTMANN, F.: Serologische Untersuchungen bei einem Fall von Serumkrankheit nach Frischzel 1-1 m plantation. Dermatologica. Baselj 17, 428-432, 1958. WRBA, H.: Die Wirkung von Organextrakten und -serum auf den Stoffwechsel von Organkulturne. Vortrag anI AXeme Congres International de Biologie Cellulaire. Patho log ie-Biolog ie. 2. 581-583. 1961. WRBA, H.: Wachstumsferdernde Stoffe und Hemmfaktoren in Warm blatlergeweben (unidentifizierte humorale Regulationsstoffe). Naturwissenschaften. 49, 97-101, 1962. WRBA, H. und KALB, H.W.: Vergleich des Phosphatumsatzes embryonalter und adulter organe in vitro. Naturwissenschaften, 46, 405, 1959. WONDISCH, .F.: Behandlung der Panmyelopathie im Kinclessalter Knochemark- transplantationen. Klin. Ricliatrie 189, 50-59 (1977). durch

- Y E. YOKE, M.S. and SAINTE-MARIE, G.: Granulocytopoiesis in the Rat Thymus. Brit. J. Haemat. 1 1, 613 (1965). E. YOUNG, Gordon: The extraordinary story of Dr. Paul Niehans. Doctors without Drugs. Frederick Muller Lim. London 1962, Conquest of Age. Rinehart u. Comp. New York -Toronto 1959.

- Z ZABAKAS, G.: Vergleichende Untersuchungen Ober die Verteilung der spezifischen AktivitAt in Organen der Ratte nach peroraler Verabreichung von L.-Histidin-2, 5-Tritium bzw. L.-Lysin-4, 5-Tritium. Inaugural-Diss.Tierarztl.Hochschule Wien, 1968. ZEITGESCHICHTE; Down-Syndrom; Stellungnahme der Deutschen Geselischaft for Zelltherapie zu den Fragen zur Anherung des Petitionsausschusses des Deutschen Bundestages am 7.12.1977. Cytobiol.Rev.2,35-39 (1977). E. ZELANDER, T.: Ultrastructure of articular cartilage.Z.Zellforschg 49, 720 (1959). ZELLER, W.: Entwicklungsdiagnostik und Entwicklungstherapie. Ber. v. d .4. Tagg. d. Forschungskreisds Zellulartherapie, 54-57, 1957. E. ZUCKER-FRANKLIN, D.: The Properties of Eosinophils. In: BACH, M.K.: Immediate Hypersensitivity. Marcel Dekker Inc., New York and Basel 1978.

177

License Agreement on Wikipedia content
0. PREAMBLE The purpose of this License is to make a manual, textbook, or other functional and useful document "free" in the sense of freedom: to assure everyone the effective freedom to copy and redistribute it, with or without modifying it, either commercially or noncommercially. Secondarily, this License preserves for the author and publisher a way to get credit for their work, while not being considered responsible for modifications made by others. This License is a kind of "copyleft", which means that derivative works of the document must themselves be free in the same sense. It complements the GNU General Public License, which is a copyleft license designed for free software. We have designed this License in order to use it for manuals for free software, because free software needs free documentation: a free program should come with manuals providing the same freedoms that the software does. But this License is not limited to software manuals; it can be used for any textual work, regardless of subject matter or whether it is published as a printed book. We recommend this License principally for works whose purpose is instruction or reference. 1. APPLICABILITY AND DEFINITIONS This License applies to any manual or other work, in any medium, that contains a notice placed by the copyright holder saying it can be distributed under the terms of this License. Such a notice grants a world-wide, royalty-free license, unlimited in duration, to use that work under the conditions stated herein. The "Document", below, refers to any such manual or work. Any member of the public is a licensee, and is addressed as "you". You accept the license if you copy, modify or distribute the work in a way requiring permission under copyright law. A "Modified Version" of the Document means any work containing the Document or a portion of it, either copied verbatim, or with modifications and/or translated into another language. A "Secondary Section" is a named appendix or a front-matter section of the Document that deals exclusively with the relationship of the publishers or authors of the Document to the Document's overall subject (or to related matters) and contains nothing that could fall directly within that overall subject. (Thus, if the Document is in part a textbook of mathematics, a Secondary Section may not explain any mathematics.) The relationship could be a matter of historical connection with the subject or with related matters, or of legal, commercial, philosophical, ethical or political position regarding them. The "Invariant Sections" are certain Secondary Sections whose titles are designated, as being those of Invariant Sections, in the notice that says that the Document is released under this License. If a section does not fit the above definition of Secondary then it is not allowed to be designated as Invariant. The Document may contain zero Invariant Sections. If the Document does not identify any Invariant Sections then there are none. The "Cover Texts" are certain short passages of text that are listed, as Front-Cover Texts or Back-Cover Texts, in the notice that says that the Document is released under this License. A Front-Cover Text may be at most 5 words, and a Back-Cover Text may be at most 25 words. A "Transparent" copy of the Document means a machine-readable copy, represented in a format whose specification is available to the general public, that is suitable for revising the document straightforwardly with generic text editors or (for images composed of pixels) generic paint programs or (for drawings) some widely available drawing editor, and that is suitable for input to text formatters or for automatic translation to a variety of formats suitable for input to text formatters. A copy made in an otherwise Transparent file format whose markup, or absence of markup, has been arranged to thwart or discourage subsequent modification by readers is not Transparent. An image format is not Transparent if used for any substantial amount of text. A copy that is not "Transparent" is called "Opaque". Examples of suitable formats for Transparent copies include plain ASCII without markup, Texinfo input format, LaTeX input format, SGML or XML using a publicly available DTD, and standardconforming simple HTML, PostScript or PDF designed for human modification. Examples of transparent image formats include PNG, XCF and JPG. Opaque formats include proprietary formats that can be read and edited only by proprietary word processors, SGML or XML for which the DTD and/or processing tools are not generally available, and the machine-generated HTML, PostScript or PDF produced by some word processors for output purposes only. The "Title Page" means, for a printed book, the title page itself, plus such following pages as are needed to hold, legibly, the material this License requires to appear in the title page. For works in formats which do not have any title page as such, "Title Page" means the text near the most prominent appearance of the work's title, preceding the beginning of the body of the text. A section "Entitled XYZ" means a named subunit of the Document whose title either is precisely XYZ or contains XYZ in parentheses following text that translates XYZ in another language. (Here XYZ stands for a specific section name mentioned below, such as "Acknowledgements", "Dedications", "Endorsements", or "History".) To "Preserve the Title" of such a section when you modify the Document means that it remains a section "Entitled XYZ" according to this definition. The Document may include Warranty Disclaimers next to the notice which states that this License applies to the Document. These Warranty Disclaimers are considered to be included by reference in this License, but only as regards disclaiming warranties: any other implication that these Warranty Disclaimers may have is void and has no effect on the meaning of this License. 2. VERBATIM COPYING You may copy and distribute the Document in any medium, either commercially or noncommercially, provided that this License, the copyright notices, and the license notice saying this License applies to the Document are reproduced in all copies, and that you add no other conditions whatsoever to those of this License. You may not use technical measures to obstruct or control the reading or further copying of the copies you make or distribute. However, you may accept compensation in exchange for copies. If you distribute a large enough number of copies you must also follow the conditions in section 3. You may also lend copies, under the same conditions stated above, and you may publicly display copies. 3. COPYING IN QUANTITY If you publish printed copies (or copies in media that commonly have printed covers) of the Document, numbering more than 100, and the Document's license notice requires Cover Texts, you must enclose the copies in covers that carry, clearly and legibly, all these Cover Texts: Front-Cover Texts on the front cover, and Back-Cover Texts on the back cover. Both covers must also clearly and legibly identify you as the publisher of these copies. The front cover must present the full title with all words of the title equally prominent and visible. You may add other material on the covers in addition. Copying with changes limited to the covers, as long as they preserve the title of the Document and satisfy these conditions, can be treated as verbatim copying in other respects. If the required texts for either cover are too voluminous to fit legibly, you should put the first ones listed (as many as fit reasonably) on the actual cover, and continue the rest onto adjacent pages.

178

If you publish or distribute Opaque copies of the Document numbering more than 100, you must either include a machine-readable Transparent copy along with each Opaque copy, or state in or with each Opaque copy a computer-network location from which the general network-using public has access to download using public-standard network protocols a complete Transparent copy of the Document, free of added material. If you use the latter option, you must take reasonably prudent steps, when you begin distribution of Opaque copies in quantity, to ensure that this Transparent copy will remain thus accessible at the stated location until at least one year after the last time you distribute an Opaque copy (directly or through your agents or retailers) of that edition to the public. It is requested, but not required, that you contact the authors of the Document well before redistributing any large number of copies, to give them a chance to provide you with an updated version of the Document. 4. MODIFICATIONS You may copy and distribute a Modified Version of the Document under the conditions of sections 2 and 3 above, provided that you release the Modified Version under precisely this License, with the Modified Version filling the role of the Document, thus licensing distribution and modification of the Modified Version to whoever possesses a copy of it. In addition, you must do these things in the Modified Version:

• • • • • • • • • • • • • • •

A. Use in the Title Page (and on the covers, if any) a title distinct from that of the Document, and from those of previous versions (which should, if there were any, be listed in the History section of the Document). You may use the same title as a previous version if the original publisher of that version gives permission. B. List on the Title Page, as authors, one or more persons or entities responsible for authorship of the modifications in the Modified Version, together with at least five of the principal authors of the Document (all of its principal authors, if it has fewer than five), unless they release you from this requirement. C. State on the Title page the name of the publisher of the Modified Version, as the publisher. D. Preserve all the copyright notices of the Document. E. Add an appropriate copyright notice for your modifications adjacent to the other copyright notices. F. Include, immediately after the copyright notices, a license notice giving the public permission to use the Modified Version under the terms of this License, in the form shown in the Addendum below. G. Preserve in that license notice the full lists of Invariant Sections and required Cover Texts given in the Document's license notice. H. Include an unaltered copy of this License. I. Preserve the section Entitled "History", Preserve its Title, and add to it an item stating at least the title, year, new authors, and publisher of the Modified Version as given on the Title Page. If there is no section Entitled "History" in the Document, create one stating the title, year, authors, and publisher of the Document as given on its Title Page, then add an item describing the Modified Version as stated in the previous sentence. J. Preserve the network location, if any, given in the Document for public access to a Transparent copy of the Document, and likewise the network locations given in the Document for previous versions it was based on. These may be placed in the "History" section. You may omit a network location for a work that was published at least four years before the Document itself, or if the original publisher of the version it refers to gives permission. K. For any section Entitled "Acknowledgements" or "Dedications", Preserve the Title of the section, and preserve in the section all the substance and tone of each of the contributor acknowledgements and/or dedications given therein. L. Preserve all the Invariant Sections of the Document, unaltered in their text and in their titles. Section numbers or the equivalent are not considered part of the section titles. M. Delete any section Entitled "Endorsements". Such a section may not be included in the Modified Version. N. Do not retitle any existing section to be Entitled "Endorsements" or to conflict in title with any Invariant Section. O. Preserve any Warranty Disclaimers.

If the Modified Version includes new front-matter sections or appendices that qualify as Secondary Sections and contain no material copied from the Document, you may at your option designate some or all of these sections as invariant. To do this, add their titles to the list of Invariant Sections in the Modified Version's license notice. These titles must be distinct from any other section titles. You may add a section Entitled "Endorsements", provided it contains nothing but endorsements of your Modified Version by various parties--for example, statements of peer review or that the text has been approved by an organization as the authoritative definition of a standard. You may add a passage of up to five words as a Front-Cover Text, and a passage of up to 25 words as a Back-Cover Text, to the end of the list of Cover Texts in the Modified Version. Only one passage of Front-Cover Text and one of Back-Cover Text may be added by (or through arrangements made by) any one entity. If the Document already includes a cover text for the same cover, previously added by you or by arrangement made by the same entity you are acting on behalf of, you may not add another; but you may replace the old one, on explicit permission from the previous publisher that added the old one. The author(s) and publisher(s) of the Document do not by this License give permission to use their names for publicity for or to assert or imply endorsement of any Modified Version. 5. COMBINING DOCUMENTS You may combine the Document with other documents released under this License, under the terms defined in section 4 above for modified versions, provided that you include in the combination all of the Invariant Sections of all of the original documents, unmodified, and list them all as Invariant Sections of your combined work in its license notice, and that you preserve all their Warranty Disclaimers. The combined work need only contain one copy of this License, and multiple identical Invariant Sections may be replaced with a single copy. If there are multiple Invariant Sections with the same name but different contents, make the title of each such section unique by adding at the end of it, in parentheses, the name of the original author or publisher of that section if known, or else a unique number. Make the same adjustment to the section titles in the list of Invariant Sections in the license notice of the combined work. In the combination, you must combine any sections Entitled "History" in the various original documents, forming one section Entitled "History"; likewise combine any sections Entitled "Acknowledgements", and any sections Entitled "Dedications". You must delete all sections Entitled "Endorsements." 6. COLLECTIONS OF DOCUMENTS You may make a collection consisting of the Document and other documents released under this License, and replace the individual copies of this License in the various documents with a single copy that is included in the collection, provided that you follow the rules of this License for verbatim copying of each of the documents in all other respects. You may extract a single document from such a collection, and distribute it individually under this License, provided you insert a copy of this License into the extracted document, and follow this License in all other respects regarding verbatim copying of that document.

179

7. AGGREGATION WITH INDEPENDENT WORKS A compilation of the Document or its derivatives with other separate and independent documents or works, in or on a volume of a storage or distribution medium, is called an "aggregate" if the copyright resulting from the compilation is not used to limit the legal rights of the compilation's users beyond what the individual works permit. When the Document is included in an aggregate, this License does not apply to the other works in the aggregate which are not themselves derivative works of the Document. If the Cover Text requirement of section 3 is applicable to these copies of the Document, then if the Document is less than one half of the entire aggregate, the Document's Cover Texts may be placed on covers that bracket the Document within the aggregate, or the electronic equivalent of covers if the Document is in electronic form. Otherwise they must appear on printed covers that bracket the whole aggregate. 8. TRANSLATION Translation is considered a kind of modification, so you may distribute translations of the Document under the terms of section 4. Replacing Invariant Sections with translations requires special permission from their copyright holders, but you may include translations of some or all Invariant Sections in addition to the original versions of these Invariant Sections. You may include a translation of this License, and all the license notices in the Document, and any Warranty Disclaimers, provided that you also include the original English version of this License and the original versions of those notices and disclaimers. In case of a disagreement between the translation and the original version of this License or a notice or disclaimer, the original version will prevail. If a section in the Document is Entitled "Acknowledgements", "Dedications", or "History", the requirement (section 4) to Preserve its Title (section 1) will typically require changing the actual title. 9. TERMINATION You may not copy, modify, sublicense, or distribute the Document except as expressly provided for under this License. Any other attempt to copy, modify, sublicense or distribute the Document is void, and will automatically terminate your rights under this License. However, parties who have received copies, or rights, from you under this License will not have their licenses terminated so long as such parties remain in full compliance. 10. FUTURE REVISIONS OF THIS LICENSE The Free Software Foundation may publish new, revised versions of the GNU Free Documentation License from time to time. Such new versions will be similar in spirit to the present version, but may differ in detail to address new problems or concerns. See http://www.gnu.org/copyleft/. Each version of the License is given a distinguishing version number. If the Document specifies that a particular numbered version of this License "or any later version" applies to it, you have the option of following the terms and conditions either of that specified version or of any later version that has been published (not as a draft) by the Free Software Foundation. If the Document does not specify a version number of this License, you may choose any version ever published (not as a draft) by the Free Software Foundation.

180